introduct
typei
interferon
ifn
use
treat
sever
type
cancer
includ
follicular
lymphoma
hairi
cell
leukemia
chronic
myeloid
leukemia
treatment
typei
ifn
howev
associ
signific
toxic
side
effect
due
ubiquit
express
typei
ifn
receptor
typeiii
ifn
elicit
similar
cellular
respons
typei
ifn
restrict
express
typeiii
receptor
may
limit
potenti
side
effect
treatment
typeiii
ifn
number
studi
explor
use
typeiii
ifn
specif
anticanc
agent
newli
discov
typeiii
ifn
genet
regul
produc
subset
individu
previous
show
inhibit
prolifer
hepatoma
cell
line
howev
anticanc
potenti
explor
comparison
typeiii
ifn
method
develop
stabl
human
hepatoma
bcell
lymphoma
raji
cell
line
engin
express
either
upon
induct
doxycyclin
compar
antiprolif
activ
measur
brdu
incorpor
induct
ifnk
express
also
compar
cell
viabil
apoptosi
chang
cell
cycl
express
cell
line
rnaseq
pathway
analysi
use
explor
antiprolif
effect
induc
show
higher
antiprolif
activ
compar
raji
cell
line
explain
inhibit
cell
cycl
express
cell
line
show
increas
apoptot
cell
death
compar
express
cell
line
also
show
antiprolif
activ
may
result
inhibit
mapk
pathway
conclus
studi
demonstr
potent
antiprolif
activ
hepatoma
b
cell
lymphoma
cell
line
anticanc
potenti
explor
introduct
potent
proinflammatori
cytokin
implic
acut
chronic
viral
infect
persist
hepat
inflamm
hallmark
hepat
c
viru
hcv
infect
wherein
serv
platform
progress
liver
injuri
onset
liver
cancer
examin
role
role
hcvinduc
hepat
inflamm
first
assess
transcript
profil
chronic
hcv
patient
liver
nextgen
sequenc
rnaseq
stage
inflamm
fibrosi
score
microenviron
role
mammari
tumor
initi
progress
result
rnaseq
bioinformat
analys
reveal
product
associ
liver
diseas
link
express
rang
inflammatori
gene
known
support
tissu
remodel
leukocyt
home
activ
proinflammatori
cytokin
product
amplif
found
hepat
macrophag
known
kupffer
cell
major
sourc
liver
typic
product
tightli
regul
pathway
requir
prime
step
trigger
transcript
activ
signal
promot
matur
process
releas
found
hcv
virion
effici
phagocytos
kupffer
cell
human
macrophag
cell
line
drive
signal
inflammasom
process
trigger
express
matur
protein
releas
respect
identifi
specif
hcvvirion
compon
hcv
core
protein
driver
inflammasom
activ
hcv
core
protein
modul
mani
cellular
event
reactiv
oxygen
speci
product
calcium
signal
shown
activ
inflammasom
pathway
found
patientderiv
core
protein
isol
patient
hcv
infect
stimul
inflammasom
activ
trigger
releas
conclus
studi
reveal
hcv
virionassoci
core
protein
trigger
viralinduc
inflammasom
activ
within
hepat
macrophag
observ
defin
hcvkupffer
cell
interact
central
node
direct
hepat
inflamm
underli
hcv
pathogenesi
introduct
chemokin
receptor
ligand
express
sever
tumour
cancer
cell
express
correl
migrat
metastasi
cancertumour
cell
express
vari
immun
condit
cell
b
cell
natur
killer
cell
basophil
dendrit
cell
furthermor
express
cancer
tissu
upregul
correl
advanc
cancertumour
metastasi
relaps
regul
genom
level
sever
transcript
factor
upon
bind
promot
gene
lead
either
upregul
downregul
gene
one
sever
protein
pathway
pathway
pathway
play
crucial
role
cell
differenti
prolifer
thu
critic
role
cancerstumour
pathway
regul
cytokin
includ
amongst
sever
other
well
studi
cancer
immunotherapi
trial
current
immunotherapi
trial
also
take
place
man
howev
precis
mechan
action
cascad
protein
event
involv
complet
understood
studi
aim
investig
regul
jakstat
pathway
role
mediat
cancer
metastasi
prostat
cancer
method
preliminari
studi
regul
gene
use
quantit
real
time
pcr
quantit
pcr
concert
bioinformat
analysi
publicli
avail
databas
identifi
regul
target
gene
interestingli
preliminari
studi
cancer
databas
shown
activ
sever
hormon
growth
factor
result
bind
site
identifi
within
gene
map
promot
gene
coordin
ucsc
genom
browser
two
site
differenti
bind
complex
gene
regul
cell
public
databas
shown
upregul
solid
cancer
role
prostat
cancer
investig
conclus
play
import
role
cancer
metastasi
prostat
cancer
common
cancer
men
unfortun
tumour
cell
may
develop
resist
therapi
becom
metastat
becom
major
obstacl
limit
success
prostat
cancer
treatment
complic
crosstalk
genom
nongenom
transcript
factor
immun
cell
cytokinesgrowth
factor
consid
crucial
factor
contribut
metastasi
although
sever
mechan
propos
far
none
defin
rational
behind
phenomena
metastasi
studi
progress
delin
role
regul
pathway
regul
gene
thu
axi
refer
lim
sy
yuzhalin
ae
gordonweek
muschel
rj
bishop
jl
thaper
zoubeidi
acanc
basel
apr
introduct
despit
signific
research
effort
breast
cancer
still
common
malign
women
common
caus
cancer
death
worldwid
major
challeng
breast
cancer
treatment
diseas
heterogen
contribut
mani
factor
includ
intrins
cell
factor
microenviron
angiogenesi
tumorspecif
immun
respons
interferon
regulatori
factor
transcript
factor
control
inflammatori
immun
respons
analysi
human
breast
cancer
tissu
reveal
high
express
correl
increas
surviv
lower
incid
metastasi
wherea
lower
quartil
express
signific
marker
poor
prognosi
recurrencefre
surviv
data
support
tumor
suppressor
role
main
purpos
studi
gener
murin
model
spontan
mammari
tumorigenesi
order
determin
whether
loss
found
human
breast
tumor
tissu
contribut
diseas
onset
andor
progress
method
knockout
ko
mice
backcross
balbc
mice
obtain
gener
balbc
mice
retain
wildtyp
express
wildtyp
balbc
mice
suscept
spontan
mammari
tumorigenesi
low
incid
rate
effect
defici
normal
mammari
gland
develop
mammari
tumorigenesi
examin
result
mammari
gland
harvest
oneyearold
femal
virgin
ko
mice
n
found
increas
incid
mammari
carcinoma
situ
compar
wildtyp
litterm
n
interest
number
tumor
bear
mice
significantli
higher
retir
ko
femal
breeder
n
howev
abnorm
detect
oneyearold
male
ko
virgin
breeder
n
cellular
molecular
analysi
femal
ko
wildtyp
litterm
reveal
defici
enhanc
mammari
epitheli
cell
prolifer
indic
increas
number
express
cell
result
abnorm
hyperbranch
may
contribut
mammari
tumorigenesi
ko
breeder
also
show
impair
mammari
gland
involut
wean
shown
facilit
mammari
tumor
format
human
conclus
taken
togeth
find
demonstr
genderspecif
tumor
suppressor
breast
cancer
ongo
studi
investig
intrins
extrins
result
could
show
cleavag
site
use
metalloproteas
vitro
found
vivo
mutat
singl
aminoacid
residu
within
stalk
region
suffici
complet
abrog
proteolysi
found
nand
oglycosyl
dispens
signal
variant
complet
devoid
glycan
still
transport
cell
surfac
biolog
activ
contrast
proteolysi
orchestr
nand
oglycosyl
sequon
near
cleavag
site
nglycan
exosit
domain
proteolysi
glycandefici
mutant
significantli
impair
conclus
identifi
first
time
solubl
form
human
serum
gener
proteas
map
occup
nand
oglycosyl
site
allow
us
describ
glycosyl
dispens
traffick
stabil
signal
import
regulatori
mechan
term
proteolysi
introduct
breast
cancer
heterogen
diseas
whose
progress
atyp
ductal
hyperplasia
ductal
carcinoma
situ
dci
invas
ductal
carcinoma
idc
regul
aberr
express
multipl
mediat
produc
mammari
tumor
adjac
reactiv
stroma
previous
found
express
transcript
factor
interferon
regulatori
factor
downregul
differ
stage
human
dci
idc
loss
express
correl
metastasi
critic
mediat
host
immun
respons
pathogen
cellular
respons
dna
damag
recent
shown
play
role
macrophag
polar
high
level
express
proinflammatori
macrophag
low
level
antiinflammatori
also
found
restor
express
metastat
human
mammari
epitheli
cell
line
led
recruit
b
cell
tumor
find
support
role
regul
tumor
immun
order
directli
address
vivo
function
mammari
tumor
versu
function
immun
system
gener
syngen
model
mammari
tumorigenesi
specif
murin
mammari
tumor
cell
gener
inject
mammari
fat
pad
balbc
litterm
mice
kinet
tumor
format
immun
respons
metastasi
monitor
method
vitro
cell
prolifer
measur
mtt
assay
vivo
flow
cytometri
analysi
express
vitro
cell
migrat
invas
measur
transwel
assay
use
noncoat
matrigelco
well
respect
primari
tumor
growth
metastasi
measur
vivo
bioluminesc
imag
metastasi
confirm
count
metastat
nodul
lung
vitro
experi
show
murin
reexpress
cell
affect
cell
prolifer
reduc
cell
migrat
around
invas
vivo
experi
examin
tumor
immun
show
signific
increas
primari
tumor
growth
metastasi
balbc
mice
bioluminesc
intens
increas
metastat
nodul
compar
wildtyp
litterm
conclus
data
show
restor
murin
express
murin
mammari
tumor
cell
inhibit
cell
migrat
invas
support
similar
tumor
suppressor
function
murin
seen
human
similarli
express
whole
anim
import
regul
establish
primari
tumor
well
metastasi
secondari
site
togeth
data
indic
act
tumor
suppressor
breast
cancer
intrins
control
tumor
cell
migrationinvas
extrins
regul
tumor
immun
microenviron
thu
determin
pathway
mechan
influenc
tumor
progress
tumor
immun
lead
discoveri
new
biomark
prognosi
molecular
target
treatment
breast
cancer
nervou
system
neoplasm
although
advanc
surgeri
radiat
chemotherapi
improv
overal
surviv
lifelong
sequela
treatment
repres
major
health
care
burden
patient
parent
societi
recent
progress
molecular
subtyp
medulloblastoma
reveal
least
four
distinct
subset
tumour
wnt
sonic
hedgehog
shh
group
group
dramat
differ
biolog
analysi
gene
express
data
reveal
elev
express
correl
significantli
wors
overal
surviv
medulloblastoma
patient
method
defin
role
develop
progress
shh
medulloblastoma
cross
two
independ
mous
model
medulloblastoma
mice
lack
granul
cell
neuron
cell
origin
medulloblastoma
identifi
depend
pathway
target
therapeut
screen
phosphoprotein
antibodi
array
compound
librari
result
condit
delet
specif
cerebellar
granul
cell
provid
signific
surviv
advantag
mous
model
shh
medulloblastoma
intriguingli
protect
almost
complet
restrict
male
phosphoprotein
array
compound
librari
converg
pathway
requir
prolifer
cell
cycl
may
prove
viabl
therapeut
option
treatment
medulloblastoma
conclus
elev
express
correl
poor
overal
surviv
medulloblastoma
patient
condit
cell
origin
two
independ
mous
model
shh
medulloblastoma
provid
signific
surviv
advantag
specif
male
moreov
identifi
compound
specif
kill
medulloblastoma
tissu
manner
introduct
signal
critic
neg
regul
immun
respons
colorect
cancer
crc
progress
littl
known
process
protein
express
aberrantli
tumor
microenviron
moreov
convent
rnai
screen
conduct
twodimension
monocultur
method
lack
physiolog
relev
limit
may
improv
recapitul
tumor
microenviron
threedimension
assay
system
contain
multipl
cell
type
found
vivo
therefor
hypothes
rnai
screen
gene
respons
neg
regul
immun
respons
would
yield
differ
result
tumor
microenviron
recapitul
versu
monolay
cultur
result
could
drastic
impact
process
target
identif
drug
discoveri
improv
reliabl
hit
select
method
ambion
silenc
select
human
kinas
sirna
librari
screen
corn
well
black
clear
round
bottom
ultralow
attach
spheroid
micropl
tumor
spheroid
compris
colorect
cancer
cell
line
atcc
densiti
cellsml
cocultur
cell
murin
fibroblast
atcc
ratio
respect
use
process
revers
transfect
greiner
bioon
well
black
clear
flat
bottom
micropl
use
rnai
highthroughput
screen
use
cell
line
similar
condit
lipofectamin
rnaimax
transfect
reagent
use
accord
manufactur
protocol
effici
deliveri
sirna
plasmid
express
cell
receptor
activ
tumor
spheroid
incub
h
recombin
jurkat
cell
h
posttransfect
jurkat
cell
express
firefli
luciferas
gene
control
nfat
respons
element
constitut
express
human
bp
bioscienc
promega
oneglo
luciferas
assay
system
use
measur
luciferas
activ
promega
celltiterglo
luminesc
cell
viabil
assay
use
measur
viabil
luminesc
quantifi
envis
multilabel
plate
reader
perkin
elmer
result
preliminari
result
robust
reproduc
assay
suggest
high
transfect
effici
sirna
plasmid
express
andor
tcr
activ
introduc
simultan
conclus
believ
high
throughput
screen
assay
system
one
first
kind
lend
discoveri
novel
target
involv
neg
regul
immun
system
cancer
express
immun
checkpoint
blockad
protein
introduct
tumortarget
therapi
effici
elimin
malign
cell
process
engag
innat
adapt
immun
system
desir
prevent
cancer
recurr
pioneer
oncolyt
polioviru
therapi
pvsripo
select
target
elimin
malign
cell
pvsripo
recombin
polio
rhinoviru
chimera
engin
elimin
neuron
compet
devoid
neuropathogen
intracerebr
inocul
nonhuman
primat
human
pvsripo
cancer
tropism
due
widespread
ectop
express
polioviru
receptor
solid
cancer
pvsripo
highli
cytotox
malign
cell
effect
despit
preexist
neutral
antibodi
viral
cell
kill
proce
presenc
activ
innat
antivir
respons
firstinhuman
studi
pvsripo
duke
univers
shown
remark
promis
patient
recurr
glioblastoma
gbm
uniformli
lethal
diseas
pvsripo
tumor
cell
kill
associ
induct
dangerand
pathogenassoci
molecular
pattern
damp
pamp
via
antivir
type
interferon
ifn
simultan
nonleth
infect
antigenpres
cell
apc
monocyt
dendrit
cell
dc
via
type
ifn
known
inhibit
tumor
prolifer
activ
innat
immun
cell
bridg
innat
adapt
immun
among
function
method
understand
immun
event
associ
polioviru
infect
apc
examin
effect
pvsripo
treatment
human
macrophag
cell
line
primari
human
monocytederiv
dc
pvsripotr
dc
evalu
express
maturationactiv
marker
compar
untreat
immatur
matur
dc
moreov
assess
pvsripo
vaccin
effect
vitro
human
immunotherapi
assay
human
dc
gener
donor
cell
incub
pvsripoinduc
tumor
cell
lysat
use
stimul
autolog
cell
vitro
follow
cytotox
lymphocyt
ctl
assay
addit
perform
vivo
studi
nude
mice
pvr
transgen
mice
util
four
differ
cancer
cell
line
result
pvsripo
infect
macrophag
induc
phosphoryl
tnfa
ifnb
releas
cocultur
dc
pvsripo
alon
pvsripoinduc
tumor
lysat
stimul
dc
activ
tnfa
product
human
dc
coincub
pvsripoinduc
tumor
cell
lysat
stimul
tumor
antigenspecif
cell
respons
vitro
human
immunotherapi
assay
tumorantigen
specif
cell
lyse
tumor
cell
target
antigenspecif
manner
pvsripo
treat
vivo
tumor
show
increas
innat
adapt
immun
cell
recruit
accompani
increas
mous
surviv
conclus
data
suggest
along
destruct
primari
tumor
oncolyt
polioviru
mediat
immun
event
importantli
demonstr
human
dc
coincub
pvsripoinduc
tumor
cell
lysat
stimul
tumor
antigenspecif
cell
respons
vitro
human
immunotherapi
assay
also
shown
oncolyt
polioviru
mediat
immun
event
xenograft
well
syngen
immunocompet
murin
model
brain
breast
prostat
cancer
introduct
suppressor
cytokin
signal
soc
famili
protein
critic
neg
feedback
inhibitor
cytokin
growth
factor
signal
help
restor
homeostasi
prevent
excess
patholog
respons
whilst
biolog
role
molecular
function
member
well
resolv
remain
poorli
characteris
shown
regul
egfr
overexpress
studi
may
contribut
egfrra
driven
cellular
transform
drosophila
homologu
also
known
regul
egfr
jak
signal
vivo
method
mous
model
breast
cancer
use
identifi
dissect
role
diseas
perform
bioinformat
analysi
gene
express
oncomin
kmplot
bcgenex
independ
analysi
tcga
breast
data
set
mass
spectrometri
use
stringent
identifi
candid
interact
protein
function
current
investig
human
mous
breast
cancer
cell
line
use
sirna
technolog
result
show
first
time
polyoma
middl
antigen
pymt
driven
mous
model
breast
cancer
mice
exhibit
acceler
tumour
onset
rel
wildtyp
mice
versu
respect
p
thu
provid
first
vivo
evid
mammalian
act
tumour
suppressor
analysi
express
databas
indic
regul
major
patient
invas
ductal
breast
carcinoma
tcga
dataset
top
underexpress
gene
p
express
level
posit
correl
patient
outcom
use
mass
spectrometri
identifi
number
known
novel
interact
protein
mani
includ
known
driver
human
breast
cancer
conclus
breast
cancer
remain
lead
caus
cancer
relat
death
women
whilst
signific
advanc
diseas
treatment
diagnosi
improv
patient
outcom
resist
therapi
metastasi
patient
respond
therapi
highlight
complex
heterogen
diseas
understand
signal
pathway
molecular
event
lead
oncogen
transform
mammari
gland
requir
discov
poorli
studi
protein
play
import
protect
role
pymt
mous
model
breast
cancer
number
type
interact
protein
identifi
mass
spectrometri
suggest
like
form
signal
scaffold
via
larg
unstructur
ntermin
region
dissect
signal
complex
form
mechan
regul
target
prevent
excess
signal
tumour
cell
current
subject
investig
mechan
underlin
hypothet
mutual
correl
autophagi
prolif
process
melanoma
cell
line
method
melanoma
cell
line
atcc
manassa
va
usa
grown
dmem
rpmi
respect
supplement
fb
lglutamin
penstrep
co
studi
cell
starv
low
serum
treatment
fb
h
rapamycin
treatment
differ
concentr
nm
cloroquin
nm
h
first
evalu
cell
viabil
mtt
subsequ
perk
kinas
modul
analyz
western
blot
andor
ip
assay
addit
confoc
fluoresc
microscopi
use
assess
express
melanoma
cell
undergo
h
starvat
h
cloroquin
treatment
result
cell
undergo
starvat
rapamycin
cloroquin
treatment
show
signific
decreas
viabil
compar
control
group
perk
western
blot
show
signific
modul
strong
erk
activ
cell
undergo
h
starvat
p
melanoma
cell
h
starvat
p
h
cloroquin
p
western
blot
analysi
nt
show
perk
modul
cell
treat
rapamycin
furthermor
adopt
posit
control
cell
treat
egf
show
signific
increas
perk
express
compar
control
group
p
timeindepend
manner
surprisingli
enough
observ
strong
express
cell
line
undergo
h
h
p
starvat
treatment
nm
rapamycin
p
cloroquin
differ
time
cours
h
p
h
p
h
p
cell
undergo
h
h
starvat
p
treatment
cloroquin
h
h
p
compar
control
group
regard
autophag
activ
western
blot
confoc
microscopi
show
slightli
increas
cell
undergo
starvat
treat
h
cloroquin
convers
cell
show
strong
modul
evid
cell
undergo
h
starvat
conclus
find
evidenc
correl
prolif
autophag
process
fact
evidenc
higher
activ
follow
mediat
perk
cell
treat
h
starvat
h
cloroquin
cell
treat
h
starvat
h
cloroquin
cell
undergo
h
starvat
find
evidenc
key
role
prolif
pathway
control
autophag
process
introduct
chronic
obstruct
pulmonari
diseas
copd
major
global
health
problem
affect
ten
million
peopl
chronic
irrevers
lung
diseas
character
abnorm
enlarg
airspac
emphysema
obstruct
airway
chronic
bronchiti
persist
macrophagerich
inflamm
progress
perman
destruct
lung
parenchyma
airway
thicken
lead
unremit
breathless
disabl
presenc
diseas
comorbid
includ
infect
suscept
metabol
syndrom
muscl
wast
osteoporosi
reduc
qualiti
life
alveolar
macrophag
believ
play
key
role
secret
factor
exacerb
inflamm
caus
irrevers
tissu
damag
treatment
copd
involv
use
bronchodil
potent
immunosuppress
drug
partial
effect
manag
symptom
cur
thu
signific
unmet
clinic
need
develop
novel
treatment
cytokin
inhibit
attract
target
copd
multitud
cytokin
link
diseas
sever
use
wellcharacter
anim
model
copd
determin
role
granulocytecoloni
stimul
factor
gcsf
lung
inflamm
associ
comorbid
genet
ablat
factor
bronchoalveolar
lavag
bal
use
isol
cell
lung
flow
cytometri
use
determin
cellular
popul
activ
histopatholog
perform
lung
tissu
airspac
size
measur
mean
linear
intercept
method
luminex
technolog
use
determin
level
proinflammatori
mediat
bal
fluid
comorbid
assess
perform
microct
analysi
bone
muscl
measur
histopatholog
heart
result
use
cll
patient
sampl
mous
model
cll
detect
reduc
level
interferon
alpha
ifna
serum
patient
cll
serum
sampl
mous
model
cll
discov
plasmacytoid
dendrit
cell
pdc
underpin
activ
effector
immun
cell
critic
antivir
immun
antitumor
respons
reduc
number
function
impair
progress
cll
defect
correl
low
level
ifna
cytokin
critic
immun
lower
pdc
number
impair
ifna
product
due
decreas
express
fmslike
tyrosin
kinas
receptor
tolllik
receptor
respect
reduc
express
revers
use
inhibitor
tgfb
tnf
effect
correl
reduct
tumor
load
conclus
defect
pdc
number
function
offer
new
insight
mechan
underpin
profound
immunodefici
affect
cll
patient
provid
potenti
novel
avenu
restor
immunocompet
cll
disclosur
interest
none
declar
introduct
abil
gener
interferon
lambda
recent
discov
member
typeiii
interferon
famili
associ
impair
clearanc
hepat
c
viru
hcv
infect
signal
ifnk
receptor
complex
lead
activ
interferonstimul
gene
antivir
effect
part
jakstat
pathway
howev
possibl
role
carcinogenesi
remain
unclear
investig
independ
function
hepatoma
cell
line
use
system
elimin
previous
establish
stabl
hepatoma
cell
line
cell
express
induc
doxycyclin
treatment
success
knockout
cell
line
confirm
dna
sequenc
western
blot
interferon
stimul
respons
element
luciferas
report
isreluc
assay
effect
parent
cell
assess
cell
viabil
apoptosi
transwel
migrat
wound
heal
assay
rnasequenc
use
investig
global
transcriptom
chang
cell
line
condit
result
success
gener
stabl
cell
line
compar
parent
cell
cell
impair
abil
induc
isreluc
report
treatment
recombin
induct
express
doxycyclin
addit
antiprolif
effect
elimin
deplet
mean
phenotyp
howev
promot
cell
migrat
observ
cell
suggest
possibl
altern
pathway
function
conclus
summari
found
exhibit
antiprolif
effect
mechan
wherea
might
promot
cell
migrat
pathway
rnasequenc
ongo
investig
possibl
independ
mechan
signal
result
contribut
better
understand
function
import
carcinogenesi
disclosur
interest
none
declar
dept
medicosurg
scienc
biotechnolog
sapienza
univers
rome
latina
itali
istituto
superior
di
introduct
connect
chronic
inflamm
risk
cancer
support
sever
studi
develop
cancer
might
process
driven
presenc
specif
combin
inflammatori
mediat
includ
cytokin
chemokin
enzym
tumor
microenviron
virusinduc
tumor
like
hpvinduc
squamou
cell
carcinoma
repres
paradigmat
exampl
interplay
inflamm
integr
part
innat
antivir
respons
malign
transform
method
studi
tumorigen
role
inflammatori
mediat
hpv
cell
analyz
real
time
rtpcr
express
select
inflammatori
cytokin
chemokin
relat
molecul
human
foreskin
keratinocyt
transduc
mucos
cutan
genotyp
compar
primari
human
foreskin
keratinocyt
hfk
evalu
contribut
singl
use
human
foreskin
keratinocyt
transduc
introduct
link
obes
inflamm
report
littl
known
immun
impact
dietari
fibr
ferment
materi
dfm
accompani
chang
gut
microbiom
context
end
effect
highenergi
diet
supplement
differ
dfm
obesityassoci
biomark
cytokin
spraguedawley
sd
rat
examin
method
male
rat
fed
highenergi
diet
contain
fat
week
segreg
obesepron
obeseresist
phenotyp
shift
highenergi
diet
supplement
vari
dfm
sourc
wheat
bran
oat
bran
resist
starch
type
ii
fructooligosaccharid
fo
addit
week
rat
display
highest
lowest
weight
gain
n
per
diet
group
examin
potenti
differ
concentr
immun
biomark
includ
cytokin
associ
inflamm
obes
cytokin
adipokin
profil
serum
mesenter
lymph
node
mln
adipos
mucos
ileum
ileal
peyer
patch
cecum
proxim
distal
colon
system
liver
spleen
tissu
compar
analyz
cytokin
adipokin
profil
use
elisa
luminex
technolog
immun
cell
popul
spleen
ileal
peyer
patch
mln
analyz
flow
cytometri
determin
impact
diet
phenotyp
result
obesepron
rat
higher
concentr
insulin
pgml
vs
pgml
p
leptin
pgml
vs
pg
ml
p
serum
obeseresist
rat
howev
differ
appar
phenotyp
diet
glucagon
adiponectin
glucos
serum
endotoxin
concentr
obesepron
rat
display
lower
concentr
cytokineinduc
neutrophil
pgg
vs
pgg
p
mln
higher
concentr
cecal
total
transform
growth
factorbeta
tgfb
pgg
vs
pgg
p
pgg
vs
pgg
p
ileal
peyer
patch
obes
resist
rat
howev
differ
attribut
dfm
fosf
rat
decreas
splenic
percentag
cell
cytotox
cell
leukocyt
b
cell
natur
killer
cell
increas
percentag
helper
cell
rel
rat
fed
control
diet
signific
differ
obesepron
obeseresist
phenotyp
conclus
highenergi
diet
differenti
impact
system
adipokin
mucos
proinflammatori
regulatori
cytokin
obesepron
obeseresist
sd
rat
highenergi
diet
supplement
fo
alter
proport
splenic
immun
cell
popul
howev
dfm
signific
effect
cytokin
adipokin
profil
associ
dietinduc
obes
phenotyp
disclosur
interest
none
declar
introduct
cytokin
small
secret
protein
mediat
regul
immun
inflamm
molecul
produc
de
novo
respons
immun
stimulu
small
protein
molecul
exhibit
autocrin
paracrin
properti
cytokin
well
studi
play
import
role
infect
gener
howev
much
inform
role
cn
infect
present
studi
focus
cytokin
analysi
chronic
cn
infect
tuberculosi
tubercul
mening
method
cytokin
detect
use
doubl
antibodi
sandwich
elisa
anticytokin
antibodi
coat
plate
test
sampl
cerebrospin
fluid
csf
ad
well
captur
cytokin
captur
cytokin
detect
enzym
conjug
antibodi
chromogen
opd
cytokin
test
tnf
alpha
ifngamma
protocol
follow
per
manufactur
instruct
standard
curv
construct
use
known
concentr
cytokin
correl
well
nanogram
level
optic
densiti
result
standard
graph
four
cytokin
fairli
accur
curv
eighteen
csf
sampl
show
gamma
interferon
level
csf
tbm
case
tnf
alpha
level
seen
case
level
seen
case
howev
type
cytokin
seen
subject
conclus
cytokin
could
detect
elisa
csf
tbm
case
presenc
cytokin
obvious
indic
molecul
contribut
immun
reaction
cn
interest
note
gamma
interferon
tnf
alpha
detect
extent
half
case
wherea
detect
almost
case
precis
signific
molecul
csf
need
evalu
need
seen
whether
hiv
infect
subject
alter
pattern
cytokin
detail
find
preliminari
observ
cytokin
express
case
without
hiv
infect
would
present
discuss
introduct
breast
cancer
common
caus
cancerrel
death
among
women
overexpress
basal
breast
cancer
subtyp
express
associ
cancer
progress
metastasi
shown
enhanc
prolifer
surviv
breast
cancer
cell
mtordepend
mrna
translat
protein
associ
cell
cycl
progress
surviv
mrna
translat
energi
depend
process
moreov
complex
mtor
pathway
function
integr
differ
signal
beyond
mrna
translat
includ
associ
nutrient
sens
increas
metabol
activ
cancer
cell
specif
increas
glycolyt
activ
increas
express
glucos
transport
associ
tumor
progress
method
use
human
breast
cancer
cell
line
primari
mammari
tumor
undertook
comprehens
analysi
effect
activ
vitro
vivo
regaul
metabol
influnec
tumor
prolifer
invas
result
provid
evid
enhanc
prolifer
human
breast
cancer
cell
line
mous
mammari
tumor
cell
mmtvpymt
mediat
activ
concomit
enhanc
prolifer
show
increas
cell
surfac
express
glucos
transport
increas
glucos
uptak
atp
product
cell
block
glucos
uptak
abrog
enhanc
prolifer
induc
provid
evid
increas
glucos
uptak
associ
enhanc
glycolysi
moreov
enhanc
invas
capac
breast
cancer
cell
use
metabolom
profil
show
metabol
signatur
primari
mous
mammari
tumor
cell
reflect
increas
level
intermedi
multipl
anabol
pathway
includ
glycolysi
pentos
phosphat
pathway
amino
acid
synthesi
lipid
metabol
accumul
metabolit
suggest
potenti
divers
intermedi
altern
pathway
macromolecul
synthesi
metabol
signatur
consist
requir
cell
prolifer
invas
mous
studi
show
delay
tumor
onset
smaller
tumor
volum
breast
tumor
lack
associ
reduc
glucos
uptak
reduc
express
diminish
metabol
activ
use
ftm
tissu
imag
mammari
tumor
provid
evid
interact
enhanc
glycolysi
amino
acid
synthesi
lipid
metabol
conclus
view
altogeth
data
indic
interact
breast
cancer
microenviron
regul
metabol
event
specif
glycolysi
amino
acid
synthesi
lipid
metabol
support
energi
biosynthet
demand
tumor
cell
prolifer
invas
introduct
type
ifn
ifnalpha
ifnbeta
possess
antivir
immunomodulatori
activ
wide
use
treatment
chronic
hepat
c
multipl
sclerosi
respect
howev
report
protein
impact
advers
microvasculatur
caus
thrombot
microangiopathi
also
observ
antivegf
mab
bevacizumab
suggest
causal
link
ifn
interfer
vascular
endotheli
function
invivo
studi
anim
model
subcutan
tumour
shown
ifnbeta
inhibit
tumour
angiogenesi
invitro
effect
ifn
endotheli
cell
prolifer
remain
controversi
present
studi
investig
role
differ
ifn
regul
endotheli
cell
activ
angiogenesi
vitro
method
cell
surfac
express
ifnar
ifnlr
detect
flow
cytometri
cell
prolifer
measur
brdu
pyrimidin
analogu
incorpor
grow
cell
cell
viabil
determin
alamarblu
assay
incorpor
redox
indic
relat
cellular
metabol
reduct
apoptosi
examin
flow
cytometr
analysi
annexinv
bind
extern
phosphatidylserin
angiogenesi
evalu
invitro
human
primari
cell
cocultur
assay
endothelialderiv
tubul
format
result
reveal
primari
human
umbil
vein
endotheli
cell
huvec
express
subunit
type
ifn
receptor
share
ifnalpha
ifnbeta
type
iii
ifnlamda
receptor
chain
also
known
also
present
huvec
inhibit
brdu
incorpor
primari
cultur
huvec
concentrationdepend
manner
show
less
inhibitori
effect
howev
dose
ifn
inhibit
growth
huvec
ifnbeta
also
reduc
cell
surviv
huvec
evidenc
dramat
reduct
metabol
activ
viabl
cell
appar
ifnalpha
type
iii
ifn
littl
effect
cell
apoptosi
induc
serum
depriv
furthermor
evalu
abil
ifn
interfer
vegf
endotheli
function
growth
factor
essenti
endotheli
cell
surviv
differenti
angiogenesi
found
ifnbeta
treatment
strongli
inhibit
vegfinduc
capillari
develop
invitro
model
angiogenesi
manner
compar
bevacizumab
antagon
vegfinduc
angiogenesi
ifnalpha
also
decreas
vegfinduc
angiogenesi
lesser
extent
interestingli
littl
impact
vegfinduc
angiogenesi
data
experi
anim
suggest
special
water
drink
behavior
may
promot
activ
immun
system
improv
health
howev
respons
treat
water
human
unknown
studi
test
associ
differ
water
drink
behavior
condit
oral
immun
protect
month
method
random
placebo
control
crossov
fashion
healthi
young
peopl
year
age
divid
repres
group
trial
group
person
consum
ml
per
kg
physic
treat
water
placebo
group
person
describ
mode
placebodevic
control
group
person
usual
water
drink
behavior
examin
saliva
tnfa
kinf
amylas
ca
p
compar
use
mannwhitney
u
test
kruskalw
test
monitor
cytokin
elisa
method
activ
amylas
quantiti
ca
calcul
use
calorimetr
method
result
group
particip
show
stabl
level
p
level
trial
group
rais
p
similar
trend
notic
kinf
tnfa
p
chang
observ
two
group
except
tnfa
p
signific
chang
level
cap
level
found
p
conclus
treat
water
intak
associ
specif
immun
respons
strategi
mechan
help
understand
healthi
peopl
consum
ml
per
kg
drink
water
bao
q
wei
water
prevent
urinari
stone
review
cochran
librari
bo
r
gore
f
bartram
j
safer
water
better
health
cost
benefit
sustain
intervent
protect
promot
healthgeneva
world
health
organ
signoretto
c
bianchi
f
burlacchini
g
sivieri
f
spratt
canepari
p
drink
habit
associ
chang
dental
plaqu
microbi
commun
journal
clinic
microbiolog
introduct
protein
kinas
r
pkr
interferoninduc
serinethreonin
kinas
play
key
role
regul
cellular
stress
respons
viral
infect
er
stress
oxid
stress
serum
depriv
protein
synthesi
inhibit
condit
pkr
activ
interact
doubl
strand
rna
dsrna
gener
viral
infect
cellular
activ
pact
protein
activ
pkr
pkr
subsequ
phosphoryl
subunit
translat
initi
factor
lead
cessat
gener
cellular
protein
synthesi
translat
attenu
allow
cell
mount
appropri
respons
stress
condit
sustain
eventu
result
apoptosi
addit
regul
two
activ
pkr
also
subject
neg
regul
variou
viral
factor
well
rnainduc
silenc
complex
protein
trbp
tar
rna
bind
protein
trbp
inhibit
pkr
activ
stress
cellular
condit
direct
interact
well
direct
associ
pkr
activ
dsrna
pact
therebi
prevent
subsequ
inhibit
protein
translat
sever
studi
link
prolong
pkr
activ
variou
neurodegen
neuromuscular
disord
recent
find
also
indic
trbp
inhibit
pkr
cellular
context
strongli
suggest
trbp
abil
effici
inhibit
pkr
affect
posttransl
modif
method
goal
studi
elucid
function
import
trbp
phosphoryl
pkr
inhibit
cell
fate
cell
stress
observ
chang
trbp
phosphoryl
statu
respons
stress
test
direct
effect
modif
pkr
activ
apoptosi
also
specif
test
chang
pkrtrbp
interact
well
trbp
homodim
format
trbp
phosphoryl
use
variou
biochem
assay
phosphomim
phosphodefect
trbp
mutant
result
indic
trbp
phosphoryl
respons
cell
stress
chang
phosphoryl
statu
significantli
enhanc
trbp
abil
effici
inhibit
pkr
increas
trbp
inhibit
pkr
support
result
show
trbp
phosphoryl
directli
enhanc
trbp
interact
pkr
weaken
trbptrbp
homodim
format
effect
differenti
preosteoblast
unclear
investig
use
preosteoblast
cell
line
current
studi
help
us
understand
role
regul
osteogen
differenti
also
anabol
potenti
treatment
bone
disord
like
osteoporosi
arthriti
method
effect
prolifer
preosteoblast
check
mtt
assay
osteogenesi
assess
matrix
miner
assay
follow
alizarin
red
quantit
express
variou
osteogen
gene
evalu
revers
transcriptas
rt
realtim
pcr
qrtpcr
western
blot
perform
assess
signal
pathway
involv
action
statist
signific
calcul
oneway
anova
subsequ
posthoc
tukey
test
multipl
comparison
result
observ
cell
express
receptor
transcript
protein
level
affect
prolifer
cell
toxic
cell
even
higher
concentr
interestingli
found
enhanc
osteogen
differenti
cell
dosedepend
manner
addit
upregul
express
osteoblast
specif
gene
alkalin
phosphatas
osteocalcin
osteopontin
runtrel
transcript
factor
osterix
also
observ
induct
phosphoryl
akt
upon
treatment
cell
result
suggest
enhanc
osteogen
differenti
cell
thu
could
potenti
therapeut
candid
treatment
variou
bone
patholog
osteoporosi
arthriti
involv
impair
osteoblast
differenti
function
introduct
tnfa
activ
involv
acut
chronic
phase
atop
dermat
ad
role
membran
receptor
regulatori
function
ad
remain
unclear
aim
studi
investig
chang
express
tnfa
receptor
patient
atop
dermat
percentag
cell
receptor
immunocompet
cell
subset
absolut
number
membranebound
receptor
method
reveal
linear
relationship
among
scorad
studi
paramet
intact
tcell
bcell
monocyt
evalu
flow
cytometri
ad
patient
n
acut
stage
within
clinic
improv
paramet
mediat
solubl
content
evalu
elisa
build
multipl
linear
regress
model
mlrm
standard
assess
regress
coeffici
least
squar
method
use
determin
receptor
number
cell
quantibritep
bead
bd
use
eas
sever
index
scorad
ad
patient
depend
phase
diseas
result
intact
cell
pbmc
subset
found
differ
rel
percentag
cell
express
type
tnfa
receptor
absolut
number
receptor
increas
decreas
percentag
cell
express
receptor
subset
immun
cell
patient
atop
dermat
associ
chang
number
receptor
cell
surfac
chang
paramet
tnfa
receptor
express
associ
diseas
sever
index
scorad
atop
dermat
conclus
differ
indic
tnfa
receptor
system
associ
diseas
sever
index
scorad
ad
patient
depend
phase
diseas
introduct
sinc
discoveri
twenti
year
ago
signal
transduc
activ
transcript
tie
divers
set
physiolog
patholog
function
pleotrop
action
nuclear
transcript
factor
activ
tyrosin
phosphoryl
thoroughli
character
addit
regul
nuclear
transcript
small
pool
resid
mitochondria
serv
sensor
signal
hub
number
metabol
stressor
includ
reactiv
oxygen
speci
ro
mitochondrialloc
larg
exert
effect
direct
indirect
regul
activ
electron
transport
chain
etc
contrast
cytokineinduc
import
nucleu
assum
level
mitochondria
static
method
variou
cell
line
incub
cytokin
hydrogen
peroxid
mitochondria
isol
treat
trypsin
remov
nonspecif
bind
protein
outer
membran
mitochondri
extract
probe
presenc
cyclophilin
gstcyclophilin
pull
assay
use
measur
associ
cyclophilin
result
show
variou
stimuli
includ
oxid
stress
cytokin
trigger
novel
signal
cascad
result
rapid
loss
recoveri
time
depend
upon
phosphoryl
new
protein
synthesi
condit
also
becom
compet
bind
cyclophilin
cypd
bind
cypd
surprisingli
mediat
nterminu
therebi
defin
site
outsid
may
import
regul
conclus
result
outlin
previous
unappreci
role
sens
extern
stimuli
provid
evid
novel
mitochondri
pathway
introduct
interleukin
il
pleiotrop
inflammatori
cytokin
associ
regul
tcell
differenti
prolifer
surviv
activ
latent
transcript
factor
critic
role
perform
mani
process
impact
signal
less
obviou
address
issu
profil
respons
tcell
examin
relationship
activ
data
show
prior
tcell
activ
lead
retun
signal
associ
loss
activ
signal
properti
examin
purifi
tcell
cultur
ex
vivo
analysi
defin
tcell
subset
tempor
chang
activ
monitor
intracellular
flow
cytometri
accompani
transcriptom
analysi
epigenet
profil
involv
use
chromatin
immunoprecipit
coupl
nextgener
sequenc
chipseq
result
data
show
control
gene
express
tcell
highli
dynam
influenc
activ
statu
popul
importantli
activ
tcell
costimulatori
antibodi
alter
signal
properti
regul
protein
tyrosin
phosphatas
activ
blockad
control
tyrosin
phosphoryl
control
compar
central
memori
effector
effector
memori
tcell
activ
promin
featur
signal
tcell
examin
differenti
bind
profil
effector
memori
tcell
identifi
potenti
genet
marker
driven
diseas
cell
chipseq
analysi
identifi
peak
induc
peak
respect
promotor
region
bioinformat
analysi
dataset
use
memechip
web
servic
map
enrich
defin
consensu
motif
three
dna
consensu
motif
associ
involv
correspond
interferonregulatori
factor
respons
element
ga
motif
third
central
enrich
motif
convers
chipseq
peak
map
predominantli
ga
motif
zinc
finger
factor
bind
site
consensu
sequenc
associ
bind
et
transcript
factor
thu
indic
potenti
associ
interact
transcript
complex
rel
enrich
control
gene
reduc
effector
memori
sampl
introduct
xlink
inhibitor
apoptosi
protein
xiap
associ
cytokineregul
tumor
necrosi
factor
tnf
receptor
associ
factor
traf
domaincontain
protein
poorli
defin
cellular
function
origin
implic
tumor
suppressor
due
put
inhibitori
effect
toward
xiap
report
possibl
role
tnfatnf
receptor
tnfr
mediat
signal
transduct
method
activ
nuclear
factor
kappa
b
nfjb
tnfa
achn
cell
assess
luciferas
assay
use
nfjb
respons
elementregul
luciferas
report
construct
realtim
rt
pcr
analysi
gene
express
effect
nfjb
activ
interact
investig
use
luciferas
assay
coimmunoprecipit
assay
respect
cell
ectop
express
protein
interest
impact
ubiquitin
assess
immunoblot
analysi
effect
complex
format
also
studi
immunoblot
analysi
individu
protein
follow
immunoprecipit
endogen
knockdown
achn
cell
without
tnfa
stimul
result
demonstr
shrna
silenc
endogen
augment
tnfa
induc
nfjb
activ
express
interact
inhibit
nfjb
activ
part
block
polyubiquitin
also
bound
directli
inhibit
nfjb
activ
howev
knockdown
promot
associ
tradd
respons
tnfa
stimul
conclus
data
suggest
inhibit
tnfainduc
nfjb
activ
via
disrupt
complex
function
possibl
physic
block
interact
compon
complex
therebi
prevent
receiv
retain
essenti
complex
format
signal
propag
introduct
upon
bind
tnfa
induc
activ
either
nfkb
pathway
apoptosi
form
signalosom
complex
complex
respect
besid
tnf
known
activ
erk
jnk
akt
pathway
although
tnf
mediat
apoptosi
nfkb
signal
extens
studi
signalosom
respons
activ
erk
jnk
akt
pathway
character
yet
known
interact
thu
hypothes
could
tyrosin
tyr
phosphoryl
trigger
activ
prolif
stressinduc
pathway
method
vitro
kinas
reaction
perform
demonstr
mediat
phosphoryl
follow
confirm
two
put
tyr
phosphoryl
site
substitut
sitedirect
mutagenesi
alanin
residu
inhibit
phosphoryl
aspart
acid
mimic
constitut
phosphoryl
mutat
wild
type
transfect
cell
effect
mutat
follow
tnf
treatment
erk
jnk
akt
activ
determin
western
blot
experi
interact
csrc
fadd
tradd
rip
examin
coip
nfkb
activ
measur
luciferas
assay
dna
bind
activ
explor
emsa
mtt
colorimetr
caspas
assay
util
quantif
prolifer
apoptosi
respect
result
interact
tnf
induc
manner
result
tyr
phosphoryl
mutant
led
activ
akt
erk
pathway
suppress
jnk
pathway
mutant
improv
interact
csrc
effect
bind
nfkb
activ
shown
correl
interact
doubl
mutat
led
maximum
activ
doubl
mutant
result
increas
apoptosi
interact
conclus
nutshel
tyr
phosphoryl
phosphoryl
augment
mediat
prolif
pathway
well
complex
format
inhibit
phosphoryl
residu
result
increas
complex
format
apoptosi
introduct
hcc
fifth
common
third
deadliest
cancer
worldwid
urgent
need
find
sensit
marker
earli
diagnosi
monitor
postop
recurr
order
provid
treatment
hcc
cytokin
play
import
role
liver
physiolog
ie
cytokin
mediat
acut
phase
respons
addit
contribut
cancer
develop
progress
thu
hccassoci
cytokin
well
mirna
candid
diagnost
prognost
biomark
hcc
result
first
step
analyz
correl
express
level
inflammatori
cytokin
hcc
nash
patient
high
risk
develop
hcc
herein
serum
level
hgf
higher
hcc
patient
healthi
control
advanc
nash
patient
confirm
bioplex
cytokin
immunoassay
next
want
studi
possibl
correl
cytokin
level
presenc
risk
variant
patient
nash
therebi
contribut
biomark
research
liver
diseas
next
studi
effect
mirnom
hepatoma
cell
line
primari
hepatocyt
surprisingli
caus
thousand
mrna
differenti
regul
hepatoma
cell
line
wherea
level
mirna
significantli
chang
fdr
logfc
contrast
hcc
cell
line
stronger
respons
mirnom
follow
stimul
observ
primari
hepatocyt
differenti
express
mirna
two
sampl
respect
address
possibl
cell
type
tissu
specif
test
effect
cytokin
ifnk
osm
mirnom
mrna
transcriptom
healthi
cancer
cell
line
deriv
human
liver
colon
skin
cell
moreov
regul
role
select
mirna
possibl
relev
hcc
current
analyz
introduct
proinflammatori
cytokin
essenti
host
defens
extracellular
pathogen
also
promot
inflamm
mani
autoimmun
diseas
set
induc
inflammatori
signal
de
novo
transcript
posttranscript
regul
downstream
gene
one
major
mechan
posttranscript
gene
regul
occur
alter
mrna
stabil
target
gene
transcript
report
new
mechan
increas
mrna
halflif
downstream
target
gene
rna
bind
protein
known
atrich
interact
domaincontain
protein
previous
shown
stabil
signal
transduc
activ
transcript
transcript
direct
bind
thu
counteract
destabil
effect
endoribonucleas
also
known
method
assess
role
signal
perform
gene
knockdown
use
sirna
murin
stromal
cell
line
follow
treatment
express
target
gene
analyz
use
qrtpcr
rnaseq
mrna
halflif
target
gene
assess
actinomycin
treatment
transcript
identifi
via
rna
immunoprecipit
coimmunoprecipit
assay
perform
studi
adaptor
protein
associ
introduct
tumor
necrosi
factor
alpha
tnfa
inflammatori
cytokin
regul
prolifer
andor
apoptosi
wide
varieti
cell
tnfa
elicit
biolog
effect
bind
cognat
type
type
ii
receptor
although
pathway
activ
extens
studi
factor
pathway
regul
signal
remain
elus
camp
previous
implic
regul
signal
howev
mechan
regul
document
death
domain
bear
two
threonin
residu
lie
within
put
pka
consensu
motif
rxxt
thu
hypothes
might
target
pka
possibl
regul
mechan
method
order
confirm
interact
perform
reciproc
coimmunoprecipit
coip
valid
phosphoryl
invitro
kinas
reaction
thereaft
sitedirect
mutat
residu
alanin
inhibit
phosphoryl
aspart
acid
mimic
phosphoryl
plasmid
carri
wild
type
mutant
transient
transfect
cell
western
blot
determin
erk
creb
activ
nfkb
activ
examin
mean
luciferas
assay
explor
dna
bind
abil
use
emsa
techniqu
determin
extent
shed
elisa
final
rate
apoptosi
induct
measur
activ
assay
result
mutant
decreas
tnfinduc
activ
increas
tnfinduc
erk
activ
follow
tnf
treatment
mutant
posit
stimul
creb
phosphoryl
wherea
mutant
fail
elicit
effect
tnfinduc
activ
decreas
mutant
increas
doubl
mutant
contrast
result
tnfinduc
nfkb
activ
upregul
mutant
downregul
mutant
apoptosi
increas
mutat
decreas
mutat
conclus
appar
substrat
pka
phosphoryl
pka
differenti
effect
upon
signal
result
differenti
modul
activ
lower
inhibitori
activ
express
abundantli
throughout
bodi
homeostasi
also
differenti
alter
cooper
action
commonli
coexpress
autoimmun
set
addit
demonstr
inact
secret
importantli
domin
isoform
express
constitut
modul
myeloid
cell
activ
retino
acid
kinet
magnitud
gene
express
differ
follow
interferon
sens
molecular
mechan
distinct
respons
type
ifn
type
iii
ifn
function
consequ
differ
fulli
understood
method
provid
detail
investig
distinct
receptorligand
interact
tempor
recruit
activ
adaptor
molecul
transcript
factor
guid
interferonstimul
gene
express
human
epitheli
cell
furthermor
examin
uniqu
translat
program
distinguish
biolog
activ
type
type
iii
ifn
ribosom
profil
introduct
interferona
ifna
belong
type
interferon
famili
cytokin
central
regul
host
antivir
immunoregulatori
respons
howev
dysregul
ifna
product
lead
diseas
central
nervou
system
cn
chronic
product
ifna
caus
number
neurolog
diseas
collect
term
cerebr
type
interferonopathi
includ
chronic
viral
infect
cn
system
lupu
erythematosusassoci
neurolog
manifest
genet
disord
exemplifi
syndrom
howev
effector
cell
cn
molecular
mechan
underli
ifna
mediat
cn
diseas
unknown
intracellular
effect
ifna
mediat
number
signal
pathway
regul
phosphoryl
signal
protein
transcript
factor
therefor
hypothesis
neurolog
diseas
phenotyp
caus
ifna
consequ
differenti
activ
signal
pathway
primarili
involv
protein
phosphoryl
cascad
phosphoproteom
ultim
lead
regul
transcript
factor
activ
method
highthroughput
phosphoproteom
use
determin
global
celltyp
specif
phosphoproteom
murin
cn
glial
cell
respect
determin
effect
ifna
global
phosphoproteom
cn
use
transgen
mice
chronic
produc
ifna
cn
gifn
mice
mice
recapitul
mani
key
featur
ifna
relat
neuropatholog
symptom
assess
celltyp
specif
chang
analys
phosphoproteom
ifna
treat
primari
astrocyt
microglia
result
preliminari
result
show
signific
chang
phosphoryl
protein
brain
gifn
mice
gene
ontolog
reveal
increas
phosphoryl
associ
protein
complex
assembl
vesicl
transport
antivir
respons
ossif
wherea
protein
decreas
phosphoryl
relat
cytoskeleton
regul
homeostasi
neurogenesi
surprisingli
analysi
phosphoryl
site
reveal
member
mitogenactiv
protein
kinas
mapk
famili
major
regul
protein
phosphoryl
cn
gifn
mice
result
demonstr
link
ifna
mediat
diseas
phenotyp
chang
number
differ
biolog
process
find
also
show
phosphoproteom
highli
suitabl
techniqu
explor
chang
signal
cn
cellular
respons
ifna
method
may
help
answer
mechan
ifna
caus
diseas
reveal
therapeut
target
type
cerebr
interferonopathi
introduct
interferon
play
major
role
control
viral
infect
key
element
innat
immun
need
effici
adapt
immun
nevertheless
associ
inflamm
immun
suppress
chronicimmuneactiv
persist
upregul
ifn
regul
gene
isg
molecular
signatur
chronic
immuneactiv
progress
hiv
siv
infect
respect
contribut
type
type
ii
ifn
remain
unclear
ifnsifnreceptor
interact
induc
isg
target
specif
sequenc
upstream
promot
ga
isr
signal
transduct
phosphoryl
latent
transcript
factor
belong
stat
famili
mediat
janu
kinas
stat
dimer
directli
activ
isg
contain
gassequ
associ
stat
interferon
regulatori
factor
activ
gene
interact
isresequ
aim
better
understand
respect
involv
type
type
ii
ifn
isg
induct
acut
chronic
infect
respect
function
enrich
gene
regul
ga
isr
gasisr
specif
biolog
function
method
six
macaqu
expos
intraven
differ
tissu
includ
pbmc
lymphnod
rectum
subject
agil
rh
dna
array
infect
acut
chronic
infect
addit
viru
load
ifn
express
monitor
analyz
differenti
express
ifn
isg
split
three
distinct
group
ga
isreand
gasisreregulatedisg
result
increas
ifna
bexpress
detect
lymphoid
tissu
acut
infect
bare
detect
chronic
stage
contrast
ifng
product
detect
phase
among
differenti
upregul
isg
display
isr
gasand
isr
gassequ
within
upstream
promot
induct
isg
higher
acut
chronic
phase
isregasisg
induc
isr
ga
gene
induc
acut
chronic
phase
isrega
isg
overrepres
inflamm
antivir
canon
function
gasisg
isreisg
introduct
macrophag
import
player
host
defenc
respons
pathogen
produc
protect
proinflammatori
cytokin
along
interleukin
il
respons
tolllik
receptor
tlr
ligat
proinflammatori
cytokin
tumor
necrosi
factor
alpha
tnfa
essenti
resist
infect
produc
high
level
may
contribut
immunopatholog
contrast
immunosuppress
cytokin
dampen
respons
also
lead
defect
pathogen
clearanc
regul
cytokin
therefor
central
gener
effect
balanc
immun
respons
method
studi
stimul
macrophag
deriv
two
differ
mous
strain
balbc
mice
either
lp
heatkil
burkholderia
pseudomallei
investig
differ
tlr
activ
respons
microarray
approach
rtpcr
elisa
western
blot
use
result
show
macrophag
mice
produc
low
level
tnfa
high
level
respons
ligand
contrast
macrophag
deriv
balbc
mice
show
reciproc
pattern
cytokin
product
differenti
product
stimul
balbc
macrophag
due
type
ifndepend
mechan
demonstr
type
ifn
act
transcript
regul
mrna
potenti
via
activ
addit
stabilis
mrna
transcript
stimul
macrophag
type
ifn
contribut
differenti
product
stimul
balbc
macrophag
via
independ
mechan
conclus
data
show
distinct
profil
proand
antiinflammatori
cytokin
product
balbc
macrophag
highlight
import
role
type
ifn
regul
innat
immun
respons
disclosur
interest
none
declar
introduct
recent
identifi
autophagyrel
kinas
novel
kinas
requir
type
interferon
ifn
induc
activ
mapk
transcript
ifnstimul
gene
isg
antiprolif
effect
normal
hematopoiesi
myeloprolif
neoplasm
light
new
find
question
whether
could
also
activ
downstream
type
ii
ifn
receptor
ifnr
requir
ifnkmedi
biolog
respons
vitro
studi
conduct
examin
role
ifnkmedi
signal
pathway
use
lcmsm
coimmunoprecipit
western
blot
analys
ifnkinduc
gene
transcript
evalu
qrtpcr
analys
measur
luciferas
activ
wild
type
wt
doubl
knockout
dko
cell
stabli
express
ifnk
activ
site
ga
elementsluciferas
cdna
ifnkantivir
respons
determin
antivir
assay
use
encephalomyocard
viru
challeng
viru
mannwhitney
u
test
use
assess
differ
two
group
oneway
anova
use
compar
two
group
follow
tukey
multipl
comparison
test
differ
consid
statist
signific
p
valu
less
initi
immunoprecipit
untreat
ifnktreat
human
cell
perform
lcmsm
analysi
result
show
bind
protein
upon
ifnk
treatment
protein
identifi
confirm
bind
protein
kinas
previous
shown
phosphoryl
upon
engag
type
ii
ifnr
next
demonstr
express
requir
activ
downstream
ifnk
signal
pathway
moreov
ifnkinduc
transcript
activ
via
ga
element
well
transcript
sever
isg
significantli
reduc
absenc
express
subsequ
studi
observ
dko
cell
less
respons
antivir
effect
ifnk
compar
wt
cell
similarli
targetspecif
inhibit
reduc
ifnkmedi
antivir
effect
human
fibrosarcoma
cell
defin
novel
ifnk
signal
pathway
requir
activ
lead
transcript
isg
antivir
respons
togeth
result
support
clinic
modul
kinas
activ
potenti
approach
select
enhanc
ifnkinduc
biolog
respons
introduct
sjogren
syndrom
ss
chronic
autoimmun
disord
result
dysfunct
exocrin
gland
particularli
salivari
lacrim
gland
pathogenesi
ss
involv
mani
compon
includ
deregul
salivari
glandular
epitheli
cell
sgec
present
antigen
present
cell
apc
like
phenotyp
increas
product
proinflammatori
cytokin
chemokin
hypothes
oral
bacteria
may
role
induc
apclik
phenotyp
sgec
commun
oral
bacteria
collect
mouth
rins
healthi
control
hc
n
patient
dri
mouth
due
medic
sicca
control
sc
n
ss
patient
n
analyz
pyrosequenc
base
result
microbiota
analysi
streptococcu
salivariu
rothia
mucilaginosa
fusobacterium
nucleatum
prevotella
melaninogenica
p
histicola
chosen
studi
human
salivari
gland
hsg
cell
infect
select
bacteria
presenc
absenc
ifng
h
kill
bacteria
gentamicin
hsg
cell
cultur
h
express
major
histocompat
complex
class
mhc
mhc
class
ii
mhc
ii
examin
flow
cytometri
result
pyrosequenc
analysi
reveal
drastic
chang
bacteri
commun
associ
dryness
mouth
although
bacteri
commun
sc
ss
quit
similar
divers
ss
microbiota
significantli
higher
sc
differ
rel
abund
speciesphylotyp
observ
sc
ss
group
particular
increas
p
melaninogenica
specif
associ
ss
risk
logist
regress
analysi
odd
ratio
p
f
nulceatum
highli
immun
stimulatori
speci
use
posit
control
p
melaninogenica
upregul
mhc
absenc
ifng
upregul
ifnginduc
upregul
mhc
p
melaninogenica
also
upregul
ifnginduc
express
mhc
ii
contrast
salivariu
abund
speci
use
neg
control
downregul
express
absenc
ifng
well
ifnginduc
upregul
mhc
r
mucilaginousa
speci
increas
sc
ss
compar
hc
also
show
suppress
effect
ifnginduc
upregul
mhc
conclus
specif
bacteria
associ
ss
oral
microbiota
may
play
role
deregul
sgec
pathogenesi
ss
disclosur
interest
none
declar
introduct
type
ii
ifn
concurr
produc
infect
type
ii
ifn
ifnk
act
macrophag
induc
proinflammatori
antimicrobi
respons
critic
resist
bacteri
infect
convers
type
ifn
promot
antivir
immun
exert
antiinflammatori
effect
associ
increas
host
suscept
listeria
monocytogen
lm
bacteri
infect
type
ifn
also
known
suppress
transcript
myeloid
cell
regul
receptor
ifnk
ifngr
hypothes
suppress
ifngr
contribut
type
ifnmedi
suscept
bacteri
infect
method
test
hypothesi
develop
transgen
mous
model
function
flagtag
ifngr
express
macrophag
low
level
use
promot
silenc
type
ifn
result
macrophag
mice
express
endogen
flagifngr
overal
surfac
ifngr
express
similar
wt
congen
cell
treat
type
ifn
wt
macrophag
lose
cell
surfac
ifngr
macrophag
larg
retain
flagifngr
wt
macrophag
respond
similarli
treat
individu
type
ifn
ifnk
presenc
type
ifn
respons
macrophag
ifnk
greater
consist
mice
heighten
resist
system
lm
infect
enhanc
resist
mice
depend
ifnk
correl
increas
express
proinflammatori
activ
marker
reduc
frequenc
lminfect
macrophag
conclus
data
demonstr
ifngr
regul
myeloid
cell
impair
macrophag
activ
increas
host
suscept
infect
intracellular
bacteri
pathogen
ifnb
induct
pathway
activ
specif
transcript
factor
bind
interferon
regulatori
factor
irf
dna
element
call
irf
stimul
transcript
sever
gene
type
ifn
includ
ifnb
bind
ifni
receptor
trigger
ifni
signal
cascad
trigger
transcript
factor
bind
dna
element
name
ifn
stimul
respons
element
isr
trigger
transcript
ifnstimul
gene
isg
similar
irf
isr
sequenc
support
fact
mani
gene
activ
signal
pathway
sever
work
describ
transgen
mice
express
report
gene
control
ifnb
promot
creat
ifni
specif
respons
promot
control
express
cre
recombinas
method
recombin
adeno
associ
vector
aav
contain
multipl
copi
optim
regulatori
sequenc
contain
irf
isr
irfisr
control
express
firefli
luciferas
report
gen
gener
intranas
intraven
administr
aav
vector
mice
syrian
hamster
show
specif
respons
two
week
administr
anim
infect
differ
dose
virus
newcastl
diseas
viru
ndv
influenza
viru
report
activ
monitor
vivo
intraven
administr
luciferin
substrat
result
vivo
luciferas
activ
detect
depend
presenc
aav
vector
administr
differ
ifni
agonist
report
vector
accommod
studi
strength
kinet
type
ifn
signatur
conclus
need
anim
transgenesi
develop
aav
report
vector
deliv
differ
organ
differ
anim
model
order
detect
quantifi
ifni
signatur
vivo
introduct
genotox
stress
induc
dna
damag
agent
dna
recombin
potenti
gener
dna
byproduct
detect
innat
immun
system
method
reli
studi
noncytotox
mild
dna
damag
mous
embryon
fibroblast
bone
marrow
deriv
macrophag
human
fibroblast
lung
cancer
cell
investig
involv
cytosol
cyclic
gmpamp
cgamp
synthas
cga
sting
detect
dna
damag
product
cell
defici
sting
cga
gap
junction
util
address
direct
contribut
pathway
protect
semliki
forest
viru
infect
show
dna
damag
caus
cre
recombin
use
select
genotox
agent
induc
robust
antivir
respons
mammalian
cell
due
accumul
cytoplasm
dna
recruit
cga
promot
cgamp
synthesi
downstream
sting
activ
target
adjac
cell
interferon
gamma
ifnk
cytokin
critic
innat
adapt
immun
ifnk
bind
dimer
ifnk
receptor
involv
activ
cell
monocyt
macrophag
cytokin
also
upregul
antigen
present
molecul
promot
immunoglobulin
class
switch
b
cell
ifnk
induc
proand
antiinflammatori
respons
involv
mani
autoimmun
disord
increas
detect
sensit
ifnk
allow
improv
understand
diseas
mechan
necessari
better
understand
cytokin
biomark
therapeut
target
ultrasensit
electrochemiluminesc
assay
format
splex
tm
base
msd
multiarray
technolog
develop
ifnk
perform
character
monoclon
antibodi
evalu
select
base
sensit
specif
affin
perform
characterist
anchor
ifnk
calibr
detect
limit
novel
ifnk
immunoassay
fgml
fold
sensit
current
ifnk
immunoassay
lower
upper
limit
quantit
fgml
fg
ml
respect
typic
intrapl
coeffici
variat
cv
rang
interpl
cv
low
mid
high
qualiti
control
qc
sampl
level
respect
n
per
qc
level
averag
percent
recoveri
spike
experi
n
specimen
dilut
linear
averag
recoveri
n
specimen
assay
optim
minim
serum
plasma
matrix
effect
interfer
specif
assay
demonstr
analyt
deplet
use
sever
antiifnk
specif
antibodi
indic
assay
specif
ifnk
homodim
ifnk
detect
serum
plasma
appar
healthi
specimen
n
median
valu
fgml
serum
n
fgml
edta
plasma
n
fgml
heparin
plasma
n
ifnk
appear
elev
small
number
rheumatoid
arthriti
specimen
test
appear
elev
system
lupu
erythematosu
crohn
specimen
msd
develop
ultrasensit
ifnk
immunoassay
time
sensit
current
limit
ifnk
immunoassay
msd
splex
immunoassay
aid
improv
character
ifnk
diseas
state
develop
target
therapeut
intervent
introduct
primari
biliari
cholang
pbc
liver
autoimmun
diseas
predominantli
affect
women
howev
sexbias
mechan
diseas
understood
report
delet
au
rich
element
ifng
aredel
lead
chronic
express
ifng
consequ
found
mice
develop
primari
autoimmun
cholang
strong
femal
bia
analyz
liver
gene
express
data
util
rna
seq
patholog
featur
understand
diseas
develop
progress
result
consequ
found
mice
develop
primari
autoimmun
cholang
strong
femal
bia
serologicalpatholog
featur
gene
express
signatur
mous
model
compar
data
seen
human
pbc
rnasequenc
liver
gene
express
reveal
differenti
express
gene
femal
aredelmic
consist
stronger
type
ii
interferon
signal
helper
cellmedi
immun
respons
femal
mice
serv
basi
sex
bia
observ
diseas
femal
aredelmic
significantli
increas
cell
decreas
cell
compar
control
litterm
result
elev
cell
ratio
consequ
transfer
cell
aredelmic
mice
induc
moder
portal
parenchym
inflamm
wherea
cell
transfer
induc
patholog
phenotyp
moreov
profil
autoantigen
reactiv
use
peptid
array
indic
femal
aredelmic
high
induct
igm
reactiv
autoantigen
associ
autoimmun
diseas
compar
male
mice
level
igg
reactiv
autoantigen
significantli
differ
femal
vs
male
assess
role
type
interferon
diseas
process
aredelifnab
receptor
doubl
knockout
mice
gener
despit
inabl
measur
circul
type
ifn
mice
much
lower
femalepreval
patholog
phenotyp
portal
lobular
duct
inflamm
granuloma
format
bile
duct
damag
induct
total
bile
acid
conclus
chronic
ifng
express
critic
femalebias
pathogenesi
pbc
involv
cell
well
type
type
ii
interferon
pathway
interact
introduct
emerg
evid
ifnk
highli
induc
respiratori
viral
infect
ifnb
defici
ifnk
relat
exacerb
respiratori
infect
pneumonia
asthma
goal
studi
determin
therapeut
effect
intranas
ifnk
treatment
influenza
viru
iav
induc
lung
infect
mous
model
method
mice
male
week
anesthet
challeng
intranas
administr
ul
iav
iavinocul
mice
euthan
day
post
infect
dpi
recombin
ifnk
ugmic
inocul
mice
n
intranas
deliveri
lung
tissu
bal
fluid
collect
result
preliminari
result
show
infect
mice
exhibit
signific
weight
loss
valu
observ
dpi
dpi
day
highest
iav
mrna
level
lung
tissu
viral
titer
bal
fluid
observ
dpi
correspondingli
histolog
find
relat
acut
lung
infect
dominantli
observ
dpi
iav
mrna
level
viral
titer
much
lower
mice
inocul
recombin
ifnk
nasal
caviti
time
iav
infect
also
sever
patholog
iavinfect
lung
tissu
observ
ifnktreat
mice
ifnstimul
gene
induc
lung
tissu
iavinfect
mice
gene
transcript
level
consider
elev
ifnktreat
mice
conclus
intranas
ifnk
treatment
contribut
enhanc
innat
immun
respons
mice
lung
iav
infect
may
import
biomateri
therapi
acut
iavinduc
lung
infect
differ
biolog
activ
exist
antivir
agent
introduct
interferon
lambda
critic
antivir
effector
hepat
mucos
infect
act
antivir
genet
associ
studi
shown
express
recent
discov
detriment
hepat
c
viru
hcv
infect
yet
unknown
mechan
intriguingli
human
harbor
genet
variant
introduc
prematur
stop
codon
perform
molecular
biochem
character
determin
role
regul
express
method
amplifi
mrna
stimul
hepatocyt
gener
cdna
librari
differ
isoform
assess
express
secret
antivir
activ
clone
isoform
overexpress
system
furthermor
gener
human
recombin
fulllength
protein
drosophila
cell
system
valid
overexpress
data
final
determin
translat
effici
isoform
ribosom
profil
result
found
exhibit
similar
antivir
activ
without
neg
affect
antivir
ifn
activ
cell
surviv
show
human
evolv
mechan
limit
express
function
noncod
splice
variant
nonfunct
protein
isoform
furthermor
proteincod
mrna
load
onto
polyribosom
lack
strong
polyadenyl
signal
result
poor
translat
effici
studi
provid
mechanist
evid
human
sustain
adapt
suppress
express
suggest
immun
function
depend
ifnl
famili
member
disclosur
interest
none
declar
method
mice
tlrrlh
mice
defici
tlr
rlh
signal
either
infect
pfu
vsv
treat
shortterm
regimen
h
post
infect
hpi
recombin
ifna
rifna
treat
rifna
hpi
infect
vsv
hpi
longterm
treatment
describ
regimen
initi
h
infect
follow
rifna
inject
everi
h
day
surviv
well
induct
vsvspecif
cytotox
lymphocyt
neutral
antibodi
respons
monitor
furthermor
spleen
vsvegfp
infect
tlrrlh
mice
subject
shortterm
rifna
treatment
initi
h
h
infect
analyz
immunohistochemistri
studi
impact
kinet
ifni
respons
induct
adapt
immun
infect
tlrrlh
mice
vsv
start
shortterm
treatment
rifna
hpi
condit
tlrrlh
mice
mount
normal
adapt
immun
respons
mice
surviv
reinfect
experi
prove
surviv
mice
develop
effect
memori
respons
vsv
initi
rifna
treatment
h
vsv
infect
significantli
prolong
surviv
wherea
reduc
vsvspecif
cytotox
cell
respons
basic
vsv
neutral
antibodi
respons
induc
eventu
mice
die
longterm
rifna
treatment
day
initi
h
vsv
infect
promot
surviv
mice
howev
adapt
immun
develop
anim
succumb
rechalleng
conclus
longterm
rifna
treatment
initi
viru
infect
prevent
induct
protect
adapt
immun
wherea
initi
rifna
treatment
h
infect
support
establish
normal
adapt
immun
protect
memori
observ
implic
patient
longterm
ifni
therapi
suppos
treat
live
attenu
vaccin
introduct
phototherapi
ultraviolet
uv
light
standard
treatment
psoriasi
yet
mechan
underli
therapeut
effect
well
understood
method
use
human
mous
keratinocyt
skin
tissu
human
patient
mice
identifi
critic
role
type
interferon
ifn
receptor
chain
regul
benefici
effect
upon
uv
treatment
psoriasi
found
uv
treatment
trigger
ubiquitin
downregul
lead
suppress
ifn
signal
ensu
decreas
express
inflammatori
cytokin
chemokin
sever
imiquimodinduc
psoriasiform
inflamm
greatli
exacerb
skin
mice
defici
ubiquitin
sa
furthermor
mice
benefit
uv
phototherapi
pharmacolog
induct
ubiquitin
degrad
antiprotozo
agent
halofuginon
also
reliev
psoriasiform
inflamm
wild
type
sa
mice
conclus
data
identifi
downregul
uv
major
mechan
uv
therapeut
effect
psoriat
inflamm
provid
proof
principl
futur
develop
agent
capabl
induc
ubiquitin
downregul
treatment
psoriasi
method
obtain
basic
knowledg
direct
antivir
well
immunomodulatori
effect
ifna
subtyp
use
hbv
hydrodynam
inject
hi
mous
model
stabli
transfect
mous
hepatocyt
hbv
express
plasmid
lead
induct
host
immun
respons
hbv
liver
thu
mimick
hbv
infect
vivo
mice
treat
daili
differ
ifna
subtyp
protein
ifnaexpress
plasmid
longterm
endogen
ifn
product
appli
hi
viral
antigen
isg
express
innat
adapt
immun
respons
monitor
serum
liver
spleen
result
applic
ifna
subtyp
protein
inhibit
hbv
replic
vivo
effect
subtyp
decreas
viral
load
therapeut
applic
correl
expand
effector
cell
popul
nk
cell
cell
liver
spleen
hydrodynam
inject
plasmid
encod
effect
ifna
subtyp
pifna
even
potent
hbv
inject
ifna
protein
combin
show
synergist
antivir
effect
hbv
replic
strong
increas
nk
cell
cell
activ
well
isg
induct
liver
result
demonstr
distinct
antihbv
effect
differ
ifna
subtyp
hbv
mous
model
may
relev
new
therapeut
approach
introduct
great
east
japan
earthquak
subsequ
fukushima
daiichi
nuclear
power
plant
incid
result
mass
evacu
reloc
resid
primarili
due
environment
radiationcontamin
due
home
destroy
respons
govern
built
commun
fulli
subsid
temporari
hous
less
per
famili
report
focu
radiat
effect
fukushima
resid
report
look
physic
psycholog
health
resid
temporari
hous
mani
afflict
advers
health
issu
deriv
radiationeffect
initi
provid
health
support
evacue
doctor
minamisoma
municip
gener
hospit
hold
health
forum
nine
temporari
hous
commun
everi
two
month
part
program
evacue
underw
medic
test
doctor
could
get
clearer
understand
health
statu
risk
temporari
hous
resid
juli
method
total
femal
male
resid
temporari
hous
enrol
studi
evacue
gener
health
statu
determin
questionnair
variou
blood
test
interferon
productiontest
measur
immun
result
discov
evacue
lower
logifn
valu
mean
se
versu
control
although
blood
test
reveal
substanti
number
evacue
afflict
ill
includ
hypertens
diabet
mellitu
kidney
diseas
approxim
half
unawar
condit
sought
medic
attent
male
evacue
unlik
femal
evacue
ifn
product
physic
activ
level
corel
also
found
correl
immun
abil
psycholog
wellb
correl
differ
male
femal
exampl
femal
evacue
larger
famili
live
grandchildren
tend
higher
ifn
product
abil
male
evacue
spous
talk
concern
troubl
higher
ifn
product
abil
convers
femal
anyon
confid
seem
neg
affect
ifn
level
femal
give
receiv
emot
support
children
live
away
home
tend
lower
ifn
product
conclus
lower
ifn
product
evacue
temporari
hous
suggest
although
safe
radiat
physic
psycholog
health
still
risk
studi
also
highlight
area
resid
need
individu
support
particular
assist
seek
medic
attent
physic
symptom
appear
counselingsupport
femal
evacue
small
famili
male
feel
confid
spous
initi
mean
panacea
believ
reduc
stress
live
temporari
hous
therefor
deserv
attent
method
studi
make
use
lymphocyt
choriomening
viru
lcmv
model
persist
viral
infect
wherein
viral
variant
clone
elicit
persist
infect
quickli
outcompet
immun
respons
induc
immunosuppress
naiv
transgen
lcmvspecif
cell
transfer
mice
onset
midst
persist
viral
infect
demonstr
sever
inhibit
de
novo
cell
prime
midst
persist
viral
infect
vivo
antibodi
blockad
variou
immunosuppress
factor
prior
cell
prime
well
variou
sort
vitro
cultur
strategi
teas
mechan
molecul
cell
type
drive
inhibit
prime
vitro
polar
lcmvspecif
cell
introduc
mice
establish
persist
viral
infect
reconstitut
lost
respons
assess
outcom
virusspecif
cell
respons
ultim
viral
control
result
demonstr
loss
inabl
gener
new
virusspecif
cell
imped
control
persist
viru
mechanist
chronic
type
interferon
ifni
signal
drive
dual
upregul
distinct
popul
suppress
dc
inhibit
prime
persist
viral
infect
therapeut
blockad
ifni
restor
differenti
new
cell
midst
infect
specif
polyfunct
cytokin
granzym
b
produc
lost
upon
viral
persist
interestingli
signal
imped
cell
gener
onset
persist
acut
infect
well
importantli
abil
reconstitut
maintain
cell
persist
viral
infect
enhanc
exhaust
cell
respons
acceler
viral
clearanc
conclus
studi
demonstr
ifni
driven
novel
combinatori
mechan
immunosuppress
limit
respons
persist
viral
infect
importantli
imped
viral
control
therapeut
transfer
mainten
cell
alongsid
tfh
cell
restor
divers
repertoir
helper
cell
subset
acceler
clearanc
persist
viru
introduct
type
ii
interferon
ifn
diverg
impact
host
resist
bacteria
type
ii
ifn
g
activ
macrophag
promot
effect
antibacteri
immun
type
ifn
ab
suppress
macrophag
respons
ifnk
increas
suscept
sever
bacteri
infect
suppress
effect
type
ifn
correl
suppress
macrophag
cell
surfac
ifnk
receptor
ifngr
show
suppress
independ
canon
signal
transduc
activ
transcript
stat
proteindepend
signal
instead
requir
activ
kinas
method
impact
inhibitor
knockdown
subunit
investig
cultur
macrophag
system
lung
bacteri
infect
result
ifnb
stimul
statprotein
phosphoryl
stimul
inflammatori
antivir
respons
independ
activ
inhibitor
block
repress
transcript
ifnbtreat
mous
human
macrophag
therapeut
administr
two
distinct
inhibitor
significantli
reduc
bacteri
burden
inhibitor
directli
impact
bacteri
viabil
therapi
instead
requir
host
ifnk
product
correl
increas
ifnk
respons
macrophag
conclus
find
demonstr
certain
suppress
effect
type
ifn
segreg
abil
induc
canon
inflammatori
antivir
respons
find
implic
target
hostdirect
therapi
bacteri
infect
introduct
interferon
regulatori
factor
key
transcript
factor
express
antivir
cytokin
interferon
stimul
gene
isg
cellular
mechan
activ
wellknown
cell
dampen
activ
less
studi
sever
studi
show
cflipl
inhibit
type
ifnb
product
sinc
gene
control
irf
question
ask
cflipl
affect
activ
method
use
cell
line
includ
x
mef
studi
detect
activ
independ
manner
examin
transcript
gene
control
detect
activ
examin
transcript
gene
control
cell
lack
result
show
cellular
flice
inhibitori
protein
cflip
l
inhibit
activ
mechan
independ
activ
degrad
bestdescrib
cellular
mechan
inhibit
instead
cflip
l
bind
inhibit
interact
map
ctermin
region
cflipl
import
function
similar
show
cflipl
also
inhibit
activ
use
system
specif
trigger
homodim
activ
system
devoid
surprisingli
cflip
l
coimmunoprecipit
impli
cflip
l
use
differ
molecular
mechan
antagon
conclus
data
show
cflipl
antagon
use
differ
molecular
strategi
inhibit
transcript
factor
data
provid
jump
point
futur
area
research
includ
cflipl
inhibit
activ
studi
futur
approach
use
mass
spectrometri
identifi
potenti
cflipl
bind
partner
would
respons
cflipl
inhibit
activ
understand
protein
modul
pathway
use
think
modul
express
applic
clinic
set
disclosur
interest
none
declar
introduct
key
compon
innat
immun
respons
dendrit
cell
dc
power
antigenpres
cell
uniqu
abl
recogn
via
pattern
recognit
receptor
prr
pathogenassoci
molecul
pamp
activ
qualit
differ
adapt
thelper
th
cell
respons
particular
respons
consid
protect
paracoccidioid
brasiliensi
pb
caus
agent
paracoccidioidomycosi
develop
cell
reli
product
subunit
dc
show
pb
inhibit
product
method
mice
defici
strainmatch
wt
control
use
investigationfungu
yeast
form
p
brasiliensi
isol
grown
favanetto
medium
gener
bmdc
bone
marrow
cell
seed
cultur
day
medium
contain
lm
ngml
gmcsf
obtain
bmdc
day
nonand
loos
adher
bmdc
harvest
plate
experiment
use
infect
bmdc
p
brasiliensi
treatment
bmdc
infect
yeasttocel
ratio
incub
fungu
conduct
h
cytokin
quantif
indic
cell
treat
lp
ngml
ngml
zymosn
ugml
zymosan
deplet
ugml
antibodi
antimincl
ugml
cytokin
measur
cellfre
supernat
bmdc
cultur
harvest
determin
tnfa
concentr
use
elisa
result
bmdc
infect
pb
yeast
cell
associ
prr
agonist
h
supernat
collect
cytokin
dosag
gener
tnfa
produc
respons
fungal
infect
amplifi
secret
observ
agonist
ad
contrast
significantli
produc
infect
infect
plu
agonist
treateddc
despit
fact
agonist
alon
induc
significantli
secret
furthermor
pb
drastic
reduc
product
induc
lp
interestingli
fungal
induc
inhibit
observ
subunit
suggest
pb
inhibit
specif
subunit
fact
mrna
express
sever
inhibit
pb
lpstreat
cell
known
fungu
fonsecaea
monophora
suppress
via
engag
prr
mincl
assess
role
prr
inhibit
product
fungal
model
use
mice
lack
prr
block
antibodi
ab
mincl
bmdc
ko
mice
treat
ab
effect
product
tnfa
infect
pb
contrast
defici
caus
reduct
product
cytokin
regard
neither
lack
ab
antimincl
revert
inhibit
cytokin
product
addit
bmdc
treat
ab
plu
lp
infect
pb
produc
signific
level
conclus
preliminari
result
show
pb
prevent
product
via
specif
inhibit
mincl
engag
associ
inhibit
import
activ
dc
infect
pb
disclosur
interest
none
declar
introduct
pathogen
sens
innat
immun
receptor
initi
adapt
immun
respons
upon
activ
sporothrix
schenckii
one
caus
agent
sporotrichosi
opportunist
mycosi
affect
human
mammal
nodlik
receptor
famili
piryn
domain
contain
receptor
togeth
asc
apoptosisassoci
specklik
protein
contain
caspas
recruit
domain
adaptor
form
inflammasom
protein
complex
report
versatil
due
broad
specif
abl
trigger
immun
respons
divers
group
pathogen
end
point
inflammasom
activ
product
fulli
matur
inflammatori
cytokin
well
cell
death
pyroptosi
method
schenckiiinfect
noninfect
wt
mice
follow
day
postinocul
periton
macrophag
total
splenocyt
challeng
schenckii
alkaliinsolubl
fraction
assess
ex
vivo
releas
nitric
oxid
periton
macrophag
also
use
assess
pyroptosi
frequenc
treg
cell
spleen
assess
flow
cytometri
result
mice
gener
suscept
schenckii
infect
shown
higher
spleen
fungal
load
lower
splenic
index
weight
compar
wt
counterpart
furthermor
except
cell
frequenc
day
postinfect
knockout
mice
diminish
mix
cell
frequenc
entir
studi
period
cell
less
prone
releas
proinflammatori
mediat
e
follow
ex
vivo
challeng
interestingli
knockout
mice
higher
treg
cell
frequenc
wt
mice
day
postinfect
coincid
time
higher
cell
frequenc
mice
conclus
intact
inflammasom
essenti
optim
schenckii
control
supposedli
own
trigger
proinflammatori
mediat
helper
cell
respons
thu
link
schenckii
innat
recognit
adapt
immun
respons
data
present
pave
way
futur
prevent
therapeut
strategi
sporotrichosi
introduct
dendrit
cell
dc
present
antigen
cell
also
commun
pivot
inform
environment
context
antigen
uptak
occur
precis
signal
integr
dc
decod
cell
remain
unresolv
address
question
use
doublestrand
dna
pathogen
herp
simplex
viru
hsv
vivo
model
cutan
infect
appli
model
mice
defici
differ
patternrecognit
receptor
prr
pathway
molecul
eg
trif
sting
mav
etc
begun
disentangl
role
differ
prr
signal
pathway
play
drive
hsvspecif
cell
prime
result
effici
cell
prime
reli
heavili
provis
type
interferon
ifn
unexpectedli
found
promin
dna
sens
pathway
lead
type
ifn
product
depend
sting
andor
play
redund
role
hsvspecif
cell
prime
howev
pathway
detect
rna
intermedi
axi
well
molecul
signal
via
mav
essenti
process
moreov
elucid
subtyp
type
ifn
induc
transcript
factor
requir
effect
factor
ifnstimul
gene
conclus
find
demonstr
dc
util
sever
differ
mechan
translat
complex
sens
pathogen
effect
adapt
immun
respons
detect
rna
intermedi
hsv
infect
key
effici
prime
cell
introduct
two
polar
state
macrophag
function
activ
known
identifi
differ
tempor
stage
inflammatori
respons
previous
report
cellular
stress
respons
dramat
enhanc
inflammatori
cytokin
product
cultur
bone
marrow
deriv
macrophag
bmdm
increas
magnitud
durat
gene
transcript
method
real
time
pcr
use
measur
cytokin
express
level
flow
cytometri
perform
identifi
cell
popul
result
use
gmcsf
mcsf
cultur
bmdm
induc
like
macrophag
resepect
report
sensit
stressinduc
enhanc
cytokin
express
vari
state
macrophag
polar
mcsf
cultur
bmdm
exhibit
lower
cytokin
product
markedli
increas
coincid
cell
stress
gmcsf
treat
cell
popul
exhibit
strong
cytokin
product
limit
stress
sensit
resid
tissu
macrophag
liver
exhibit
low
cytokin
express
monocyt
infiltr
liver
follow
acetaminophen
apap
induc
acut
liver
injuri
show
phenotyp
transit
phenotyp
h
exposur
cell
stress
ip
inject
tunicamycin
dramat
elev
lpsinduc
cytokin
product
resid
liver
macrophag
restor
phenotyp
infiltr
cell
transit
statu
late
time
follow
injuri
introduct
west
nile
viru
wnv
infect
human
lead
rang
diseas
outcom
vari
clinic
sign
diseas
sever
mening
enceph
death
inbr
mous
model
use
wnv
diseas
studi
fail
captur
breadth
human
diseas
outcom
limit
conclus
made
term
genet
transcriptom
underpin
viral
suscept
diseas
progress
collabor
cross
cc
mous
model
develop
recombin
inbr
popul
encompass
divers
within
mous
genom
cc
mous
model
effect
present
full
spectrum
diseas
associ
human
wnv
infect
appli
cc
model
toward
understand
transcript
respons
wnv
rang
diseas
outcom
reveal
immun
inflammatori
respons
wnv
infect
method
total
rna
brain
spleen
three
cc
line
asymptomat
symptomat
follow
wnv
infect
analyz
genomewid
microarray
multipl
sampl
postinfect
signatur
differenti
gene
express
link
genotyp
differ
reveal
gene
whose
express
correl
particular
infect
outcom
phenotyp
weight
loss
viral
neuroinvas
clinic
score
result
identifi
set
gene
track
suscept
wnv
infect
includ
number
gene
within
known
innat
signal
pathway
along
potenti
novel
immun
molecul
determin
whether
gene
track
suscept
wnv
infect
cc
mous
model
relev
human
diseas
develop
compar
differenti
gene
signatur
found
cc
mice
rnasequenc
sampl
brain
autopsi
sampl
human
patient
die
wnv
infect
identifi
viral
sequenc
read
infect
human
brain
albeit
differenti
among
brain
region
human
wnv
brain
exhibit
innat
immun
signatur
consist
cn
immun
activ
link
respons
aspect
cc
cn
infectionrespons
profil
conclus
studi
demonstr
util
cc
model
understand
complex
wnv
diseas
outcom
host
respons
includ
tissuespecif
respons
infect
introduct
viral
infect
trigger
fast
effect
cellular
respons
mediat
primarili
product
infb
induc
antivir
state
complex
signal
cascad
therefor
regul
induct
subsequ
ifnb
signal
need
tightli
control
grow
evid
implic
member
tripartitemotif
trim
protein
famili
ligas
critic
player
regul
howev
exact
role
mechan
action
physiolog
relev
activ
vivo
still
remain
poorli
investig
previou
work
lab
reveal
unpreced
larg
number
trim
play
critic
role
enhanc
regul
innat
immun
signal
pathway
studi
role
innat
immun
signal
use
luciferas
assay
overexpress
cell
transient
knock
use
sirna
cell
western
blot
rtqpcr
antivir
assay
result
recent
studi
focus
reveal
overexpress
strongli
increas
activ
infb
isr
promot
consequ
ifnb
well
mrna
level
decreas
knock
cell
upon
infect
compar
infect
treat
control
cell
data
suggest
stimulatori
role
innat
immun
signal
besid
show
antivir
activ
compar
antivir
assay
conclus
sinc
ubiquitin
ligas
activ
mani
trim
link
antivir
function
futur
studi
aim
identifi
interact
factor
potenti
substrat
delin
molecular
mechan
ubiquitin
ubiquitinlik
modif
could
regul
respons
viral
infect
better
understand
posit
regulatori
network
ifn
respons
provid
new
knowledg
help
design
effect
therapeut
disclosur
interest
none
declar
introduct
induct
cellintrins
antivir
defens
via
type
interferon
ifni
requir
recognit
viral
signatur
infect
cellular
recognit
extracellular
cytosol
nucleic
acid
consid
primari
mean
viru
detect
howev
avoid
recognit
self
nucleic
acid
also
import
prevent
autoimmun
threshold
respons
modul
disrupt
homeostasi
membran
perturb
suggest
viral
infect
envelop
virus
must
fuse
cell
membran
entri
evid
suggest
membran
fusion
sens
cell
impact
antivir
gene
induct
method
examin
respons
envelop
viru
entri
absenc
replic
use
ultraviolet
uv
light
inactiv
viru
fusion
associ
small
transmembran
fast
protein
resuspend
lipid
vesicl
examin
role
calcium
nucleic
acid
signal
pathway
upstream
ifnstimul
gene
isg
induct
use
combin
fluoresc
microscopi
chemic
inhibitor
genet
knockout
result
found
calcium
signal
nucleic
recognit
pathway
requir
full
antivir
respons
envelop
viru
inhibit
calcium
signal
reduc
antivir
respons
uvinactiv
viru
infect
prevent
complet
activ
signal
complex
lipid
vesicl
contain
fast
protein
fusiondefect
mutant
suffici
induc
antivir
respons
despit
lack
nucleic
acid
vesicl
appear
induc
ifni
pathway
involv
calcium
mav
calcium
signal
respons
variou
fusogen
lipidbas
particl
appear
trigger
envelopemembran
fusion
play
role
cellintrins
antivir
respons
respons
envelop
rna
dna
virus
requir
calcium
signal
nucleic
acid
sens
appear
requir
assembl
activ
complex
vesicl
use
model
viru
entri
appear
suffici
induc
ifni
mavsdepend
pathway
absenc
exogen
nucleic
acid
work
elucid
natur
antivir
respons
role
calcium
activ
disclosur
interest
none
declar
introduct
cell
intrins
innat
immun
provid
rapid
first
line
defens
thwart
invad
viral
pathogen
product
antivir
cytokin
inflammatori
chemokin
howev
presenc
mani
signal
pathway
liver
role
hbv
pathogenesi
unknown
recent
identif
intracellular
dna
sens
pathway
involv
numer
divers
diseas
process
includ
viral
pathogenesi
carcinogenesi
suggest
role
process
hbv
infect
dna
genom
method
order
character
hbv
intrins
innat
immun
respons
role
dna
rna
sens
pathway
liver
recognit
hbv
util
vivo
vitro
model
includ
analysi
gene
express
liver
biopsi
hbv
infect
patient
addit
mrna
protein
express
measur
hbv
stimul
dna
treat
hepatoma
cell
line
heparg
primari
human
hepatocyt
phh
specif
rna
dna
depend
innat
inflammatori
pathway
signal
studi
well
addit
pathway
involv
product
interferon
chemokin
may
drive
subsequ
liver
diseas
sirna
experi
util
determin
signal
pathway
involv
hbv
recognit
microarray
analys
use
character
global
transcriptom
chang
hbv
infect
primari
human
hepatocyt
uv
inactiv
hbv
util
determin
effect
observ
viral
replic
result
hbv
foreign
dna
result
rapid
innat
immun
respons
hepatocyt
character
product
inflammatori
chemokin
mrna
protein
level
analysi
liver
biopsi
hbvinfect
patient
support
correl
among
hepat
express
specif
antivir
gene
includ
addit
hbv
elicit
much
broader
rang
gene
express
alter
demonstr
microarray
analysi
induct
chemokin
includ
mediat
predominantli
nfkbdepend
pathway
follow
hbv
stimul
conclus
hbv
stimul
pathway
predominantli
activ
inflammatori
respons
would
promot
develop
hepat
hcv
stimul
much
stronger
interferon
respons
understand
mechan
underli
inflammatori
antivir
respons
may
provid
new
strategi
trigger
noncytopath
clearanc
cccdna
ultim
cure
patient
hbv
infect
disclosur
interest
none
declar
introduct
cell
autonom
immun
mediat
innat
adapt
immun
system
correct
coordin
system
critic
control
intracellular
pathogen
proinflammatori
interferon
ifn
play
key
role
combat
intracellular
pathogen
ifn
capabl
stimul
sever
hundr
gene
includ
ifninduc
gtpase
guanylatebind
protein
gbp
shown
import
control
intracellular
pathogen
order
gbp
exert
antimicrobi
function
must
first
correctli
recogn
target
intracellular
pathogen
show
target
intracellular
pathogen
gbp
part
control
galectin
cytosol
galectin
known
guardian
membran
integr
galectin
bind
galactosid
lumin
surfac
endosom
membran
upon
loss
membran
integr
method
bone
marrow
deriv
macrophag
wild
type
galectin
knockout
mice
stimul
interferon
gamma
ifnk
infect
virul
avirul
vacuolar
pathogen
assess
abil
gbp
target
pathogen
vacuol
immunofluoresc
host
endomembran
disrupt
hypoton
shock
calcium
phosphat
precipit
measur
recruit
gbp
damag
vesicl
immunofluoresc
presenc
bacteri
secret
system
present
pattern
pathogenesi
associ
bacteri
pv
recogn
host
protein
galectin
show
presenc
bacteri
secret
system
lead
recruit
galectin
pv
like
indic
presenc
membran
lesion
associ
insert
bacteri
secret
system
pv
membran
addit
steril
disrupt
host
endomembran
vesicl
chemic
agent
result
gbp
recruit
site
damag
recruit
depend
galectin
direct
deliveri
interferon
ifn
induc
antimicrobi
guanyl
bind
protein
gbp
pv
well
steril
damag
host
vesicl
studi
thu
identifi
galectin
danger
sensor
control
recruit
gbp
pv
damag
vesicl
introduct
human
mxa
protein
belong
famili
dynaminlik
larg
gtpase
exert
antivir
activ
primarili
negativestrand
rna
virus
includ
influenza
iav
mxa
abl
form
higher
order
oligomer
structur
howev
mode
action
mxa
remain
unknown
increas
evid
mxa
target
iav
nucleoprotein
np
conjunct
cellular
deadbox
rna
helicas
requir
effici
iav
replic
order
better
understand
molecular
mechan
action
mxa
analyz
detail
interplay
mxa
viral
target
np
method
assess
potenti
interact
mxa
np
employ
coimmunoprecipit
coip
well
tripartit
splitgfp
system
particular
investig
effect
variou
np
mutant
bind
sensit
mxa
result
data
clearli
show
dimer
variant
mxa
abl
form
stabl
complex
np
addit
bind
mxa
greatli
enhanc
presenc
np
moreov
observ
dimer
form
mxa
abl
sequest
complex
catalyt
inact
form
mxa
fail
mutat
np
reduc
nucleocytoplasm
shuttl
activ
strongli
increas
bind
mxa
mutat
abrog
oligomer
np
strongli
reduc
bind
conclus
data
demonstr
dimer
form
mxa
play
critic
role
antivir
function
henc
oligomer
mxa
presum
storag
form
first
disassembl
dimer
order
sequest
complex
disclosur
interest
none
declar
introduct
sporotrichosi
mycosi
caus
fungi
sporothrix
schenckii
speci
complex
affect
human
anim
sporotrichosi
therapi
difficult
mainli
complic
aris
long
durat
high
toxic
convent
drug
drug
choic
cutan
lymphocutan
form
sporotrichosi
human
small
anim
itraconazol
broad
spectrum
antifung
agent
consid
research
report
associ
antifung
immunomodul
abl
reduc
therapi
durat
decid
assess
possibl
use
imiquimod
associ
itraconazol
increas
therapi
efficaci
sporotrichosi
imiquimod
synthet
imidazoquinolin
immunostimul
properti
own
tolllik
receptor
tlr
activ
innat
adapt
immun
cell
result
secret
proinflammatori
cytokin
chemokin
method
male
balbc
mice
infect
suspens
contain
schenckii
atcc
yeast
cell
pb
subcutan
rout
metacarp
pad
left
back
paw
imiquimod
therapi
initi
h
postinfect
topic
rout
alon
associ
itraconazol
mgkg
oral
rout
day
day
postinfect
mice
euthan
poplit
lymph
node
spleen
remov
respect
cfu
determin
assess
ex
vivo
releas
cytokin
quantifi
cultur
supernat
total
splenocyt
elisa
addit
nitric
oxid
product
imiquimodestimul
thioglycolateelicit
periton
macrophag
healthi
mice
determin
griess
assay
result
number
cfu
recov
imiquimodetr
mice
significantli
greater
itraconazolor
itraconazol
plu
imiquimodetr
mice
seven
time
untreat
control
mice
noteworthi
treatment
itraconazol
alon
ineffect
reduc
fungal
burden
assess
ex
vivo
releas
cytokin
show
level
much
higher
cultur
supernat
total
splenocyt
untreat
imiquimodetr
mice
wherea
increas
cell
imiquimodetr
mice
regard
product
imiquimodestimul
macrophag
higher
concentr
mgml
abl
induc
express
amount
molecul
result
indic
imiquimod
alon
associ
itraconazol
effici
altern
sporotrichosi
therapi
model
use
us
introduct
commun
acquir
pneumonia
caus
primarili
streptococcu
pneumonia
respons
million
ill
episod
hospit
death
annual
us
children
younger
year
old
individu
older
year
vulner
invas
diseas
interleukin
secret
cytokin
produc
mainli
cell
lymphoid
lineag
innat
lymphoid
cell
ligat
result
activ
kinas
downstream
phosphoryl
stat
protein
particular
characterist
express
epitheli
cell
activ
involv
pathogenesi
extracellular
organ
includ
klebsiella
pneumonia
lung
infect
signal
relat
maintain
barrier
integr
mediat
recruit
leukocyt
induct
antimicrobi
peptid
hypothes
enhanc
either
recombin
absenc
translat
decreas
pneumococc
lung
burden
dissemin
method
flfl
albumincr
mice
use
assess
endogen
product
upon
pneumonia
lung
infect
recombin
fc
isotyp
control
given
intraperiton
rout
mice
pneumococcu
infect
evalu
exogen
effect
bacteri
dissemin
result
rapidli
induc
lung
pneumococc
infect
wild
type
mice
mice
higher
pneumococc
burden
compar
control
addit
mice
hepaticspecif
delet
also
higher
bacteri
burden
lung
liver
compar
litterm
control
intrapulmonari
pneumococc
infect
thu
hypothes
enhanc
signal
would
control
pneumococc
burden
lung
tissu
experiment
pneumonia
model
administr
recombin
system
infect
wild
type
mice
decreas
bacteri
burden
lung
liver
h
post
infect
vitro
studi
also
show
serum
mice
treat
improv
opson
capac
complement
increas
complement
bind
spneumonia
pretreat
wild
type
increas
transcript
protein
express
liver
furthermor
pretreat
increas
neutrophil
recruit
higher
cpsa
transcript
lung
neutrophil
mice
pretreat
suggest
may
increas
neutrophil
phagocytosi
due
depend
bacteri
bind
univers
melbourn
parkvil
australia
hokkaido
univers
sapporo
japan
gifu
univers
gifu
japan
introduct
lyssavirus
includ
rabi
viru
compris
global
distribut
genu
zoonot
pathogen
caus
incur
rabi
diseas
human
anim
casefat
rate
human
deathsyear
central
lyssaviru
pathogenesi
capac
shut
inflamm
central
nervou
system
involv
intric
mechan
immun
evas
lyssaviru
p
protein
viral
interferon
ifn
antagonist
interact
subvert
typei
interferon
signal
recent
found
p
also
target
stat
includ
therebi
modul
respons
multipl
cytokin
includ
suggest
broad
role
modul
innat
immun
signal
show
prevent
pstat
interact
prevent
subvers
ifn
signal
render
normal
lethal
rabi
viru
nonleth
thu
pstat
interact
critic
diseas
potenti
target
design
vaccin
therapeut
howev
structur
basi
p
bind
stat
consequ
mechan
stat
antagon
unresolv
furthermor
precis
impact
p
complex
signal
network
initi
cytokin
remain
poorli
understood
method
elucid
structur
pstat
interact
delin
effect
cytokin
signal
use
combin
approach
incorpor
immun
signal
assay
function
genom
techniqu
viral
revers
genet
diseas
model
biophys
structur
biolog
approach
gener
first
direct
structur
data
pstat
complex
data
indic
involv
novel
surfac
p
previous
implic
statbind
use
approach
defin
region
stat
bound
p
provid
insight
mechan
pdepend
stat
shut
well
discov
pprotein
coordin
regul
stat
interact
respect
critic
interact
viralhost
protein
also
defin
detail
relationship
p
member
stat
famili
data
indic
specif
interact
distinct
stat
enabl
precis
regul
cytokin
signal
conclus
data
provid
first
insight
region
p
mediat
interact
stat
p
coordin
interact
stat
import
interactor
virushost
interfac
togeth
function
data
pprotein
modul
cytokin
signal
provid
import
new
insight
fundament
molecular
event
lethal
viru
effici
disabl
inflamm
addit
structur
data
identifi
new
target
antivir
approach
aim
render
viru
sensit
innat
immun
granulocytemacrophag
colonystimul
factor
gmcsf
key
cytokin
adapt
innat
immun
system
infect
inflamm
caus
macrophag
mast
cell
lymphocyt
secret
gmcsf
stimul
differenti
myeloid
progenitor
cell
immun
cell
chemotherapi
patient
sometim
given
recombin
gmcsf
molgramostim
sargramostim
increas
product
white
blood
cell
prevent
neutropenia
basal
level
gmcsf
blood
fgml
rang
therefor
low
measur
standard
elisa
enabl
accur
measur
gmcsf
msd
develop
ultrasensit
splex
tm
immunoassay
evalu
perform
clinic
sampl
antigmcsf
monoclon
antibodi
screen
select
base
sensit
specif
affin
gmcsf
secret
differenti
cell
line
develop
character
splex
immunoassay
perform
use
recombin
gmcsf
express
e
coli
anchor
gmcsf
intern
standard
nibsc
code
normal
sera
plasma
specimen
sever
cell
model
screen
assess
perform
ultrasensit
assay
result
splex
gmcsf
assay
provid
limit
detect
lod
fgml
dynam
rang
four
order
magnitud
lower
upper
limit
quantit
fgml
fgml
respect
intrapl
coeffici
variat
cv
qualiti
control
qc
sampl
span
assay
rang
interpl
cv
replic
plate
assay
accuraci
assess
spike
recoveri
experi
averag
spike
recoveri
gmcsf
n
specimen
dilut
linear
averag
recoveri
n
specimen
analyt
specif
demonstr
deplet
eight
specimen
sera
plasma
commerci
antigmcsf
antibodi
includ
splex
assay
deplet
result
show
assay
measur
true
analyt
rather
nonspecif
interact
gmcsf
detect
appar
healthi
specimen
n
median
valu
fgml
serum
n
fg
ml
edta
plasma
n
gmcsf
appear
elev
small
set
autoimmun
specimen
sepsi
specimen
test
valid
assay
specif
perform
measur
chang
gmcsf
secret
sever
cell
model
preand
postdifferenti
undifferenti
monocyt
cell
line
shown
secret
gmcsf
differenti
matur
macrophag
also
expect
gmcsf
secret
hacat
cell
line
decreas
substanti
differenti
matur
keratinocyt
conclus
msd
develop
ultrasensit
gmcsf
immunoassay
fgml
limit
detect
improv
current
elisa
approxim
fold
improv
current
measur
understand
gmcsf
immuneinflamm
cascad
div
immunol
dept
biomol
sci
saga
univ
faculti
med
saga
japan
div
immunol
dept
mol
microbiol
immunol
nagasaki
univ
grad
school
biom
sci
nagasaki
japan
immunolog
kagoshima
univ
grad
school
med
dent
sci
kagoshima
japan
introduct
heterodimer
cytokin
famili
consist
reportedli
produc
innat
immun
cell
myeloid
origin
macrophag
dendrit
cell
respons
tlr
stimul
well
known
maralia
infect
variou
type
immun
suppress
occur
method
mice
infect
plasmodium
berghei
anka
pba
cell
pbaspecif
activ
examin
regulatori
function
cytokin
product
surfac
marker
found
cell
mice
infect
plasmodium
berghei
anka
pba
produc
respons
malaria
antigen
antitcr
mab
cell
hi
hi
express
inhibit
prolifer
cell
tcrb
ko
mice
transfer
cell
either
ko
ko
mice
show
increas
frequenc
ifngproduc
cell
improv
resist
pbainfect
compar
transfer
wildtyp
cell
suggest
cell
regul
protect
host
immun
respons
mannerintracellular
cytokin
stain
indic
cell
distinct
ifngproduc
cell
addit
mab
profoundli
neutral
inhibitori
activ
cultur
supernat
cell
pbainfect
mice
mab
littl
effect
suggest
major
inhibitori
cytokin
produc
cell
infect
pba
conclus
studi
impli
cell
novel
cell
induc
infect
would
like
propos
name
cell
cell
introduct
toll
like
receptor
tlr
essenti
compon
pathogen
detect
system
innat
immun
comparison
cell
surfac
tlr
recogn
extern
specif
pathogenderiv
structur
endosom
tlr
recogn
broadli
nucleic
acid
activ
immun
recognit
pathogenderiv
nucleic
acid
benefici
hostderiv
nucleic
acid
recognit
highli
detriment
host
therefor
activ
endosom
tlr
must
subject
tight
regul
method
use
mice
defici
irap
insulin
respons
aminopeptidas
studi
impact
vivo
immunolog
respons
tlr
ligand
pathogen
studi
vitro
gener
bone
marrow
deriv
dendrit
cell
variou
subclass
ex
vivo
dendrit
cell
macrophag
proinflammatori
cytokin
interferon
respons
studi
elisa
supernat
fluid
qrtpcr
cleavag
irap
interact
studi
immunoprecipit
western
blot
studi
irap
lamp
traffick
confoc
microscopi
gener
lentiviru
contain
irap
specif
shrna
specif
shrna
studi
impact
cytoskeleton
anchor
respons
traffick
result
describ
new
role
irapcontain
endosom
cellular
compart
regul
inflamm
modul
traffick
activ
irapdefici
dendrit
cell
dc
activ
fragment
abnorm
accumul
signal
compart
instead
store
inact
proreceptor
endoplasm
reticulum
er
vitro
experi
demonstr
exacerb
inflammatori
interferon
respons
irapdefici
dc
macrophag
upon
ligand
irapdefici
mice
consist
demonstr
uncontrol
inflamm
culmin
high
level
proinflammatori
cytokin
secret
respons
increas
death
anim
follow
infect
pseudomona
aeruginosa
addit
identifi
molecular
interact
irap
forminlik
protein
mediat
anchor
irap
vesicl
actin
cytoskeleton
network
accordingli
delet
lead
specif
misloc
exacerb
inflamm
confirm
role
irapcontain
endosom
compartment
system
regul
traffick
lysosom
subsequ
activ
conclus
irapcontain
endosom
regul
activ
link
cytoskeleton
remodel
shape
inflammatori
respons
driven
newli
identifi
function
irap
togeth
previous
describ
role
irap
cross
present
antigen
dc
prime
adapt
cell
reveal
irapcontain
endosom
regul
crossroad
innat
adapt
immun
introduct
rigi
key
cytosol
sensor
detect
rna
virus
ctermin
region
activ
product
antivir
interferon
ifn
proinflammatori
cytokin
posttransl
modif
demonstr
regul
rigi
signal
activ
signific
sens
viral
rna
remain
unclear
method
mice
suscept
lethal
rna
viru
infect
show
decreas
cytokin
product
surviv
ageand
sexmatch
mice
mice
monitor
day
intraven
vsv
infect
confirm
posit
regul
innat
antivir
respons
bone
marrow
deriv
macrophag
peripher
blood
mononuclear
cell
viru
replic
hpi
bmdm
respons
vsvgfp
moi
infect
moi
infect
confirm
interact
deacetyl
rigi
respons
rna
viral
infect
cell
transfect
poli
c
cell
lysat
prepar
indic
time
coimmunoprecipit
analysi
endogen
rigi
check
rigi
deacetyl
regul
rigi
bind
doubl
strand
rna
cell
transfect
indic
express
plasmid
day
posttransfect
whole
cell
lysat
subject
dsrna
pulldown
assay
confirm
acetyl
interact
bind
bind
viral
rna
structur
model
result
rigidsrna
complex
posit
lysin
residu
present
result
first
show
rigi
ctermin
region
undergo
deacetyl
regul
viral
rna
sens
activ
deacetyl
rigi
critic
viral
rna
detect
transient
bound
rigi
remov
lysin
acetyl
presenc
viral
rna
promot
rigi
sens
viral
rna
deplet
express
led
impair
antivir
respons
rna
virus
dna
virus
consequ
knockout
mice
highli
suscept
rna
viru
infect
compar
wildtyp
mice
conclus
find
underscor
critic
role
modul
rigimedi
antivir
sens
pathway
method
gain
insight
complex
regul
pathway
kinomewid
sirna
screen
perform
primari
screen
reveal
sirna
significantli
alter
transloc
nucleu
upon
rigi
stimul
top
candid
analyz
three
independ
valid
screen
base
promot
report
assay
riftvalleyfev
viru
replic
take
three
valid
screen
account
novel
regul
rigi
signal
pathway
could
identifi
relev
identifi
hit
regul
hostcel
antivir
defens
demonstr
analyz
impact
influenza
viru
replic
result
cours
screen
identifi
inhibitor
rigi
mediat
activ
shown
activ
rigi
stimul
therefor
constitut
bonafid
neg
feedback
loop
extens
map
experi
reveal
minim
construct
includ
kinas
domain
suffici
inhibit
report
activ
overexpress
experi
furthermor
interact
studi
reveal
bind
rigi
suggest
mediat
phosphoryl
rigi
inhibit
activ
fact
mean
vitro
kinas
assay
could
demonstr
rigi
substrat
subsequ
phosphomass
spectrometri
analysi
identifi
specif
site
rigi
phosphoryl
use
phosphomimet
mutant
identifi
site
could
show
phosphoryl
singl
amino
acid
complet
abrog
rigi
signal
conclus
mean
high
throughput
screen
identifi
novel
feedback
regul
antivir
rigi
signal
pathway
get
activ
subsequ
inhibit
signal
phosphoryl
sensor
rigi
introduct
respiratori
tract
popul
innat
immun
cell
repres
uniqu
compart
pathogen
entri
protect
immun
control
local
innat
immun
poorli
defin
method
use
knoxkout
mice
vivo
viru
infect
bacteri
infect
histolog
luciferas
report
gene
assay
vitro
pulldown
immunoblot
analysi
vitro
ubiquitin
assay
confoc
microscopi
assay
investig
role
control
local
innat
immun
respiratori
tract
result
report
alveolar
macrophag
select
express
ubiquitin
ligas
serv
key
regul
type
interferon
ifn
well
proinflammatori
cytokin
product
upon
infect
found
genet
delet
enhanc
type
ifn
product
fold
bronchoalveolar
lavag
fluid
balf
respons
intranas
influenza
viru
infect
importantli
challeng
wildtyp
mice
influenza
viru
led
lethal
pulmonari
inflamm
injuri
contrast
duo
enhanc
type
ifn
product
none
mice
succumb
infect
histolog
lung
mice
exhibit
attenu
viral
load
reduc
edema
alveolar
hemorrhag
alveolar
wall
thick
neutrophil
infiltr
similarli
delet
markedli
enhanc
product
proinflammatori
cytokin
fold
respons
intranas
lipopolysaccharid
lp
challeng
consequ
mice
die
uncontrol
product
proinflammatori
cytokin
wherea
wildtyp
mice
surviv
lp
induc
endotoxin
shock
mechanist
demonstr
induc
link
ubiquitin
degrad
nemo
key
adaptor
protein
interferon
regulatori
factor
irf
signal
nfjb
signal
use
omphomph
domain
bind
nemo
ubiquitin
nemo
site
conclus
data
demonstr
function
nemo
control
lung
innat
immun
effect
especi
import
mainten
local
immun
homeostasi
disclosur
interest
none
declar
circul
nucleic
acid
associ
caus
agent
autoimmun
diseas
lupu
previous
discov
class
scaveng
receptor
sra
ubiquit
express
essenti
type
interferon
product
respons
extracellular
dsrna
moreov
sra
thought
mediat
uptak
via
clathrinmedi
endocytosi
found
full
interferon
product
requir
signal
endosom
cytosol
rlr
pathway
short
cytosol
tail
sra
predict
signal
capac
recent
show
sra
mediat
interferon
product
absenc
rlr
pathway
involv
although
previou
studi
focus
extracellular
dsrna
prototyp
pathogen
associ
molecular
pattern
hallmark
mani
autoimmun
diseas
presenc
autoantibodi
circul
dna
thu
studi
compar
signal
capac
extracellular
rna
versu
dna
purifi
collagen
cysteinerich
domain
srai
produc
vitro
bind
assay
monitor
traffick
extracellular
rna
dna
follow
uptak
employ
confoc
microscopi
differenti
centrifug
final
identifi
protein
interact
cytosol
tail
srai
employ
bioid
techniqu
biotin
ligas
fuse
cytosol
tail
srai
lead
biotinyl
protein
come
close
contact
biotinyl
protein
precipit
use
streptavidin
identifi
mass
spectrometri
result
found
purifi
collagen
domain
cysteinerich
domain
bind
dna
rna
equal
effici
length
sequenc
independ
fashion
similarli
sracontain
fibroblast
bind
intern
extracellular
dna
rna
similar
effici
kinet
howev
extracellular
dna
fail
elicit
type
interferon
product
despit
presenc
compet
cytosol
dna
sens
pathway
determin
dna
transfect
result
suggest
either
intern
dna
rna
differenti
traffick
upon
bind
uptak
crosstalk
endosom
cytosol
sens
pathway
differ
dna
rna
current
experi
underway
investig
possibl
conclus
understand
cell
recogn
respond
circul
foreign
self
nucleic
acid
critic
develop
clinic
tool
fight
infecti
autoimmun
diseas
find
despit
sra
bind
dna
rna
indiscriminantli
subsequ
cellular
outcom
differ
littl
understood
extracellular
nucleic
acid
traffick
within
cell
upon
uptak
thu
studi
shed
import
light
differenti
traffick
signal
extracellular
dna
rna
fibroblast
import
sentinel
cell
innat
immun
system
given
express
sra
famili
member
robust
induct
type
interferon
respons
pathogen
danger
associ
molecular
pattern
introduct
tolllik
receptor
tlr
detect
pathogen
molecul
mount
immun
respons
requir
microbi
resist
howev
inappropri
activ
also
contribut
inflammationdriven
diseas
atherosclerosi
inflammatori
arthriti
uncov
mechan
rang
tlr
trigger
noncanon
nfkb
initi
inflammatori
respons
pathogen
molecul
also
explor
mechan
might
also
promot
autoinflammatori
diseas
result
mutat
iap
famili
member
xiap
method
bone
marrow
deriv
macrophag
stimul
rang
tlr
ligand
signal
cytokin
induct
examin
western
blot
elisa
assay
mice
challeng
endotoxin
serum
cytokin
level
assay
result
document
rang
differ
tlr
signal
via
adaptor
protein
induc
degrad
iap
protein
bind
partner
result
two
distinct
cellular
outcom
firstli
show
tlrinduc
loss
trigger
noncanon
nfjb
activ
induc
subset
proinflammatori
cytokin
chemokin
secondli
demonstr
absenc
relat
iap
protein
xiap
tlrinduc
degrad
trigger
activ
inflammasom
cleav
therebi
activ
precursor
consist
genet
delet
xiap
myeloid
cell
although
result
overt
phenotyp
sensit
endotoxin
induc
product
vitro
vivo
mechan
tlrinduc
loss
may
explain
respons
pathogen
infect
xiap
mutant
patient
develop
sever
autoinflammatori
diseas
character
enhanc
inflammasom
activ
final
identifi
novel
mechan
prevent
mediat
degrad
requir
type
interferon
ifn
product
abl
repress
tlrinduc
inflammasom
respons
conclus
tlrinduc
loss
repres
univers
mechan
activ
noncanon
nfkb
rang
differ
tlr
famili
member
pathway
like
import
activ
appropri
immun
respons
microbi
infect
case
xiap
loss
trigger
patholog
autoinflamm
mediat
excess
inflammasom
activ
disclosur
interest
none
declar
method
test
hypothesi
exogen
enhanc
act
absenc
lymphodeplet
purpos
select
melanoma
mous
model
tumor
cell
express
melanoma
cellassoci
antigen
act
therapi
transgen
mice
use
sourc
cell
recogn
cell
transfer
melanomabear
mice
compar
strategi
cell
transfer
without
lymphodeplet
act
ii
cell
transfer
irradi
mice
actxrt
iii
cell
transfer
plu
exogen
administr
lymphoreplet
mice
perform
analysi
tumorinfiltr
lymphocyt
flow
cytometri
multicolor
immunohistochemistri
result
treatment
promot
infiltr
persist
adopt
transfer
cell
endogen
cell
tumor
follow
irradi
cell
also
local
tumor
site
effici
persist
sever
reduc
comparison
mice
treat
importantli
found
treatment
led
preferenti
enrich
cell
tumor
site
antigendepend
manner
treatment
also
increas
prolifer
cytotox
abil
tumorinfiltr
cell
reduc
level
result
improv
tumor
control
surviv
benefit
introduct
type
diabet
character
progress
immunemedi
destruct
pancreat
bcell
associ
metabol
dysfunct
caus
mostli
loss
regulatori
cell
treg
recent
studi
shown
defici
receptor
signal
pathway
fact
decreas
respons
measur
phosphoryl
observ
patient
origin
develop
immun
stimul
abl
enhanc
effector
cell
teff
natur
killer
nk
cell
function
well
known
anoth
function
gener
surviv
treg
sever
studi
mous
human
demonstr
therapi
suppress
autoimmun
major
goal
immunotherapi
would
develop
would
select
activ
boost
tolerogen
immun
respons
method
order
achiev
result
select
gener
highqual
anti
human
antibodi
use
phage
display
scfv
librari
antibodi
screen
use
technolog
later
select
rel
inhibit
versu
pakt
select
antibodi
test
vitro
purifi
human
immun
cell
treg
evalu
abil
affect
cell
prolifer
function
also
test
human
pbmc
assay
antibodi
show
total
inhibitori
activ
lymphocyt
popul
other
abl
increas
treg
prolifer
inhibit
time
conclus
current
effort
devot
understand
correl
differ
activ
antibodi
characterist
vivo
test
human
mous
model
underway
disclosur
interest
none
declar
introduct
cytokin
play
key
role
sever
inflammatori
diseas
includ
asthma
atop
dermat
releas
damag
cell
stimul
proinflammatori
signal
pathway
variou
cell
type
cell
innat
lymphoid
cell
mast
cell
macrophag
signal
receptor
complex
cell
membran
consist
receptor
coreceptor
block
signal
axi
solubl
extracellular
form
receptor
shown
benefici
experiment
model
asthma
howev
effect
rather
weak
due
low
ligand
bind
affin
implic
need
better
stronger
antagonist
show
fusion
protein
consist
extracellular
domain
mous
refer
much
potent
inhibit
mous
activ
vitro
vivo
method
isotherm
titrat
calorimetri
use
studi
affin
compar
vivo
mice
inject
intraperiton
consecut
day
follow
periton
eosinophil
infiltr
well
product
splenocyt
upon
vitro
restimul
pma
analyz
day
final
effect
analyz
housedust
mite
hdm
induc
asthma
model
mice
result
isotherm
titrat
calorimetri
show
least
higher
affin
compar
studi
abil
neutral
activ
recombin
vivo
treatment
show
consider
bigger
potenti
inhibit
activ
compar
furthermor
deliveri
sensit
phase
hdminduc
asthma
model
strongli
prevent
infiltr
eosinophil
type
ii
innat
lymphoid
cell
lung
sensit
mice
challeng
hdm
current
test
therapeut
potenti
administ
later
time
point
conclus
togeth
studi
demonstr
improv
potenti
cytokin
blocker
therapeut
use
introduct
respons
viral
infect
type
type
iii
interferon
ifn
exert
common
antivir
activ
distinct
receptor
complex
activ
share
ifntrigg
jakstat
pathway
although
contribut
type
ifn
antivir
defens
well
character
understand
distinct
role
type
iii
k
ifn
overal
antivir
protect
still
emerg
function
beyond
antivir
protect
larg
unknown
method
mice
lack
matur
lymphocyt
ko
mous
strain
total
cell
typespecif
defici
ifnk
signal
use
investig
contribut
adapt
immun
type
iii
ifn
protect
heterolog
simian
rotaviru
rrv
infect
suckl
mice
result
recent
demonstr
type
type
iii
ifn
serv
import
mediat
limit
replic
heterolog
simian
rotaviru
rrv
suckl
mice
cooper
engag
antivir
defens
gastrointestin
gi
tract
howev
also
demonstr
level
rrv
replic
gi
tract
directli
associ
diarrheal
diseas
ko
mice
develop
chronic
infect
resolv
rvtrigger
diarrheal
diseas
kinet
wild
type
mice
clear
rv
infect
also
unexpectedli
observ
rrv
replic
higher
titer
ifnlrdefici
anim
diarrhea
better
control
absenc
ifnk
signal
reduc
diarrhea
elev
viral
titer
also
detect
mice
lack
ifnk
receptor
intestin
epitheli
compart
villincreifnlr
flfl
mice
reveal
depend
observ
effect
presenc
ifnk
receptor
intestin
epitheli
cell
conclus
therefor
type
iii
ifn
may
exert
doubleedg
action
gi
tract
restrict
rv
replic
one
hand
promot
intestin
patholog
introduct
immunotherapi
current
use
combin
radioand
chemotherapi
order
improv
clinic
outcom
surgic
resect
particular
interest
target
stimul
immun
system
optim
dose
regimen
still
need
determin
aim
present
studi
defin
treatment
modal
agonist
method
order
studi
differ
tumor
type
use
two
model
two
differ
mous
strain
compar
two
dose
regimen
depend
whether
metastat
solid
tumor
model
comparison
kruskal
walli
kaplan
meier
analys
perform
also
look
role
cell
nk
cell
interact
within
vivo
deplet
studi
ex
vivo
prolifer
assay
case
expans
immun
cell
test
flow
cytometri
result
appear
metastat
model
two
inject
agonist
suffici
reach
maxim
therapeut
effect
wherea
sever
inject
need
get
therapeut
benefit
solid
tumor
pharmacolog
analysi
show
differ
correl
decreas
nk
cell
respons
sever
inject
agonist
wherea
central
memori
cell
respons
remain
high
even
multipl
inject
interestingli
lack
nk
cell
respons
restor
cell
deplet
suggest
close
relationship
nk
cell
use
agonist
cancer
immunotherapi
much
promis
enabl
signific
reduct
metastas
metastat
solid
tumor
model
howev
dose
regimen
chosen
care
order
maxim
therapeut
effect
agonist
moreov
understand
mechan
tumor
context
crucial
combin
treatment
studi
possibl
futur
human
trial
disclosur
interest
none
declar
introduct
function
overlap
cytokin
cchain
cc
famili
link
varieti
inflammatori
autoimmun
diseas
therapeut
agent
exhibit
select
cc
cytokin
inhibitori
profil
would
display
optim
balanc
efficaci
toxic
vivo
fill
critic
therapeut
void
exist
singl
mab
therapi
lack
optim
efficaci
multipl
cytokin
diseas
modul
small
molecul
jak
inhibitor
display
pancytokin
inhibit
unwant
sideeffect
develop
antagonist
peptid
specif
block
signal
cc
cytokin
without
display
signific
inhibitori
activ
remain
cytokin
cc
famili
hypothes
pegyl
would
increas
halflif
clinic
potenti
peptid
monitor
follow
longterm
administr
mous
monkey
evalu
rheumatoid
arthriti
mous
model
diseas
condit
involv
signal
method
evalu
multipl
concentr
repeatdos
studi
mice
cynomolgu
monkey
blood
sampl
util
flowcytometr
analysi
potenti
effect
lymphocyt
subset
studi
midpoint
upon
studi
complet
evalu
one
aspect
efficaci
agent
compar
steroid
dexamethason
small
molecul
jak
inhibitor
tofacitinib
mice
semiestablish
type
ii
collageninduc
arthriti
cia
result
display
highli
target
effect
lymphoidimmun
cell
lineag
expect
follow
effect
blockad
mous
monkey
compound
exhibit
advers
effect
thu
highlight
agent
select
cytokin
inhibitori
profil
without
strong
offtarget
activ
often
observ
follow
administr
small
molecul
jak
inhibitor
show
moder
yet
equipot
efficaci
compar
small
molecul
jak
inhibitor
tofacitinib
cia
model
determin
evalu
clinic
histopatholog
paramet
conclus
effect
target
vivo
welltoler
follow
longterm
administr
compound
display
high
select
without
signific
impact
remain
cc
cytokin
cytokin
famili
lack
offtarget
effect
stark
contrast
small
molecul
jak
inhibitor
act
block
signal
entir
cc
cytokin
famili
therebi
elicit
cytotox
effect
follow
vivo
administr
repres
welltoler
effect
altern
therapeut
strategi
employ
small
molecul
jak
inhibitor
method
vitro
vivo
model
hbv
infect
use
human
hepatoma
cell
line
chimer
mice
human
liver
respect
antivir
effect
test
articl
assess
measur
hbv
core
antigen
hbv
nucleotid
via
immunoassay
quantit
polymeras
chain
reaction
assay
investig
profil
antivir
effect
dna
microarray
technolog
employ
level
chemokin
secret
determin
enzymelink
immunoassay
result
cell
hbvproduc
human
hepatoma
cell
line
remark
inhibit
product
hbv
replic
intermedi
notabl
time
potent
pegylatedifna
addit
reduc
amount
releas
hbsag
strong
predictor
svr
wherea
pegylatedifna
superior
antivir
effect
probabl
due
rel
greater
induct
ifnstimul
gene
isg
direct
antivir
activ
administr
chronic
hbvinfect
chimer
mice
led
signific
decreas
serum
hbvdna
hbeag
intrahepat
cccdna
lower
level
serum
hbsag
also
observ
compar
control
mice
although
chang
statist
signific
end
examin
global
gene
express
profil
treat
liver
analyz
dna
microarray
although
isg
upregul
larg
disappear
point
gene
set
enrich
analysi
reveal
varieti
process
network
remark
alter
treat
liver
includ
relat
chemotaxi
therefor
examin
effect
chemokin
secret
use
fresh
human
hepatocyt
isol
chimer
mice
compar
pegylatedifna
evok
remark
increas
secret
chemokin
cxc
motif
ligand
drive
immun
cell
chemotaxi
find
indic
vivo
antivir
effect
probabl
account
least
partial
immun
cellmedi
viral
clearanc
conclus
studi
show
potent
antivir
effect
due
prior
activ
induct
isg
also
stimul
immun
cell
chemotaxi
take
introduct
mani
cytokin
potenti
therapeut
applic
sever
includ
interferon
ifn
ifnb
approv
treatment
cancer
andor
autoimmun
diseas
agent
effect
associ
signific
doselimit
toxic
prevent
use
level
suffici
promot
optim
therapeut
benefit
toxic
therapeut
cytokin
like
mediat
via
cognat
receptor
activ
cell
mediat
therapeut
effect
exampl
ifna
indic
treatment
multipl
myeloma
mm
narrow
therapeut
index
approach
seek
minim
doselimit
system
toxic
maxim
tumorspecif
cytokin
exposur
could
greatli
enhanc
therapeut
index
effect
class
ifn
cytokin
method
moder
degre
tumorspecif
may
achiev
attach
cytokin
ifna
tumortarget
antibodi
antibodytarget
cytokin
immunocytokin
highli
activ
show
moder
tumorspecif
sinc
cytokin
still
potent
stimul
receptor
antigenneg
cell
sought
improv
therapeut
index
antibodytarget
cytokin
mutat
cytokin
portion
significantli
reduc
affin
receptor
therebi
make
depend
antibodybas
celltarget
result
demonstr
fusion
protein
consist
mutant
attenu
cytokin
attenukin
tm
attach
tumortarget
antibodi
potent
targetposit
cell
compar
targetneg
normal
cell
shown
antibodyattenukin
tm
fusion
protein
base
multipl
tumor
antigen
hmwmaa
hla
multipl
attenu
mutant
ifna
ifnb
furthermor
evalu
ifna
molecul
tm
variou
mm
xenograft
model
found
molecul
retain
potent
tumortarget
activ
antitumor
efficaci
recent
studi
present
indic
multipl
mechan
involv
robust
antitumor
respons
conclus
taken
togeth
find
suggest
administr
antibodyattenu
cytokin
fusion
protein
cancer
patient
may
promot
robust
cytokinedepend
tumorkil
minim
system
toxic
introduct
increas
list
human
necrot
diseas
cytokin
play
pathogen
role
diseas
often
involv
two
cytokin
share
receptor
compon
henc
display
function
redund
target
monoclon
antibodi
approach
specif
neutral
one
cytokin
often
fail
suppress
vivo
activ
caus
cooper
address
issu
tagaya
lab
bioniz
therapeut
develop
new
technolog
base
structur
inform
avail
short
util
gc
common
gamma
use
cytokin
famili
target
design
first
peptid
block
access
gcmolecul
detail
proofofconcept
demonstr
technolog
seen
recent
public
nata
et
al
novel
inhibitor
block
action
cytokin
effici
vivo
next
switch
focu
block
interplay
anoth
gcfamili
cytokin
two
implic
pathogenesi
celiac
diseas
hypothes
may
show
function
synerg
cell
primari
pathogen
cell
celiac
diseas
method
purifi
human
cell
blood
fac
use
iel
cell
line
establish
celiac
patient
target
cell
stimul
variou
dose
combin
assess
intracellular
signal
event
convent
immunoblot
well
examin
induc
gene
rnaseq
result
report
induc
robust
prolifer
cell
ex
vivo
caus
strong
phosphoryl
akt
mapkinas
wherea
act
preferenti
show
rather
weak
activ
nonstat
intracellular
signal
compon
curious
suboptim
dose
combin
saw
synerg
phosphoryl
major
signal
molecul
stat
akt
erk
also
confirm
rnaseq
induct
granzym
b
key
compon
mediat
cytotox
presum
caus
intestinaltissu
damag
celiac
diseas
environ
conclus
data
although
preliminari
suggest
distinct
role
cell
show
combin
synergist
effect
upon
cooper
may
give
rise
new
mode
cellular
activ
neither
factor
could
accomplish
alon
thu
believ
coinhibit
two
factor
may
effici
therapeut
effect
monotherapi
target
either
second
peptid
show
potent
inhibitori
action
vitro
without
block
gcor
nongc
cytokin
thu
prime
candid
safe
effici
treat
refractori
sprue
diseas
without
establish
treatment
bioniz
therapeut
pursu
clinic
develop
introduct
interleukin
proinflammatori
cytokin
produc
cell
cell
varieti
innat
immun
cell
transcript
mainli
driven
retinoidrel
orphan
receptor
gamma
rorgt
product
induc
vitro
upon
cell
receptor
activ
presenc
certain
cytokin
investig
rel
contribut
differ
immun
cell
type
product
human
rat
mous
whole
blood
compar
effect
sever
select
rorgt
modul
evalu
rel
contribut
rorgt
immun
cell
differ
speci
method
whole
blood
human
rat
mous
stimul
vitro
cell
analyz
fac
analysi
addit
gd
cell
isol
mous
spleen
stimul
product
effect
rorgt
modul
product
cell
evalu
fac
elisa
analysi
result
found
human
rat
whole
blood
predomin
cell
produc
cell
mous
whole
blood
gd
cell
popul
major
cell
also
produc
cell
whole
blood
three
speci
highest
percentag
human
lowest
mous
select
rorgt
modul
show
potent
inhibit
product
cell
gd
cell
interestingli
rorgt
modul
demonstr
differenti
inhibitori
activ
cell
gd
cell
conclus
certain
rorgt
modul
observ
differ
pharmacolog
activ
whole
blood
differ
speci
base
find
differ
across
speci
predomin
cell
sourc
produc
could
one
factor
contribut
observ
underli
mechan
result
differenti
activ
rorgt
modul
cell
vs
gd
cell
clear
requir
investig
disclosur
interest
none
declar
chemokin
receptor
undergo
basal
level
recycl
enhanc
bind
appropri
ligand
addit
canon
marker
use
identifi
popul
mani
subset
particular
cell
popul
identifi
express
chemokin
receptor
chemokin
secret
activ
cell
bind
specif
chemokin
receptor
nearbi
distant
cell
cell
express
appropri
chemokin
receptor
attract
chemokin
site
infect
report
evalu
effect
incub
temperatur
chemokin
receptor
antibodi
outcom
stain
resolut
method
anticoagul
peripher
blood
edta
collect
three
healthi
volunt
donor
use
within
h
collect
cocktail
two
chemokin
receptor
plu
one
follow
antibodi
ad
ul
fresh
whole
blood
incub
min
either
room
temperatur
dark
incub
cocktail
antibodi
ad
sampl
incub
addit
min
room
temperatur
dark
erythrocyt
lyse
leukocyt
fix
use
bd
lyse
solut
sampl
wash
resuspend
stain
buffer
analysi
sampl
acquir
immedi
bd
lsrfortessa
flow
cytomet
acquir
use
applic
set
deriv
whole
blood
specimen
fmo
control
use
evalu
popul
boundari
spectral
spread
acquisit
analysi
done
bd
fac
diva
result
preincub
antihuman
antibodi
demonstr
enhanc
resolut
compar
room
temperatur
control
addit
mani
cell
popul
express
chemokin
receptor
increas
stain
index
antichemokin
receptor
antibodi
preincub
compar
room
temperatur
preincub
conclus
use
peripher
blood
antibodi
identifi
major
subset
cell
observ
incub
antichemokin
receptor
antibodi
min
led
improv
resolut
certain
chemokin
receptor
measur
stain
index
compar
room
temperatur
increas
resolut
receptor
import
consid
low
percentag
subset
help
identifi
introduct
critic
involv
induct
patholog
respons
gut
via
unknown
mechan
previou
studi
use
high
throughput
transcriptom
approach
identifi
gene
signatur
mrna
level
mous
pathogen
cell
target
propos
regul
util
high
throughput
method
includ
microarray
phosphoproteom
defin
regul
network
vitro
differenti
mous
cell
rna
protein
level
also
employ
quantit
pcr
western
blot
test
express
select
target
wild
type
receptordefici
cell
vitro
use
flow
cytometryassist
cell
sort
final
characteris
express
gene
steadi
state
inflam
gut
use
cell
transfer
model
murin
coliti
result
integr
omic
approach
employ
studi
shown
global
impact
signal
gene
express
protein
phosphoryl
vitro
differenti
mous
cell
analysi
data
reveal
novel
gene
protein
regul
signal
previous
uncharacteris
context
confirm
express
select
top
hit
rna
protein
level
use
low
throughput
method
furthermor
isol
distinct
cell
popul
steadi
state
murin
colon
confirm
express
select
target
cell
valid
hit
eg
previous
link
pathogen
cell
shown
involv
inflammatori
bowel
diseas
mimic
human
condit
induc
coliti
mice
via
adopt
transfer
mixtur
wild
type
report
cell
shown
enrich
express
shortlist
gene
target
cell
isol
murin
spleen
mesenter
lymph
node
inflam
colon
integr
omic
approach
use
studi
reveal
novel
target
may
respons
patholog
intestin
disclosur
interest
none
declar
introduct
express
type
interferon
ifn
immedi
host
respons
viral
infect
cytokin
induc
antivir
state
cell
product
antivir
protein
apart
type
ifn
also
modul
immun
cell
function
well
elicit
antiprolif
respons
ifna
compos
multipl
ifna
subtyp
mice
although
bind
receptor
differ
biolog
activ
interest
immunoregulatori
function
ifna
subtyp
cell
respons
use
immunotherapeut
agent
chronic
retrovir
infect
method
investig
influenc
differ
ifna
subtyp
cell
prolifer
activ
effector
function
perform
antigenspecif
cell
prolifer
assay
vitro
impact
ifna
subtyp
cytolyt
capac
cell
analyz
use
vitro
kill
assay
investig
role
ifnabreceptor
ifnar
usag
ifnar
cell
ifnar
dendrit
cell
dc
set
cell
dc
character
flow
cytometri
result
detect
direct
antiprolif
capac
test
ifna
subtyp
cell
particular
strongli
induc
express
cytokin
like
tnfa
ifnk
vitro
ifna
subtypetr
dc
highli
activ
matur
show
increas
product
tnfa
induct
cytokin
cell
ifna
subtyp
requir
ifnar
express
dc
furthermor
ifna
subtyp
stimul
especi
induc
highli
activ
effector
cell
exhibit
improv
cytotox
phenotyp
granzym
b
eom
wherebi
kill
target
cell
cell
enhanc
conclus
result
demonstr
distinct
immunostimulatori
properti
ifna
subtyp
use
develop
futur
immunotherapi
retrovirus
introduct
express
activ
lymphocyt
import
modul
tissu
respons
inflamm
cytokin
induc
prolif
antiapoptot
pathway
epitheli
cell
allow
enhanc
cell
surviv
posit
effect
mainten
epitheli
barrier
gastrointestin
tract
also
neg
effect
contribut
colorect
tumorigenesi
dualnatur
hypothes
biolog
activ
tightli
regul
order
limit
express
site
inflamm
one
environment
cue
could
low
oxygen
often
accompani
inflamm
method
mous
cell
high
low
activ
antibodi
presenc
ficz
last
h
cultur
cell
remain
normoxia
oxygen
cultur
hypoxia
oxygen
three
day
postactiv
introduct
balanc
immun
respons
requir
protect
host
pathogen
microorgan
without
caus
host
damag
critic
host
defens
tcell
depend
local
cytokin
milieu
differenti
effector
helper
th
cell
defin
cytokin
product
function
metabol
play
essenti
role
th
cell
respons
includ
product
hallmark
proinflammatori
cytokin
howev
th
cell
caus
immunopatholog
unless
restrain
antiinflammatori
mechan
interleukin
il
howev
contribut
metabol
th
cell
proinflammatori
hallmark
cytokin
product
versu
known
method
studi
use
glucos
analogu
tunicamycin
restrict
metabol
pathway
th
cell
differenti
intracellular
cytokin
phospho
protein
stain
rtpcr
elisa
cglucos
label
follow
gsm
western
blot
rnaseq
use
determin
effect
differenti
th
cell
result
show
specif
inhibit
cell
differenti
accompani
product
suggest
product
tightli
link
differenti
program
cell
contrast
enhanc
product
cell
even
presenc
known
cytokin
howev
also
accompani
loss
product
mechanist
show
rather
inhibit
glycolysi
inhibit
glycosyl
dampen
surfac
express
thu
reduc
downstream
signal
strikingli
demonstr
essenti
product
cell
contrast
inhibitori
effect
product
also
increas
respons
upregul
express
conclus
studi
reveal
novel
previous
unappreci
antiinflammatori
role
cell
product
respons
furthermor
data
indic
modul
signal
directli
glycosyl
may
exploit
therapeut
target
treatment
cellmedi
inflammatori
diseas
disclosur
interest
none
declar
method
analyz
peripher
blood
mononuclear
cell
pbmc
matern
cord
blood
patient
preterm
labor
ptl
healthi
term
control
examin
cytokin
profil
plasma
sampl
also
perform
utero
fetal
liver
inject
pregnant
femal
order
address
fetal
immun
system
activ
mous
model
found
activ
cord
blood
myeloid
plasmacytoid
dendrit
cell
concord
increas
inflammatori
cytokin
preterm
infant
compar
control
preterm
infant
higher
level
central
memori
cell
phenotyp
well
increas
express
cell
activ
gene
compar
healthi
control
importantli
fetal
cell
prolifer
robustli
produc
ifnk
stimul
fetal
antigen
present
cell
matern
antigen
patient
ptl
alloreact
low
healthi
pregnanc
level
matern
microchimer
increas
among
preterm
infant
possibl
sourc
prime
final
product
cell
immun
activ
result
uterin
contractil
vitro
direct
fetal
liver
inject
activ
cell
pregnant
mice
result
fetal
resorpt
process
prevent
inject
ifnk
ko
tnfa
ko
activ
cell
find
indic
inflammatori
environ
ptl
result
activ
dendrit
cell
cascad
culmin
fetal
cell
prime
matern
antigen
breakdown
maternalfet
toler
thu
aberr
fetal
immun
system
activ
consid
pathogenesi
preterm
birth
subsequ
neonat
complic
disclosur
interest
none
declar
induc
eae
mice
immun
mog
subcutan
score
previous
describ
result
hbcgm
identifi
mint
allel
import
effector
th
cell
differenti
result
confirm
effect
sirnamedi
knockdown
mint
express
cell
diminish
ifnk
express
differenti
analysi
mint
express
differ
th
subset
reveal
mint
highli
express
cell
cell
mint
cko
mice
exhibit
defect
treg
differenti
even
though
rbpj
express
affect
cell
previous
demonstr
notchrbpj
signal
cooper
tgfbsmad
pathway
induc
express
regul
autoimmun
respons
experiment
autoimmun
encephalomyel
eae
eae
mint
cko
mice
reduc
diseas
sever
lower
clinic
score
rel
control
mice
also
less
cell
infiltr
spinal
cord
mint
cko
mice
well
lower
level
product
inflammatori
cytokin
sinc
rbpj
transactiv
promot
possibl
mint
could
indirectli
function
rbpj
regul
express
howev
chip
assay
show
rbpj
bind
locu
intact
mint
ko
cell
conclus
mint
novel
regul
th
differenti
modul
express
via
novel
rbpjsmad
independ
mechan
innatelik
properti
blood
mait
cell
defin
respond
rang
cytokin
produc
proinflammatori
cytokin
independ
tcr
signal
seek
understand
whether
gut
mait
cell
either
health
diseas
possess
similar
innatelik
properti
respons
cytokin
trigger
addit
aim
dissect
tcrdepend
tcrindepend
signal
may
combin
induc
activ
mait
cell
blood
gut
method
pbmc
obtain
adult
whole
blood
leukocyt
cone
nh
blood
transplant
follow
appropri
ethic
review
store
liquid
nitrogen
requir
colon
lamina
propria
lymphocyt
lpl
obtain
either
healthi
adjac
resect
colonrect
cancer
patient
inflam
resect
patient
inflammatori
bowel
diseas
ibd
fresh
gut
cell
use
experi
patient
approach
appropri
consent
tissu
use
scientif
research
pbmc
lpl
either
stain
surfac
marker
includ
rest
stage
stain
intracellularli
express
ifnk
tnfa
follow
overnight
stimul
tcrcytokin
trigger
result
compar
blood
lymphocyt
gut
either
health
diseas
higher
surfac
express
notabl
compart
wherea
less
frequent
express
gut
mait
cell
respond
cytokin
stimul
similar
way
blood
mait
cell
synergis
low
dose
induc
higher
level
activ
addit
combinatori
trigger
tcr
cytokin
signal
potent
activ
mait
cell
blood
gut
health
diseas
howev
gut
mait
cell
show
slightli
differ
function
profil
comparison
blood
counterpart
gut
mait
cell
produc
less
ifnk
cell
tnfa
conclus
gut
lymphocyt
higher
surfac
express
compar
healthi
pbmc
gut
cell
produc
less
ifnk
tnfa
respons
tcrcytokin
trigger
suggest
gut
environ
cytokin
milieu
gut
microbiota
etc
could
impact
phenotyp
function
gut
cell
studi
may
translat
valu
develop
novel
therapi
ibd
target
cell
gut
disclosur
interest
none
declar
introduct
parasit
intestin
worm
helminth
often
establish
chronic
infect
within
host
part
due
abil
activ
modul
andor
downregul
host
immun
respons
inflamm
paradox
also
propos
molecul
deriv
helminth
may
har
novel
immunemodul
treat
autoimmun
diseas
investig
whether
product
deriv
porcin
helminth
parasit
ascari
suum
modul
inflammatori
cytokin
secret
human
dendrit
cell
dc
method
suum
bodi
fluid
abf
harvest
adult
worm
collect
intestin
infect
pig
monocytederiv
human
dc
cultur
tlragonist
lipopolysaccharid
lp
either
presenc
absenc
abf
cytokin
secret
measur
cell
cultur
supernat
elisa
addit
rna
extract
cell
microarray
illumina
beadchip
geneset
enrich
analysi
gsea
perform
elucid
intracellular
pathway
modul
suum
select
gene
shown
differenti
regul
microarray
valid
qpcr
correspond
protein
level
investig
elisa
flow
cytometri
andor
western
blot
result
respons
dc
lp
profoundli
affect
abf
secret
inflammatori
cytokin
tnfa
strongli
suppress
abftreat
dc
microarray
analysi
abftreat
dc
indic
downregul
numer
gene
encod
cytokin
chemokin
well
molecul
involv
intracellular
inflammatori
pathway
dc
adhes
migrat
gsea
indic
abf
treatment
signific
disrupt
number
pathway
involv
inflamm
chemokin
signal
notabl
abf
strongli
inhibit
product
abrog
secret
reduc
express
adrenerg
receptor
contrast
express
nrro
neg
regul
reactiv
oxygen
product
inflammatori
respons
significantli
enhanc
conclus
bodi
fluid
helminth
parasit
suum
contain
molecul
strongli
inhibit
inflammatori
respons
human
dc
aberr
inflammatori
cytokin
product
dc
link
autoimmun
inflammatori
disord
abf
may
provid
sourc
immunomodulatori
molecul
therapeut
potenti
result
also
may
shed
light
hostparasit
interact
ascari
infect
suum
human
counterpart
lumbricoid
success
colonis
billion
pig
peopl
worldwid
result
first
examin
express
receptor
surfac
cell
pbmc
express
peripher
blood
cell
express
detect
h
stimul
presenc
found
signific
increas
differenti
induc
treg
although
signific
increas
frequenc
induc
treg
upon
treatment
differ
observ
express
induc
natur
treg
preliminari
find
found
regul
percentag
cell
gener
memori
cell
presenc
polar
factor
present
studi
reveal
could
potenti
candid
treatment
inflammatori
disord
like
rheumatoid
arthriti
inflamm
modul
balanc
result
loss
immun
toler
antibodi
induct
phase
eae
show
similar
attenu
diseas
reduct
respons
mice
indic
key
role
prime
autoreact
cell
surprisingli
cell
mogimmun
mice
capabl
induc
diseas
follow
transfer
wt
recipi
mice
demonstr
product
autoreact
cell
essenti
develop
eae
previous
demonstr
induc
express
cell
also
enhanc
tlrinduc
product
dendrit
cell
final
express
cytokin
reduc
lymph
node
mice
compar
wt
mice
earli
stage
eae
provid
evid
play
role
promot
develop
cell
conclus
find
studi
suggest
cn
autoimmun
may
function
primarili
effector
cytokin
promot
chemokin
product
neutrophil
recruit
cell
polar
cytokin
directli
indirectli
promot
induct
expans
pathogen
cell
disclosur
interest
none
declar
introduct
transcript
factor
interferon
regulatori
factor
primarili
express
human
monocyt
b
cell
dendrit
cell
polymorph
gene
significantli
associ
suscept
autoimmun
diseas
system
lupu
erythematosu
sle
peripher
blood
mononuclear
cell
pbmc
sle
patient
express
significantli
elev
compar
express
healthi
donor
pbmc
specif
immun
cell
subset
dy
function
contribut
sle
pathogenesi
known
sle
patient
character
increas
level
autoreact
b
cell
autoantibodi
mice
previous
shown
drastic
reduc
number
antibodi
secret
cell
conclus
made
mice
howev
compromis
discoveri
secondari
mutat
import
multipl
murin
model
lupu
show
mice
protect
pathogen
autoantibodi
determin
similar
function
human
primari
b
cell
sought
character
role
plasmablast
differenti
antibodi
secret
b
cell
activ
method
knockdown
perform
primari
human
b
cell
use
amaxa
nucleofector
follow
vitro
cultur
assay
differenti
b
cell
plasmablast
b
cell
receptor
crosslink
antibodi
combin
stimuli
cpgb
use
activ
b
cell
identif
transcript
target
done
chromatin
immunoprecipit
combin
next
gener
sequenc
b
cell
prolifer
assess
reactiv
dye
dilut
result
upon
knockdown
primari
human
b
cell
mark
decreas
plasmablast
differenti
seen
secret
level
sever
decreas
interestingli
upstream
b
cell
activ
pathway
also
found
decreas
b
cell
knockdown
b
cell
prolifer
also
found
consist
decreas
follow
knockdown
chipseq
experi
identifi
enrich
promot
region
sever
plasmablastassoci
gene
well
sever
gene
known
impact
b
cell
prolifer
conclus
find
demonstr
first
time
critic
regul
plasmablast
differenti
furthermor
work
suggest
knockdown
impact
earli
stage
b
cell
activ
prolifer
chipseq
result
suggest
upon
activ
act
transcript
regul
larg
group
gene
regul
plasmablast
differenti
b
cell
function
given
plasmablast
overrepres
sle
conclus
work
demonstr
therapeut
potenti
inhibit
disclosur
interest
none
declar
introduct
genet
variant
interferon
regulatori
factor
associ
suscept
system
lupu
erythematosu
sle
regul
express
proinflammatori
cytokin
type
interferon
ifn
believ
involv
pathogenesi
sle
risk
genotyp
shown
associ
elev
express
high
serum
ifna
activ
autoantibodi
product
sle
patient
howev
elev
express
may
result
diseaseassoci
factor
elev
type
ifn
rather
genotyp
furthermor
previou
data
lab
shown
constitut
activ
sle
immun
cell
avoid
interfer
diseas
took
advantag
genotyp
phenotyp
gap
registri
feinstein
institut
medic
research
examin
express
function
healthi
donor
carri
homozyg
risk
nonrisk
genotyp
intermedi
haplotyp
aim
studi
identifi
function
contribut
risk
genotyp
sle
onset
method
express
cellular
local
examin
b
cell
subset
peripher
blood
mononuclear
cell
pbmc
healthi
donor
carri
risk
nonrisk
allel
cgggg
promot
insertiondelet
use
imag
flow
cytometri
activ
determin
ex
vivo
stimul
pbmc
b
cell
subset
gate
follow
plasmablast
character
high
low
surfac
marker
express
b
cell
low
igd
express
transit
b
cell
high
high
express
ifn
gene
signatur
determin
report
assay
antinuclear
antibodi
ana
detect
differ
express
activ
subset
profil
gene
signatur
ana
determin
statist
analysi
surprisingli
neither
express
activ
show
signific
differ
risk
nonrisk
carrier
furthermor
percentag
b
cell
transit
b
cell
show
signific
differ
howev
percentag
plasmablast
significantli
higher
homozyg
risk
carrier
compar
nonrisk
carrier
conclus
result
gap
registri
indic
altern
function
directli
relat
express
activ
given
plasmablast
overrepres
sle
find
support
earli
effect
risk
genotyp
sle
diseas
onset
furthermor
fact
autoantibodi
occur
sle
patient
blood
prior
diseas
onset
data
present
suggest
contribut
risk
genotyp
multipl
aspect
diseas
pathogenesi
conclus
first
find
genotypephenotyp
effect
sle
suscept
healthi
donor
introduct
indoleamin
potent
immunoregulatori
enzym
catalyt
noncatalyt
effect
involv
regul
immun
autoimmun
diseas
cytokin
import
modul
express
interferonc
upregul
dendrit
cell
interleukin
promot
proteasom
degrad
enzym
current
data
show
approxim
patient
type
diabet
exhibit
posttransl
genet
defect
subset
pbmc
character
high
low
high
phenotyp
interestingli
phenotyp
complet
correct
coincub
pbmc
tocilizumab
licens
receptor
blocker
therefor
data
indic
exist
subset
individu
may
gain
clinic
benefit
restor
immunoregulatori
mechan
treatment
tocilizumab
method
aim
verifi
whether
profil
identifi
pbmc
may
also
demonstr
pancreata
use
tissu
specimen
obtain
network
pancreat
organ
donor
npod
pancreat
section
patient
nondiabet
analys
express
local
mmunohistochemistri
result
result
show
produc
alpha
beta
cell
diabet
nondiabet
donor
compar
islet
nondiabet
control
express
level
tend
higher
donor
lower
doubl
autoantibodi
posit
donor
hand
ido
predominantli
produc
beta
cell
interestingli
ido
express
insulin
defici
islet
donor
wherea
still
express
insulin
contain
islet
introduct
system
lupu
erythematosu
sle
often
thought
diseas
driven
molecular
pathway
relat
autoreact
b
cell
antinuclear
antibodi
howev
therapeut
target
b
cell
includ
baff
blockad
partial
effect
sle
nfjb
induc
kinas
nik
mediat
baff
signal
also
noncanon
nfjb
signal
downstream
tnfr
famili
member
thu
hypothes
nik
inhibitor
might
efficaci
baff
blockad
lupu
method
ifnaadv
treat
nzbw
lupu
prone
mice
use
gene
express
monitor
rnaseq
elisa
fluidigm
result
address
gener
nik
small
molecul
inhibitor
highli
select
potent
cellular
assay
molecul
inhibit
noncanon
nfjb
signal
downstream
multipl
tnfrsf
famili
member
signal
includ
tweak
order
differenti
effect
nik
inhibit
baff
blockad
vivo
compar
nik
inhibit
baff
blockad
context
ifnaacceler
nzbw
lupu
prone
mice
predict
nik
inhibit
recapitul
pharmacolog
effect
baff
blockad
furthermor
also
abl
demonstr
role
nik
driven
cell
costimul
vitro
effector
cell
number
ifnanzbw
mice
final
tweak
induc
gene
renal
tubulointerstiti
cell
highli
nik
depend
express
correl
diseas
associ
proinflammatori
gene
ifnanzbw
lupu
prone
mice
inde
express
gene
suppress
nik
smi
treat
antibaff
treat
ifnanzbw
lupu
mice
conclus
collect
data
suggest
nik
inhibit
affect
multipl
diseaserelev
pathway
therefor
superior
efficaci
compar
baff
inhibit
sle
introduct
abc
transport
famili
protein
shown
regul
innat
immun
respons
risk
gene
autoimmun
pancreat
unlik
member
abc
transport
famili
lack
transmembran
domain
thought
function
translat
initi
interact
eukaryot
translat
initi
factor
method
order
studi
develop
diseas
use
singl
gene
trap
insert
gene
embryon
stem
cell
es
cell
allow
lineag
trace
endogen
promot
follow
express
bgalactosidas
report
gene
es
cell
heterozyg
mice
produc
live
born
ever
gener
lethal
mous
strain
specif
result
found
embryon
lethal
day
post
coitum
dpc
appear
development
normal
fertil
show
signific
differ
anatomi
compar
wild
type
litterm
promot
found
activ
tissu
adult
mice
vari
level
differ
cell
type
furthermor
observ
high
promot
activ
blastocyst
embryo
conclus
overal
express
embryo
requir
develop
express
adult
highli
correl
activ
prolifer
differenti
cell
type
introduct
drive
pathogenesi
autoimmun
diseas
promot
immun
fungal
infect
date
signal
pathway
still
well
understood
bind
receptor
initi
recruit
adaptor
protein
lead
activ
nfjb
mapk
pathway
pathway
neg
regul
ubiquitin
edit
protein
gene
associ
autoimmun
diseas
gwa
studi
gene
product
factor
accordingli
hypothes
might
function
inhibitor
signal
pathway
method
use
cell
murin
fibroblast
perform
sirna
knockdown
mrna
extract
rtpcr
analysi
protein
extract
western
blot
analysi
analysi
supernat
elisa
addit
cell
use
analyz
proteinprotein
interact
overexpress
protein
interest
immunoprecipit
wb
promot
activ
measur
luciferas
assay
result
first
knockdown
murin
stromal
cell
line
led
enhanc
express
gene
lipocalin
reconstitut
fibroblast
gene
normal
express
surprisingli
dispens
inhibit
knockdown
enhanc
signal
cell
line
similar
deubiquitin
enhanc
presenc
sinc
mani
neg
regulatori
signal
part
ligandinduc
feedback
loop
investig
whether
express
regul
signal
interestingli
mrna
express
upregul
follow
stimul
cell
protein
level
decreas
conclus
collect
data
indic
inhibit
signal
pathway
independ
feedback
loop
differenti
impact
mrna
protein
method
evalu
proinflammatori
role
osm
mous
model
skin
inflamm
induc
intraderm
inject
murin
osmencod
adenoviru
adosm
comparison
adress
contribut
model
imiquimodinduc
psoriasislik
skin
inflamm
result
firstli
show
osm
potent
regul
express
gene
involv
skin
inflamm
epiderm
differenti
murin
primari
keratinocyt
vivo
intraderm
inject
adosm
mous
ear
led
skin
inflamm
epiderm
thicken
keratinocyt
prolifer
minim
effect
observ
inject
osm
overexpress
skin
increas
express
antimicrobi
peptid
chemokin
cytokin
correl
neutrophil
macrophag
infiltr
contrast
osm
downregul
express
epiderm
differenti
gene
filaggrin
howev
osm
express
requir
murin
model
psoriasi
induc
topic
applic
imiquimod
demonstr
inflammatori
phenotyp
osmdefici
mice
wildtyp
mice
treat
antiosm
antibodi
conclus
collect
result
support
proinflammatori
role
osm
overexpress
skin
express
necessari
develop
psoriasislik
skin
inflamm
topic
applic
imiquimod
method
construct
experiment
autoimmun
encephalomyel
eae
model
detect
whether
express
correl
autoimmun
diseas
eae
model
transgen
mice
protein
use
moreov
diseas
symptom
observ
histopatholog
chang
analyz
inflamm
reaction
detect
fac
elisa
realtim
pcr
result
studi
found
level
mous
sera
increas
onset
peak
stage
eae
moreov
demonstr
efficaci
model
eae
mirror
chronic
progress
multipl
sclerosi
shortterm
system
treatment
recombin
reduc
clinic
sever
incid
eae
addit
use
mice
model
found
onset
sever
eae
appear
inflammatori
infiltr
spinal
cord
subsequ
demyelin
axon
damag
significantli
allevi
mice
compar
control
mice
sought
elucid
basi
protect
effect
eae
character
effectorregulatori
respons
presenceactiv
encephalitogen
cell
sever
inflammatori
mediat
peripher
lymphoid
organ
central
nervou
system
downregul
mice
conclus
find
indic
play
pivot
role
pathogenesi
eae
provid
insight
role
recombin
uniqu
therapeut
agent
treatment
autoimmun
diseas
disclosur
interest
none
declar
introduct
function
essenti
factor
inflammatori
respons
induc
migrat
adhes
neutrophil
also
trigger
differenti
myeloid
cell
studi
investig
contribut
differenti
chemotact
activ
human
eosinophil
leukemia
cell
line
perform
prolifer
assay
chemotaxi
assay
western
blot
result
induc
morpholog
chang
product
vacuol
indic
induc
differenti
cell
induc
migrat
cell
migrat
inhibit
rottlerin
inhibitor
protein
kinas
c
delta
inhibitor
erk
inhibitor
mapk
induc
phosphoryl
erk
mapk
timedepend
manner
conclus
induc
differenti
cell
chemotaxi
mechan
due
involv
erk
mapk
pathway
find
contribut
understand
eosinophil
biolog
develop
novel
therapi
treatment
allergi
introduct
allerg
asthma
character
bronchoconstrict
allergenspecif
ige
bronchial
inflamm
import
protein
pathogenesi
allerg
asthma
studi
examin
pathogen
mechan
asthma
associ
interact
cytokin
releas
bronchial
epitheli
cell
constitut
apoptosi
neutrophil
method
perform
elisa
assay
western
blot
fac
result
increas
secret
time
dose
depend
manner
secret
suppress
inhibitor
inhibitor
akti
inhibitor
akt
inhibitor
erk
inhibitor
mapk
inhibitor
nfjb
induc
erk
mapk
activ
timedepend
manner
supernat
collect
bronchial
epitheli
cell
treatment
suppress
apoptosi
neutrophil
conclus
find
improv
understand
role
interact
bronchial
epitheli
cell
neutrophil
allerg
asthma
enabl
elucid
asthma
pathogenesi
introduct
hous
dust
mite
hdm
essenti
allergen
allerg
diseas
allerg
rhiniti
asthma
pathogen
mechan
allergi
associ
cytokin
releas
lymphocyt
constitut
apoptosi
neutrophil
studi
examin
whether
hdm
induc
cytokin
releas
lymphocyt
secret
cytokin
involv
modul
neutrophil
apoptosi
method
perform
elisa
western
blot
nfjb
activ
assay
apoptosi
assay
result
normal
allerg
subject
extract
dermatophagoid
pteronissinu
dp
increas
gmcsf
secret
timedepend
manner
secret
suppress
inhibitor
dosedepend
manner
well
inhibitor
akti
inhibitor
akt
inhibitor
erk
inhibitor
nfjb
erk
activ
suppress
akti
nfjb
activ
block
akti
supernat
collect
normal
allerg
neutrophil
dp
treatment
inhibit
apoptosi
normal
allerg
neutrophil
suppress
caspas
caspas
cleavag
conclus
dp
induc
releas
cytokin
pathway
antiapoptot
effect
neutrophil
normal
allerg
subject
result
facilit
elucid
pathogen
mechan
allerg
diseas
method
neonat
pdcdiphtheria
toxin
receptor
pdcdtr
knockin
mice
wildtyp
wt
litterm
control
infect
lowdos
pneumonia
viru
mice
pvm
pfuin
challeng
pfu
week
later
dt
ngg
bodi
weightip
administ
day
post
infect
wt
pdcdtr
neonat
mice
patholog
featur
bronchiol
asthma
assess
treg
isol
viruschalleng
donor
transfer
pdcdtr
wt
recipi
result
temporari
pdc
deplet
reduc
antivir
cytokin
product
increas
viral
load
induc
sever
bronchiol
airway
epitheli
cell
slough
neutrophil
inflamm
phenotyp
associ
significantli
lower
level
failur
expand
treg
ligat
necessari
pdcmediat
prolifer
treg
ex
vivo
viral
challeng
pdcdtr
wt
mice
induc
hallmark
featur
asthma
includ
airway
hyperreact
inflamm
associ
lower
number
antigenexperienc
treg
adopt
transfer
antigenexperienc
wt
treg
primari
infect
prior
viral
challeng
pdcdeplet
mice
prevent
develop
sever
bronchiol
postvir
asthma
contrast
treg
asthmat
pdcdtr
mice
insuffici
suppress
virusinduc
asthma
pdcdtr
recipi
mice
introduct
frequent
viral
lower
respiratori
infect
vlri
allerg
sensit
earli
life
independ
risk
factor
asthma
onset
yet
togeth
significantli
increas
develop
persist
asthma
develop
experiment
model
asthma
investig
synergi
neonat
balbc
mice
inocul
low
dose
pneumonia
viru
mous
pvm
pfu
expos
low
dose
lg
cockroach
antigen
vehicl
control
day
post
infect
dpi
mice
reinfect
week
later
expos
weekli
dose
allergen
result
viru
allergen
coexposur
critic
earli
later
life
diseas
onset
progress
includ
airway
hyperreact
airway
remodel
type
inflamm
allergen
exposur
primari
vlri
increas
releas
impair
antivir
cytokin
product
lead
increas
epitheli
viral
burden
inflamm
airway
smooth
muscl
growth
neutralis
earli
life
prevent
type
inflamm
airway
remodel
revers
dampen
interferon
respons
mediat
cockroach
antigen
substitut
allergen
exogen
attenu
antivir
cytokin
elev
viral
load
promot
airway
remodel
mechanist
found
degrad
dampen
type
ifn
product
plasmacytoid
dc
conclus
summari
identifi
novel
role
regul
antivir
immun
target
attenu
synergist
interplay
two
import
environment
insult
onset
progress
asthma
disclosur
interest
none
declar
introduct
der
p
major
allergen
hous
dust
mite
play
import
role
pathogenesi
allerg
diseas
controversi
regard
whether
der
p
bind
tolllik
receptor
inflammatori
effect
yet
elucid
current
studi
examin
interact
der
p
effect
der
p
cytokin
releas
cell
lymphocyt
among
hous
dust
mite
extract
recombin
protein
interact
der
p
method
perform
malditoftof
ms
analysi
eli
assay
apoptosi
assay
overal
structur
der
p
characterist
immunoglobulin
superfamili
contain
ten
bstrand
form
bcup
fold
two
antiparallel
bsheet
short
helix
two
sheet
separ
allow
format
larg
intern
pocket
narrow
suitabl
bind
larg
flat
molecul
lipidlik
molecul
der
p
caus
increas
secret
neutrophil
surviv
factor
human
monocyt
cell
timedepend
manner
der
p
also
induc
releas
cytokin
normal
allerg
lymphocyt
supernat
treatment
der
p
inhibit
neutrophil
apoptosi
cocultur
lymphocyt
neutrophil
der
p
inhibit
spontan
apoptosi
allerg
neutrophil
conclus
summari
der
p
bind
induc
inflammatori
respons
cytokin
secret
immun
cell
find
may
enabl
elucid
allergi
pathogenesi
specif
allergen
hous
dust
mite
introduct
necrot
cell
death
trigger
inflamm
wherea
apoptosi
contribut
resolut
famili
cytokin
key
player
interact
produc
necrot
cell
induc
steril
inflamm
releas
famili
protein
apoptot
cell
regul
inflamm
describ
novel
cytokin
share
homolog
famili
receptor
antagonist
therefor
propos
neg
regul
famili
receptor
signal
method
concentr
measur
elisa
apoptotictumor
cell
condit
medium
acm
use
stimul
human
primari
immun
cell
respons
acm
determin
cytokin
releas
cytometr
bead
array
well
transcript
factor
activ
luciferas
report
assay
ntermin
process
determin
mass
spectrometri
bind
put
receptor
determin
receptor
bind
assay
pathophysiolog
function
analyz
use
imiquimod
imq
induc
psoriasi
mous
model
anim
compar
wt
control
statist
analysi
perform
use
anova
bonferroni
correct
show
produc
select
human
apoptot
cell
limit
inflamm
deplet
apoptot
cell
provok
enhanc
level
activ
cocultur
human
primari
macrophag
subsequ
induc
cell
activ
ntermin
process
apoptot
cell
gener
matur
cytokin
distinct
properti
fulllength
truncat
bound
xlink
receptor
accessori
proteinlik
howev
show
higher
affin
bind
matur
likewis
confirm
previous
report
lowaffin
bind
precursor
show
increas
affin
matur
receptor
function
precursor
induc
increas
product
human
macrophag
wherea
truncat
reduc
product
attenu
pathway
downstream
ongo
studi
show
select
secret
die
cell
challeng
tolerogen
chemotherapi
immunogen
chemotherapi
moreov
strengthen
role
tolerogen
factor
mice
subject
imqinduc
psoriasi
show
increas
immun
respons
strong
delay
restor
skin
architectur
identifi
mechan
apoptot
celldepend
immun
regul
requir
process
secret
limit
cytokin
product
macrophag
antagon
pathway
subsequ
preserv
low
cell
product
propos
apoptot
cellderiv
counterregulatori
equival
necrot
cellderiv
alarmin
famili
might
relev
resolut
inflamm
autoimmun
cancer
disclosur
interest
none
declar
introduct
first
human
retroviru
discov
still
enigmat
caus
malign
inflammatori
diseas
contrast
hiv
carrier
remain
asymptomat
lifelong
minor
progress
either
fatal
hematolog
malign
adult
tcell
leukemia
atl
neuroinflamm
myelopathi
ham
function
fa
promot
polymorph
correspond
bind
site
associ
increas
atl
ham
suscept
recent
shown
fa
polymorph
link
ifndepend
apoptosi
circul
stem
cell
memori
tscm
fa
hi
level
moreov
fa
identifi
part
ifninduc
gene
signatur
ham
role
pathogenesi
remain
unclear
method
comprehens
explor
fa
express
protein
mrna
function
lymphocyt
activ
apoptosi
prolifer
transcriptom
use
flow
cytometri
thymidin
incorpor
microarray
analysi
pbmc
total
ham
patient
asymptomat
individu
ac
healthi
control
result
tscm
fa
hi
level
differ
three
clinic
group
howev
fa
surfac
express
follow
twostep
increas
first
upon
infect
second
upon
hamtsp
diseas
progress
p
ham
patient
fa
level
correl
posit
lymphocyt
activ
marker
p
neg
age
diseas
onset
p
r
suggest
higher
level
fa
predispos
earlier
aggress
diseas
surpris
find
studi
select
defect
fasmedi
apoptosi
ham
first
ex
vivo
vitro
fa
surfac
express
correl
neg
vitro
apoptosi
p
r
second
fluoresc
microscopi
document
fa
lo
fa
hi
cell
preferenti
undergo
apoptosi
vitro
convers
vitro
treatment
pbmc
agonist
antifa
mab
antagonist
antifa
mab
abl
trigger
apoptosi
restor
select
defect
ham
patient
indic
receptor
function
skew
toward
biolog
pathway
eg
prolifer
inde
fa
express
posit
correl
p
r
lymphoprolifer
upon
vitro
cultur
provir
load
viral
protein
level
system
analysi
ham
vitro
ex
vivo
gene
express
show
trigger
fa
receptor
induc
specif
gene
set
central
role
nfkb
prosurviv
signal
confirm
hypothesi
transcriptom
level
transcript
significantli
correl
fa
mrna
level
enrich
prolif
apoptot
pathway
conclus
comprehens
approach
reveal
twostep
increas
fa
hi
tscm
level
upon
infect
diseas
progress
defect
fasmedi
apoptosi
link
earli
age
onset
possibl
factor
ham
pathogenesi
introduct
proteolyt
process
cytokin
receptor
import
element
regul
signal
capac
control
amount
receptor
cell
surfac
also
creat
solubl
receptor
distinct
biolog
function
interleukin
il
member
famili
initi
describ
antiinflammatori
properti
howev
recent
studi
reveal
overshoot
activ
involv
inflamm
progress
epitheli
cancer
bind
membranebound
receptor
complex
recruit
two
molecul
breceptor
glycoprotein
gp
predominantli
lead
activ
jakstat
pathway
analys
whether
substrat
proteas
whether
proteolysi
might
involv
signal
activ
inhibit
proteas
cell
analys
result
fragment
well
cell
surfac
express
furthermor
use
chimer
receptor
well
receptor
mutant
determin
structur
trait
respons
proteolysi
biolog
activ
solubl
evalu
help
cytokinedepend
cell
addit
investig
whether
present
human
blood
result
found
subject
proteolysi
could
detect
serum
healthi
human
concentr
around
pgml
interestingli
metalloproteas
close
rel
abl
releas
solubl
ectodomain
found
small
part
stalk
region
respons
proteas
specif
furthermor
show
singl
amino
acid
mutat
within
stalk
suffici
gener
variant
addit
ectodomain
shed
membran
stub
process
intramembran
proteas
gammasecretas
releas
abl
bind
result
complex
activ
signal
transduc
activ
transcript
pathway
via
cell
express
membranebound
transsignal
pathway
inhibit
antiinflammatori
design
protein
conclus
proteas
regul
signal
via
cell
surfac
express
gener
biolog
activ
newli
identifi
transsignal
pathway
widen
number
cell
activ
previous
shown
inhibit
transsignal
also
inhibit
transsignal
open
possibl
benefici
effect
vivo
could
least
part
due
blockad
transsignal
disclosur
interest
none
declar
k
ozato
pgd
nichd
nation
institut
health
bethesda
unit
state
introduct
studi
bet
famili
bromodomain
protein
bind
acetyl
core
histon
interact
ptefb
regul
transcript
numer
gene
thought
influenc
epigenet
state
mani
cell
recent
develop
small
molecul
inhibitor
ibet
first
gener
drug
imped
histonebromodomain
interact
demonstr
bet
protein
critic
cell
prolifer
immun
respons
inhibitor
hinder
growth
variou
leukemia
lymphoma
amelior
inflammatori
autoimmun
diseas
thu
inhibitor
offer
new
epigenet
therapi
test
wide
rang
cancer
chronic
diseas
howev
due
uncertainti
specif
metabol
drug
role
innat
immun
inflammatori
respons
fulli
understood
construct
condit
knockout
mice
investig
role
cytokinestimul
macrophag
inflammatori
autoimmun
condit
result
rnaseq
data
indic
regul
highli
select
set
cytokin
chemokin
inflammatori
gene
macrophag
cell
addit
selfrenew
hematopoiet
stem
cell
chipseq
data
show
global
distribut
enhanc
superenhanc
highlight
role
shape
chromatin
landscap
macrophag
conclus
data
support
view
affect
epigenet
state
chromatin
potenti
promis
target
chronic
diseas
introduct
immunotherapi
consider
potenti
improv
diseas
outcom
surviv
patient
cancer
highlight
recent
approv
checkpoint
inhibitor
treatment
melanoma
lung
renal
cancer
immun
cell
cell
target
kill
tumour
cell
howev
tumour
number
mechan
evad
suppress
immun
respons
secret
antiinflammatori
cytokin
recruit
suppress
cell
type
express
immun
checkpoint
ligand
obstacl
develop
success
cancer
immunotherapi
aim
studi
characteris
immunosuppress
mechan
elicit
tumour
cell
util
inform
develop
cancer
vaccin
combin
block
suppress
enhanc
effector
antitumour
immun
respons
method
balbc
mice
inject
tumour
cell
tumourinfiltr
lymphocyt
analys
flow
cytometri
vaccin
experi
mice
immun
heatshock
irradi
tumour
cell
agonist
day
post
tumour
induct
antibodi
inject
one
day
prior
immun
result
develop
tumour
mice
found
invers
correl
cytokin
product
express
coinhibitori
receptor
socal
immun
checkpoint
cell
tumour
drain
lymph
node
cell
express
low
level
checkpoint
secret
high
concentr
tnf
ifnk
contrast
tumourinfiltr
cell
express
high
secret
low
concentr
tnf
ifnk
suggest
coinhibitori
receptor
neg
regul
cell
effector
function
tumour
cell
secret
tgfb
promot
induct
treg
cell
creat
suppress
tumour
microenviron
block
vitro
revers
suppress
effect
tgfb
cell
result
enhanc
cell
prolifer
ifnk
secret
cytotox
activ
moreov
block
reduc
tgfbinduc
treg
convers
possibl
enhanc
secret
ifnk
use
tumour
model
found
therapeut
administr
antibodi
alon
littl
effect
tumour
growth
contrast
treatment
mice
one
day
prior
therapeut
immun
cancer
vaccin
led
erad
establish
tumour
significantli
prolong
surviv
moreov
spleen
cell
mice
immun
vaccin
induc
higher
level
cell
death
ex
vivo
secret
significantli
higher
level
ifnk
compar
cell
mice
immun
vaccin
alon
conclus
find
demonstr
axi
major
control
mechan
dampen
antitumour
cell
respons
block
axi
significantli
enhanc
effector
cell
respons
efficaci
therapeut
vaccin
murin
cancer
model
introduct
cardiovascular
diseas
cvd
includ
atherosclerosi
disord
heart
blood
vessel
key
factor
contribut
earli
stage
cvd
includ
proinflammatori
cytokin
interferon
ifn
ifnk
interleukin
il
tolllik
receptor
stimuli
togeth
trigger
activ
member
signal
transduc
activ
transcript
stat
interferon
regulatori
factor
irf
famili
particular
recent
recogn
promin
modul
inflamm
especi
immun
vascular
cell
atherosclerosi
use
rnaseq
identifi
specif
set
statand
irfdepend
proatherogen
gene
synergist
affect
interact
ifnk
lp
primari
aortic
vsmc
name
multipl
chemokin
adhes
molecul
antivir
antibacteri
respons
gene
base
stat
irf
repres
interest
therapeut
target
target
inhibit
could
promis
novel
treatment
strategi
cvd
method
research
combin
compar
silico
dock
model
vitro
multipl
stat
activ
inhibit
assay
stat
model
gener
use
homolog
procedur
follow
dock
inhibitor
stattic
select
bind
caviti
domain
human
stat
subsequ
perform
follow
vitro
experi
western
blot
analysi
verifi
specif
test
compound
toward
gene
express
analys
qpcr
show
inhibit
express
stat
irf
specif
gene
induc
ifnk
lp
moreov
carri
scratch
assay
check
prolifer
migrat
human
microvascular
endotheli
cell
presenc
test
compound
ifn
result
due
import
inflamm
also
cancer
develop
search
compound
numer
yield
mani
synthet
small
molecul
potent
known
inhibitor
chose
stattic
increas
understand
molecular
basi
stat
protein
small
compound
inhibitor
interact
purpos
gener
new
structur
model
human
stat
subsequ
compar
silico
dock
strategi
appli
provid
evid
suggest
crossbind
specif
stattic
confirm
hmec
vitro
stattic
inhibit
ifnainduc
phosphoryl
also
vari
concentr
second
set
experi
test
effect
stattic
express
mention
stat
irf
depend
gene
respons
ifnk
lp
hmec
strikingli
compound
complet
inhibit
stattic
pretreat
h
h
respect
addit
observ
stattic
abl
inhibit
prolifer
migrat
hmec
respons
ifn
lp
similar
concentr
rang
conclus
collect
data
prove
stattic
simultan
block
activ
proatherogen
statand
irftarget
gene
express
may
offer
promis
avenu
treatment
cvd
introduct
nucleotidebind
oligomer
domain
cytosol
sensor
bacteri
peptidoglycanderiv
muramyl
dipeptid
play
import
role
host
defens
sever
bacteri
viral
infect
acinetobact
baumannii
multidrug
resist
gramneg
bacteria
infect
one
major
caus
mortal
intens
care
unit
although
known
mediat
innat
immun
acinetobact
baumannii
airway
epitheli
cell
role
vivo
pulmonari
infect
baumannii
remain
unknown
studi
sought
defin
role
host
defens
pulmonari
infect
baumannii
method
wildtyp
wt
mice
infect
intranas
baumannii
cfu
bacteri
load
bronchoalveolar
lavag
bal
lung
determin
h
infect
immun
cell
recruit
bal
fluid
also
determin
cytospin
vitro
studi
alveolar
macrophag
isol
infect
baumannii
h
cytokin
chemokin
level
bal
fluid
cell
cultur
supernat
analyz
use
elisa
result
compar
wt
mice
mice
show
significantli
higher
pulmonari
bacteri
load
defici
influenc
immun
cell
recruit
bal
fluid
level
tnfa
higher
bal
fluid
mice
wherea
lower
compar
wt
mice
vitro
assay
reveal
product
tnfa
impair
alveolar
macrophag
final
show
mice
defici
adaptor
molecul
exhibit
impair
bacteri
clearanc
lung
conclus
result
demonstr
pathway
play
import
role
host
defens
pulmonari
infect
baumannii
introduct
pleiotrop
cytokin
produc
mani
cell
type
promot
inflamm
immun
respons
differenti
prolifer
princip
signal
pathway
receptor
activ
janu
kinas
transcript
factor
studi
sought
determin
impact
cellular
surviv
tumor
develop
mycdriven
tumorigenesi
use
transgen
mous
model
burkitt
b
cell
lymphoma
elev
level
cmyc
express
b
cell
lineag
method
mice
gener
either
lack
gene
lack
gene
specif
b
cell
introduct
basophilia
frequent
observ
hematolog
abnorm
chronic
myeloid
leukemia
cml
pathophysiolog
role
undefin
previous
demonstr
inflammatori
chemokin
preferenti
act
normal
hematopoiet
stemprogenitor
cell
hspc
crucial
contribut
mainten
leukemia
initi
cell
lic
bone
marrow
bm
initi
process
cml
howev
major
cellular
sourc
bm
precis
mechan
mainten
lic
remain
investig
delin
cellular
process
facilit
crosstalk
normal
leukem
hematopoiesi
precis
examin
cell
function
normal
hematopoiesi
cml
leukemogenesi
delin
cell
bone
marrow
normal
healthi
mice
cml
mice
flow
cytometr
analysi
gener
bone
marrow
chimera
inject
hematopoiet
progenitor
cell
ten
million
intraven
right
bone
marrow
caviti
cell
hspc
obtain
bone
marrow
wt
toxin
receptor
dtr
mice
transuduc
bcrabl
gene
use
rectroviru
vector
system
result
lic
total
cell
inject
tibial
bone
experi
dt
mutant
dt
administ
licinject
mice
result
basophil
normal
healthi
mice
constitut
express
reveal
flow
cytometr
analysi
moreov
neg
act
hspc
express
either
receptor
regul
normal
hematopoiet
process
especi
hematopoiet
reconstitut
bone
marrow
transplant
moreov
basophillik
leukemia
cell
found
accumul
cml
bone
marrow
mousederiv
lic
induc
cml
develop
inject
tibia
bone
marrow
howev
lic
fail
caus
cml
basophil
deplet
treatment
dt
moreov
cml
develop
prevent
maraviroc
select
inhibitor
specif
receptor
maraviroc
administr
start
immedi
lic
inject
bone
marrow
conclus
intrabon
marrow
basophil
expans
observ
cml
favor
leukemiatrop
hematopoiesi
cml
provid
potent
inhibitor
normal
hematopoiesi
therefor
basophilderiv
may
novel
target
molecul
treatment
cml
introduct
signal
key
compon
inflammatori
respons
complex
recruit
two
molecul
signal
transduc
subunit
ubiquit
express
wherea
express
restrict
hepatocyt
leukocyt
popul
besid
membranebound
form
solubl
form
receptor
found
bind
affin
transsign
mechan
greatli
expand
target
cell
spectrum
shown
mechan
mediat
proinflammatori
action
also
involv
recruit
mononuclear
cell
acut
inflamm
aim
find
proteas
contribut
circul
blood
analyz
whether
gener
site
inflamm
proteolyt
cleavag
infiltr
leukocyt
analyz
proteolyt
process
leukocyt
mous
model
acut
inflamm
air
pouch
model
acut
inflamm
measur
cellular
migrat
inflammatori
cell
releas
cytokin
defin
microenviron
investig
respons
proteas
cleavag
vivo
analyz
differ
proteas
knockout
mous
strain
level
serum
insid
air
pouch
result
could
demonstr
cleav
bone
marrowderiv
macrophag
vitro
well
system
inflamm
vivo
line
hypomorph
exex
mice
show
significantli
ttest
p
less
pouch
lavag
acut
inflamm
compar
wildtyp
mice
although
steadi
state
level
blood
unchang
howev
mice
still
exhibit
normal
cell
migrat
air
pouch
caviti
contrast
defici
mice
orchestr
cellular
influx
rather
reach
site
inflamm
circul
sinc
found
substanti
amount
serum
protein
within
pouch
lavag
result
suggest
one
major
proteas
inflammatori
condit
demonstr
although
transsign
mechan
mandatori
cellular
infiltr
model
local
proteolysi
within
air
pouch
coordin
inflammatori
process
instead
infiltr
circul
independ
manner
sinc
exclud
neutrophil
serin
proteas
potenti
proteas
respons
proteas
gener
circul
remain
unknown
introduct
potent
proinflammatori
cytokin
regul
surviv
prolifer
haematopoiet
cell
yet
cell
type
contextspecif
regul
remain
unclear
found
nfjb
famili
member
play
essenti
role
prevent
uncontrol
product
matur
follicular
fo
b
cell
method
utilis
mice
lack
studi
effect
increas
product
vivo
bone
marrow
chimer
mice
demonstr
caus
dysregul
due
intrins
loss
matur
b
cell
extens
b
cell
vitro
assay
vivo
block
experi
reveal
effect
b
cell
autocrin
paracrin
specif
manner
result
age
studi
reveal
mice
lack
develop
sever
multiorgan
autoimmun
diseas
succumb
prematur
diseas
progress
primarili
mediat
effect
contribut
enhanc
differenti
prolifer
fo
b
cell
turn
result
elev
product
immunoglobulin
autoantibodi
immun
cell
infiltr
sever
organ
due
excess
product
fo
b
cell
activ
threshold
respons
antigen
receptor
tlr
stimul
significantli
reduc
b
cell
paracrin
manner
higher
level
increas
differenti
follicular
helper
cell
fh
show
compon
repressor
transcript
fo
b
cell
absenc
key
regul
lead
uncontrol
express
via
rela
major
dimer
partner
conclus
find
highlight
novel
role
limit
autocrin
signal
matur
b
cell
support
role
prevent
multiorgan
autoimmun
diseas
neg
regul
gene
asid
potent
antiapoptot
properti
iap
central
nfjb
signal
immun
tumor
evas
immun
attack
discov
potent
therapeut
strategi
target
cancer
combin
variou
immunotherapi
class
iap
antagonist
call
smac
mimet
assess
efficaci
determin
mechan
action
combin
smac
mimet
immun
checkpoint
inhibitor
orthotop
syngen
mous
model
glioblastoma
result
smac
mimet
synerg
immun
checkpoint
inhibitor
produc
durabl
cure
mous
model
aggress
cranial
glioblastoma
singl
agent
therapi
ineffect
longterm
survivor
tumor
growth
observ
upon
tumor
rechalleng
suggest
tumorspecif
immun
memori
respons
gener
combin
smac
mimet
inhibitori
checkpoint
blockad
increas
activ
tcell
decreas
suppress
immun
cell
within
tumor
microenviron
furthermor
complement
activ
class
therapeut
depend
cytotox
tcell
activ
conclus
iap
antagonist
incorpor
innat
adapt
immun
kill
tumor
cell
suggest
approach
combin
immunotherapi
highli
effect
treatment
cancer
disclosur
interest
none
declar
introduct
inflamm
genet
mutat
tie
tumor
initi
interact
promot
tumorigenesi
less
investig
underli
mechan
larg
unknown
inflammatori
signal
affect
mutant
mous
model
mimic
mutat
seen
lifraumeni
mous
model
mutat
amino
acid
correspond
human
hot
spot
mutat
amino
acid
investig
addit
possess
pro
antiinflammatori
properti
vivo
contextdepend
manner
endogen
level
affect
spontan
tumor
develop
surviv
mice
remain
larg
unknown
present
interact
defici
mutat
caus
sarcoma
bone
discuss
method
genet
model
mutaion
plu
receptor
defici
use
investig
ineract
defect
signal
defici
caus
tumor
initi
bone
ra
mutat
mice
fed
signal
use
studi
skin
tumorigenesi
current
convent
molecular
patholog
analysi
use
investig
tumor
initi
result
current
studi
found
lack
signal
significantli
shorten
surviv
mice
tumor
express
copi
mutant
gene
lifraumeni
mous
model
interestingli
mice
heterozyg
mutant
lack
signal
significantli
shorten
surviv
also
doubl
incid
osteosarcoma
result
suggest
signal
modul
oncogen
properti
mutant
vivo
lack
signal
close
associ
earli
mutant
stabil
vivo
interestingli
signal
may
play
opposit
role
skin
tumorigenesi
tumorigen
stem
cell
prolifer
shown
ra
mutat
model
descrip
may
due
induct
inflmmatori
cell
via
opposit
molecular
mechan
differ
tissu
author
feel
topic
would
gener
excit
broad
readership
shown
first
time
know
specif
inflamm
genet
defect
caus
tumor
initi
bone
skin
introduct
chronic
myeloid
leukemia
cml
patient
philadelphia
chromosom
ph
gener
reciproc
transloc
chromosom
contain
abl
gene
chromosom
contain
bcr
gene
result
bcrabl
fusion
gene
translat
protein
product
constitut
activ
tyrosin
kinas
protein
tyrosin
kinas
tyrosin
kinas
inhibitor
tki
target
bcrabl
standard
treatment
cml
howev
patient
receiv
tki
start
exhibit
resist
cml
one
resist
mechan
bcrabl
mutat
kinas
domain
effect
manag
newli
develop
tki
howev
bcrabl
mutationindepend
mechan
also
present
exact
mechan
known
method
determin
bcrabl
mutationindepend
mechan
gener
tkiresist
cml
cell
line
mutat
within
bcrabl
fusion
gene
line
call
higher
express
mother
cell
line
result
imatinib
effici
induc
apoptosi
cell
treatment
significantli
inhibit
apoptosi
moreov
viabil
cell
decreas
secret
neutral
addit
autocrin
effect
cml
cell
surviv
secret
affect
stromal
cell
product
chemokin
turn
promot
cell
migrat
stromal
cell
conclus
conclus
data
indic
imatinibresist
cell
acquir
abil
produc
elev
level
affect
imatinib
resist
via
autocrin
effect
promot
cell
surviv
paracrin
effect
control
migrat
stroma
observ
ramif
treatment
tkiresist
patient
introduct
constitut
activ
jakstat
signal
associ
progress
variou
tumor
esophag
squamou
cell
carcinoma
escc
chronic
inflamm
involv
carcinogenesi
cancer
growth
previou
report
show
significantli
associ
treatmentresist
prognosi
escc
also
act
import
transcript
mediat
proinflammatori
cytokin
signal
pathway
contribut
oncogenesi
prevent
apoptosi
enhanc
cell
prolifer
suppressor
cytokin
clone
neg
regul
variou
cytokin
signal
includ
jakstat
pathway
howev
epigenet
silenc
methyl
cpg
island
detect
implic
cancer
develop
variou
cancer
studi
aim
evalu
antitumor
effect
overexpress
use
adenoviru
vetctor
method
evalu
methyl
statu
escc
cell
line
human
tumornorm
tissu
methylationspecif
pcr
vitro
evalu
antiprolif
effect
mechan
examin
antiprolif
mechan
use
jak
inhibitor
faksirna
vivo
model
escc
cell
line
xenograft
mice
patientderiv
tumor
xenograft
mice
pdx
use
human
escc
also
assess
mice
intratumor
inject
control
adenoviru
vector
adlacz
twice
week
week
result
gene
methyl
human
escc
tissu
escc
cell
line
normal
tissu
realtim
pcr
analysi
escc
cell
line
fail
upregul
express
low
level
respons
ifnk
wherea
human
pbmc
remark
upregul
express
respons
ifnk
markedli
suppress
prolifer
escc
cell
line
vitro
regardless
activ
level
induc
apoptosi
via
inhibit
jakstat
pathway
also
fakerk
signal
although
low
activ
level
significantli
suppress
jak
inhibitor
inhibit
jak
stat
fakerk
signal
use
jak
inhibitor
andor
faksirna
show
antiprolifer
effect
regardless
activ
level
vitro
tumor
volum
tumor
weight
significantli
lower
adlacz
especi
pdx
mice
show
better
antitumor
effect
therapi
confirm
express
inhibit
fakerk
signal
vitro
western
blot
inject
tumor
introduct
common
gamma
receptor
cytokin
receptor
signal
pathway
involv
play
pivot
role
control
tlymphocyt
immun
respons
abnorm
constitut
activ
system
pervas
divers
tcell
malign
assess
constitut
phosphoryl
nuclear
transloc
follow
antibodi
purchas
cell
signal
technolog
ruxolitinib
purchas
lc
laboratori
shrna
target
clone
doxycyclineinduc
prsmxpurogfp
vector
retrovirus
contain
shrna
produc
cotransfect
cell
helper
plasmid
express
gagpol
gene
ecotrop
pseudotyp
env
gene
retrovir
vector
use
promega
rnaseq
perform
rna
sampl
extract
tcell
leukemialymphoma
line
mutat
confirm
sanger
sequenc
nanostr
analys
rna
tcell
tumor
extract
rneasi
ffpe
mini
kit
qiagen
ng
total
rna
use
analysi
human
immunoglobulin
gene
express
follow
protocol
nanostr
technolog
fold
increas
calcul
compar
gene
express
normal
purifi
cell
result
activ
mutat
defin
case
constitut
activ
signal
pathway
defin
jak
kinas
inhibitor
ruxolitinib
major
inhibitori
impact
leukem
tcell
line
prolifer
express
nuclear
cell
line
manifest
addict
stat
whether
stat
element
mutat
except
leukemia
chromosom
transloc
activ
stat
mutat
suffici
initi
leukem
cell
prolifer
rather
augment
signal
cytokinecytokin
receptor
pathway
therefor
search
jak
mutat
jak
mutat
identifi
synerg
constitut
phosphoryl
mutat
stat
use
shrna
lossoffunct
analysi
pstat
malign
tcell
line
jak
stat
requir
prolifer
surviv
tcell
line
whether
jak
stat
element
mutat
examin
jak
mutat
cytokin
receptor
requir
jak
activ
scaffold
stat
dock
site
therefor
constitut
activ
requir
full
pathway
includ
cytokinecytokin
receptor
jakstat
element
addit
jakstat
mutat
abnorm
indirectli
augment
cc
cytokin
express
jakstat
signal
demonstr
pervas
constitut
activ
cytokinecytokinereceptor
jakstatpathway
form
tcell
malign
repres
excit
develop
activ
mutat
stat
jak
identifi
mani
case
mutat
suffici
support
leukem
cell
prolifer
augment
signal
cytokinecytokin
receptor
jakstat
signal
pathway
basic
observ
support
clinic
evalu
inhibitor
jakstat
pathway
excit
candid
inclus
multidrug
combin
therapi
tcell
malign
introduct
vascular
endotheli
growth
factor
vegfa
thought
play
pivot
role
lymph
node
expans
inflamm
human
cell
type
mechan
regul
vegfa
intranod
product
remain
elus
investig
abil
dendrit
cell
dc
produc
vegfa
human
activ
lymph
node
unveil
molecular
mechan
respons
activ
vegfa
transcript
inflamm
method
immunohistochemistri
perform
human
reactiv
secondari
lymphoid
organ
dc
day
cultur
stimul
differ
tlr
ligand
h
supernat
collect
vegfa
pge
product
evalu
elisa
eia
respect
involv
differ
transcript
factor
vegfa
product
assess
wb
chip
inhibitor
experi
result
reveal
protumourigen
role
key
inflammasom
adaptor
asc
gc
genet
ablat
asc
reduc
gastric
tumour
growth
augment
cell
death
tumour
epithelium
independ
hematopoieticderiv
immun
cell
chronic
inflamm
suppress
tumourigenesi
associ
reduc
express
gastric
tumour
target
defici
ff
mice
also
decreas
tumour
burden
character
increas
tumour
cell
death
antibodymedi
blockad
reduc
human
gc
cell
growth
vitro
elev
protein
asc
mrna
level
observ
human
gc
tumour
biopsi
conclus
collect
find
reveal
axi
potenti
therapeut
target
gc
disclosur
interest
none
declar
introduct
stroma
play
import
role
breast
cancer
occurr
develop
fibroblast
main
compon
breast
cancer
stroma
order
investig
molecular
mechan
effect
cancer
stromal
fibroblast
breast
cancer
studi
fibroblastspecif
express
investig
human
fibroblast
cocultur
vitro
cogrowth
vivo
human
breast
cancer
cell
impact
breast
cancer
growth
method
human
fibroblast
line
esf
cocultur
human
breast
cancer
cell
line
use
transwel
method
level
mrna
examin
cocultur
esf
cell
rtqpcr
express
level
protein
detect
immunofluoresc
flow
cytometri
prolifer
cocultur
singl
cultur
cell
test
use
cell
count
method
express
breast
cancer
tissu
tumorburden
nude
mice
analyz
use
immunofluoresc
laser
confoc
microscop
effect
tumor
growth
tumorburden
nude
mice
examin
experiment
data
analyz
use
spss
statist
softwar
version
data
present
mean
standard
deviat
differ
two
group
analyz
student
ttest
probabl
valu
p
consid
indic
statist
signific
differ
result
demonstr
absenc
lethal
virusinduc
diseas
caus
intestin
mnv
infect
associ
mnv
dissemin
beyond
mucos
barrier
surfac
hyperact
cytokin
product
virusspecif
cell
model
natur
mnv
exposur
defici
litterm
acquir
mnv
part
commens
microbiom
mice
accumul
elev
number
virusspecif
effector
cell
high
viral
burden
multipl
tissu
associ
patholog
tissu
inflamm
mechanist
combin
uncontrol
viral
replic
heighten
activ
impair
resolut
antivir
cell
respons
contribut
widespread
viralinduc
diseas
conclus
togeth
data
suggest
addit
limit
earli
viral
replic
infect
cell
signal
critic
establish
toler
persist
enter
viral
exposur
limit
viralinduc
diseas
disclosur
interest
none
declar
introduct
tuberculosi
tb
million
death
everi
year
thu
remain
lead
caus
death
infecti
diseas
world
grow
bodi
evid
demonstr
type
ifn
play
detriment
role
tb
pathogenesi
like
interf
ifnkdepend
immun
method
use
murin
aerosol
model
tb
virul
strain
mycobacterium
tuberculosi
btb
induc
high
level
type
ifn
reveal
novel
mechan
type
ifn
may
confer
protect
tuberculosi
infect
absenc
ifnk
signal
result
absenc
type
type
ii
ifn
receptor
led
strikingli
increas
level
arginas
gene
express
activ
infect
lung
characterist
altern
activ
macrophag
correl
increas
bacteri
burden
patholog
decreas
surviv
compar
mice
defici
either
receptor
increas
express
gene
associ
altern
activ
macrophag
well
increas
express
cytokin
decreas
tnf
express
also
observ
thu
absenc
ifnk
signal
type
ifn
suppress
switch
macrophag
protect
classic
activ
permiss
altern
activ
phenotyp
conclus
togeth
data
support
model
suppress
altern
macrophag
activ
type
ifn
tuberculosi
infect
absenc
ifnk
signal
contribut
host
protect
disclosur
interest
none
declar
introduct
similar
type
ifn
ifnab
type
iii
ifn
exert
antivir
antiprolif
effect
jakstat
mediat
pathway
activ
consequ
induc
express
interferonstimul
gene
isg
ifnk
signal
receptor
complex
distinct
ifnab
compos
ifnkr
appear
preferenti
express
epitheli
cell
suggest
ifnk
primari
role
provid
antivir
protect
mucos
compart
ifnkrdefici
mice
develop
due
overlap
activ
type
iii
type
ifn
uniqu
role
ifnk
antivir
immun
yet
elucid
viral
infect
induc
express
type
type
iii
ifn
unclear
cell
respons
ifnk
product
vivo
whether
ifnk
product
induc
mechan
trigger
type
ifn
synthesi
method
order
identifi
sourc
type
iii
ifn
cours
vivo
viru
infect
gener
novel
ifnk
report
mous
code
sequenc
replac
egfp
homolog
recombin
maintain
promot
region
utr
intact
allel
replac
egfp
mice
retain
gene
encod
intact
use
ifnk
report
mous
abl
identifi
ifnkproduc
cell
popul
follow
poli
c
treatment
rna
viru
infect
vivo
result
ifnk
report
mice
show
intraven
administ
poli
c
dsrna
mimet
induc
ifnk
express
predominantli
dendrit
cell
spleen
infect
gastrointestin
tract
indic
mice
rhesu
rotaviru
rrv
dsrna
viru
famili
reovirida
show
epitheli
cell
small
intestin
predomin
sourc
ifnk
induc
pathogen
also
observ
viral
titer
ifnk
report
mice
nonreport
wild
type
mice
genet
background
equival
follow
rrv
infect
suggest
alon
suffici
elicit
adequ
type
iii
ifnbas
antivir
respons
therefor
report
mice
expect
show
enhanc
suscept
viru
infect
experi
suggest
subset
cell
type
respons
ifnk
product
vivo
like
pathogenspecif
sourc
type
type
iii
ifn
given
infect
appear
differ
identifi
cellular
sourc
ifnk
may
offer
insight
ifn
typespecif
versu
disclosur
interest
none
declar
import
type
interferon
ifn
infect
immun
welldocu
vivo
play
import
role
regul
inflamm
classic
known
immunomodulatori
antivir
effect
elicit
follow
bind
cell
surfac
receptor
ifn
also
shown
previous
neg
regul
respons
howev
role
ifn
receptor
specif
regul
respons
characteris
utilis
mice
lack
one
type
ifn
receptor
well
iav
mous
model
infect
identifi
ifn
receptor
play
import
role
regul
respons
vivo
iav
infect
airway
mice
follow
iav
infect
observ
increas
neutrophil
infiltr
elev
level
elucid
mechan
involv
regul
respons
examin
express
inact
precursor
protein
determin
immunoblot
lung
tissu
wildtyp
mice
express
significantli
increas
lung
untreat
mice
suggest
limit
protein
express
vivo
identifi
regul
posttransl
mechan
involv
current
investig
importantli
dysregul
express
mice
correl
increas
suscept
iav
infect
comparison
wildtyp
mice
particular
day
postinfect
mice
lack
display
sever
weight
loss
clinic
sign
diseas
hallmark
featur
ard
name
pulmonari
edema
vascular
leakag
method
stimul
human
peripher
blood
mononuclear
cell
pbmc
plasmacytoid
dendrit
cell
pdc
carri
either
respond
nonrespond
genotyp
synthet
tlr
ligand
hcv
hcvinfect
hepatoma
cell
result
interestingli
irrespect
whether
human
peripher
blood
mononuclear
cell
pbmc
carri
respond
nonrespond
genotyp
stimul
synthet
tolllik
receptor
tlr
ligand
induc
similar
ifn
mrna
well
ifna
protein
respons
furthermor
upon
direct
stimul
hcv
variant
primari
human
plasmacytoid
dendrit
cell
pdc
homozyg
respond
nonrespond
genotyp
show
similar
ifna
protein
express
contrast
cocultur
infect
hepatoma
cell
pdc
carri
nonrespond
genotyp
result
reduc
ifna
well
protein
respons
effect
independ
whether
pdc
carri
normal
hypofunct
variant
unlik
poli
c
stimul
primari
human
hepatocyt
hcv
trigger
pdc
show
mrna
express
line
experi
similar
pdc
preincub
recombin
also
enhanc
ligandinduc
ifn
respons
conclus
data
support
hypothesi
pdc
snp
within
ifnk
locu
affect
cell
function
independ
secret
extracellular
ifnkr
trigger
previous
shown
ifnb
bind
directli
absenc
transmit
signal
contribut
lethal
mous
model
sepsi
previou
studi
also
determin
crystal
structur
ifnb
bound
extracellular
domain
ecd
show
uniqu
interact
interfac
previous
defin
ifnreceptor
complex
enabl
us
hypothesis
molecular
basi
higher
bind
affin
ifnb
compar
ifn
light
structur
function
insight
uniqu
signal
complex
herein
sought
investig
molecular
determin
influenc
stabil
complex
contribut
ifnb
driven
signal
effort
inform
drug
discoveri
antagon
ligandreceptor
interact
method
current
studi
use
sitedirect
mutagenesi
recombin
form
ifnb
transient
transfect
system
express
mutant
form
investig
contribut
key
residu
format
stabl
function
complex
observ
effect
mutat
ifnb
andor
function
use
surfac
plasmon
reson
measur
affin
proteinprotein
interact
flow
cytometri
measur
downregul
cell
surfac
luciferas
assay
western
blot
observ
activ
signal
molecul
realtim
pcr
measur
gene
induct
antivir
antiprolif
assay
observ
effect
mutat
biolog
outcom
identifi
key
interact
interfac
third
subdomain
stabil
ligandreceptor
complex
influenc
aspect
ifnb
function
investig
studi
demonstr
interfac
two
residu
residu
ifnb
central
interfac
f
l
e
v
r
collect
crucial
nanomolar
affin
ifnb
ifnbdriven
downregul
cell
surfac
effici
transmiss
signal
activ
induc
isg
express
drive
antivir
antiprolif
respons
ifnb
well
character
result
current
studi
suggest
key
interact
interfac
influenc
ifnb
driven
signal
locat
site
may
use
target
develop
therapeut
treatment
ifnbmedi
diseas
includ
sepsi
autoinflammatori
diseas
introduct
circul
antibodi
access
tissu
mediat
surveil
elimin
invad
pathogen
immunoprivileg
tissu
brain
peripher
nervou
system
shield
plasma
protein
bloodbrain
barrier
bloodnerv
barrier
respect
yet
circul
antibodi
must
somehow
gain
access
tissu
mediat
antimicrobi
function
method
investig
mechan
antibodymedi
protect
within
barrierprotect
tissu
use
mous
model
genit
herp
infect
result
examin
mechan
antibodi
gain
access
neuron
tissu
control
infect
demonstr
antibodi
cell
requir
protect
host
immun
distal
site
show
memori
cell
migrat
dorsal
root
ganglia
spinal
cord
respons
infect
herp
simplex
viru
type
insid
neuron
tissu
cell
secret
interferonc
mediat
local
increas
vascular
permeabl
enabl
antibodi
access
viral
control
similar
requir
cell
antibodi
access
brain
observ
intranas
challeng
vesicular
stomat
viru
result
reveal
previous
unappreci
role
cell
mobil
antibodi
peripher
site
infect
help
limit
viral
spread
introduct
plasmacytoid
dendrit
cell
pdc
function
potent
produc
typei
typeiii
interferon
viral
infect
express
interferon
pdc
initi
innat
sens
microbi
self
dna
apart
endosom
tolllik
receptor
mediat
dnasens
pathway
parallel
pathway
initi
cytosol
dnasensor
cyclic
gmpamp
synthas
cga
mediat
stimul
interferon
gene
sting
report
induc
immun
activ
differ
human
murin
cell
type
report
function
cgasst
pathway
exist
human
pdc
method
pdc
isol
pbmc
healthi
donor
magnet
beadbas
neg
select
transcript
protein
level
cga
sting
measur
via
qrtpcr
intracellular
flow
cytometri
respect
express
cga
sting
compar
two
known
subset
human
pdc
high
low
pbmc
treat
differ
virus
cytokin
see
express
cga
sting
modifi
differ
stimuli
pdc
flow
cytometri
confirm
subcellular
local
cga
cytosol
compart
pdc
transfect
pdc
non
cpg
doublestrand
singlestrand
dna
see
coloc
cga
imag
flow
purifi
pdc
transfect
sting
agonist
cyclic
gmpamp
cgamp
treat
dsdna
viru
herp
simplex
hsv
synthet
cpga
product
typei
typeiii
interferon
measur
intracellular
flow
cytometri
elisa
result
cga
sting
found
constitut
transcrib
translat
human
pdc
express
cga
sting
compar
high
low
pdc
cga
express
upregul
treatment
typei
typeiii
interferon
hsv
sting
express
remain
unalt
cga
coloc
noncpg
dsdna
timedepend
manner
coloc
ssdna
upon
stimul
cgamp
pdc
produc
ifna
ifnk
timedepend
dosedepend
manner
conclus
function
cgasst
pathway
cytosol
dna
sens
induc
typei
typeiii
interferon
product
human
pdc
serv
complement
endosom
pathway
disclosur
interest
none
declar
method
mice
infect
f
novicida
subcutan
surviv
rate
bacteri
burden
spleen
liver
tissu
monitor
follow
infect
show
compar
infect
wildtyp
mice
mice
lack
type
ifn
receptor
exhibit
increas
resist
toward
f
novicida
infect
wherea
mice
lack
suscept
addit
mice
lack
core
compon
ifnstimul
gene
factor
transduc
type
ifn
signal
show
increas
resist
follow
infect
result
suggest
type
ifn
signal
essenti
activ
francisellainduc
inflammasom
macrophag
compon
strikingli
contrast
effect
vivo
importantli
found
mice
lack
resist
infect
wildtyp
mice
mice
lack
method
use
mice
defici
express
probe
involv
gene
host
respons
lp
three
paralog
gene
ortholog
human
gene
irgm
previous
associ
outcom
sepsi
specif
examin
function
lp
sens
pathway
mice
cross
strain
defici
express
perform
cell
cultur
studi
use
ifnprim
bone
marrow
deriv
macrophag
bmdm
mice
variou
genet
background
defin
role
irgm
protein
pathogenesi
sepsi
mice
inject
intraperiton
lp
monitor
immun
function
morbid
experi
involv
mice
agonist
poli
c
use
stimul
ifn
product
vivo
result
bmdm
show
mark
increas
cell
death
product
follow
treatment
lp
consist
result
mice
exhibit
decreas
surviv
increas
serum
follow
lp
challeng
mice
bmdm
defici
show
increas
sensit
lp
rel
mice
singli
lack
express
hand
bmdm
lack
express
protect
lpsinduc
cytotox
conclus
result
show
protect
lpsinduc
inflamm
cellular
whole
organism
level
furthermor
data
impli
act
key
regul
activ
support
model
wherein
ifn
signal
requir
potent
respons
also
help
contract
inflamm
disclosur
interest
none
declar
introduct
interferon
ifn
classifi
three
differ
type
type
type
ii
type
iii
k
ifn
base
structur
receptor
complex
biolog
activ
human
type
iii
ifn
ifnk
repres
recent
identifi
share
limit
homolog
ifnk
frequent
occur
frame
shift
mutat
gene
use
predict
marker
respons
patient
chronic
infect
hcv
ifnabas
therapi
paradox
presenc
intact
gene
associ
poor
respons
antihcv
treatment
suggest
uniqu
function
studi
temper
difficulti
gener
biolog
activ
protein
particularli
mammalian
cell
due
poor
secret
human
cell
gener
mammalian
express
construct
human
ntermin
flag
tag
result
product
function
protein
express
chines
hamster
ovari
cho
cell
use
mammalian
cellproduc
protein
assess
receptor
bind
biolog
activ
introduct
interferon
lambda
ifnl
potent
antivir
cytokin
wide
implic
mani
chronic
inflammatori
diseas
ifnl
best
known
role
clearanc
hepat
c
viru
infect
substanti
data
support
role
acut
viral
infect
influenza
viral
gastroenter
well
chronic
autoimmun
liver
diseas
numer
tissu
report
ifnl
express
remain
controversi
blood
cell
subset
respons
ifnl
thu
contribut
inflammatori
activ
chronic
diseas
method
monocyt
isol
select
differenti
macrophag
vitro
macrophag
colonystimul
factor
mcsf
granulocytemacrophag
colonystimul
factor
gmcsf
alon
presenc
monocyt
macrophag
ifnl
respons
ifnl
receptor
express
assay
quantit
pcr
qpcr
interferon
stimul
gene
isg
express
western
blot
flow
cytometri
proinflammatori
role
macrophag
differenti
examin
use
rna
sequenc
qpcr
mass
spectrometri
function
readout
includ
chemotaxi
phagocytosi
assay
fluoresc
microscopi
use
identifi
ifnl
receptor
express
macrophag
tissu
affect
chronic
inflamm
result
upon
examin
ifnl
sensit
vitro
demonstr
macrophag
monocyt
respons
myeloid
plasmacytoid
dendrit
cell
leukocyt
popul
signific
ifnl
respons
investig
role
ifnl
macrophag
matur
function
human
monocyt
healthi
subject
differenti
macrophag
use
either
gmcsf
proinflammatori
mcsf
antiinflammatori
alon
combin
macrophag
matur
gmcsf
express
ifnl
receptor
respons
support
role
proinflammatori
cytokin
moreov
increas
express
numer
inflammatorychemotact
cytokin
activ
marker
measur
qpcr
flow
cytometri
respect
function
macrophag
differenti
presenc
phagocyt
toward
apoptot
cell
chemoattract
toward
nk
nkt
cell
lastli
demonstr
accumul
express
macrophag
numer
chronic
inflammatori
condit
support
potenti
drive
proinflammatori
state
conclus
data
suggest
ifnl
may
contribut
chronic
inflammatori
diseas
stimul
proinflammatori
phenotyp
macrophag
thu
drive
advers
immun
cell
respons
unclear
howev
compon
host
immun
respons
regul
process
use
mous
model
iav
sought
determin
rel
role
type
ii
interferon
ifn
dictat
pulmonari
inflammatori
respons
infect
method
pulmonari
cellular
respons
wt
mice
investig
flow
cytometri
gene
express
analyz
qrtpcr
result
recent
work
show
addit
known
antivir
activ
signal
coordin
host
inflamm
iav
infect
mice
regulatori
mechan
depend
type
ifn
ifnk
receptor
signal
importantli
requir
function
interplay
two
pathway
work
demonstr
type
ifn
act
promot
monocyt
recruit
lung
infect
mice
well
prevent
excess
activ
monocyt
ifnk
interestingli
show
type
ifn
preferenti
regul
ifnk
signal
lo
compar
hi
mononuclear
cell
popul
absenc
type
ifn
signal
lo
monocytesmacrophag
becom
phenotyp
function
proinflammatori
hi
cell
reveal
unanticip
function
lo
mononuclear
cell
subset
tissu
inflamm
addit
effect
mononuclear
cell
type
ifn
also
suppress
recruit
neutrophil
iavinfect
tissu
howev
full
neutrophilsuppress
effect
requir
cooper
type
ii
ifn
conclus
studi
demonstr
type
ii
ifn
interplay
link
innat
adapt
antivir
immun
orchestr
tissu
inflamm
furthermor
work
reveal
addit
level
complex
ifndepend
regulatori
mechan
function
prevent
excess
immunopatholog
preserv
antimicrobi
function
disclosur
interest
none
declar
result
first
found
murin
human
pdc
share
lyn
fyn
express
albeit
differ
rel
level
lyn
activ
residu
phosphoryl
tlr
stimul
next
observ
facspurifi
pdc
either
fyn
lyn
defici
mice
exhibit
impair
ifni
proinflammatori
cytokin
product
exvivo
stimul
wherea
differ
enhanc
cytokin
product
observ
facspurifi
convent
dc
furthermor
similar
phenotyp
recapitul
vivo
infect
murin
cytomegaloviru
importantli
could
extend
aforement
find
human
pdc
show
treatment
either
pansfk
inhibitor
bafetinib
profoundli
ablat
tlrinduc
ifni
product
cell
primari
pdc
human
peripher
blood
furthermor
genet
ablat
lyn
cell
also
result
diminish
tlr
respons
inhibit
sfk
activ
impair
key
signal
event
downstream
tlr
stimul
includ
activ
ikkab
nfjb
mtor
human
pdc
strikingli
bcap
phosphoryl
known
bridg
tlr
pathway
profoundli
abolish
pansfk
inhibitor
bafetinib
tlr
engag
conclus
taken
togeth
result
contribut
understand
mechan
tune
pdc
respons
reveal
previous
unappreci
posit
role
sfk
particularli
lyn
tlrinduc
ifni
proinflammatori
cytokin
product
conserv
murin
human
pdc
addit
find
support
model
pdc
receiv
constitut
sfkmediat
tonic
signal
enabl
optim
respons
subsequ
pathogen
encount
given
import
role
pdc
multipl
human
ill
manipul
sfk
activ
pdc
perhap
small
molecul
bafetinib
coupl
pdc
specif
antibodi
could
bring
novel
therapeut
strategi
disclosur
interest
none
declar
method
use
microarray
rnai
molecular
biolog
techniqu
valid
role
differenti
macrophag
cell
result
analysi
differ
step
tlr
activ
respons
lipopolysaccharid
lp
show
knockdown
lead
enhanc
upstream
signal
activ
phosphoryl
phosphoryl
nuclear
local
although
signific
chang
observ
activ
key
compon
pathway
interferon
express
microarray
analysi
cell
suggest
role
posit
regul
interferon
gene
program
induc
lp
unexpectedli
deplet
led
signific
reduct
interferonb
ifnb
express
numer
interferonstimul
gene
consist
result
activ
also
significantli
attenu
deplet
cell
also
observ
reduc
express
respons
influenza
viru
sendai
viru
burkholderia
cenocepacia
bacteri
infect
deplet
cell
suggest
broad
role
support
tbev
replic
inhibit
rodentspecif
isg
function
bind
target
viral
rna
polymeras
lysosom
degrad
closest
human
paralog
highli
character
restrict
factor
thought
retrovirusspecif
studi
reveal
human
h
rhesu
rh
restrict
replic
virus
belong
tbev
serogroup
wnv
denv
method
replic
multipl
flavivirus
test
cell
stabli
express
h
control
altern
express
deplet
use
rnai
cell
treat
ifnb
result
ectop
express
significantli
reduc
product
tbev
affect
wnv
denv
zikv
overexpress
impos
reduct
tbev
titer
wherea
knockdown
partial
rescu
antivir
effect
interferon
treatment
demonstr
first
time
function
viral
pathogen
reduc
product
viral
rna
protein
indic
target
earli
step
viru
replic
howev
unlik
interact
instead
interact
degrad
viral
proteas
critic
viru
replic
unusu
mechan
involv
proteasom
autophagi
protein
gabarap
moreov
coloc
dsrna
suggest
disrupt
viral
replic
complex
conclus
work
demonstr
isg
target
two
differ
viral
protein
hiv
capsid
tbev
proteas
understand
genet
tradeoff
enabl
restrict
one
viru
versu
anoth
illumin
evolut
antivir
interferon
respons
host
resist
shape
multipl
pathogen
disclosur
interest
none
declar
introduct
outcom
mani
diseas
differ
women
men
women
experienc
higher
incid
sever
pathogenesi
autoimmun
infecti
diseas
suggest
partial
due
tolllik
receptor
tlr
mediat
activ
plasmacytoid
dendrit
cell
pdc
main
produc
interferon
ifn
respons
stimul
investig
induct
type
ifn
ifni
upon
stimul
isol
pdc
use
qrtpcr
intracellular
cytokin
stain
ifnab
receptor
ifnar
surfac
express
determin
use
flow
cytometri
result
data
reveal
sexspecif
differenti
express
ifni
pdc
femal
show
significantli
higher
mrna
express
ifnasubtyp
p
addit
pdc
femal
higher
level
ifnb
mrna
p
stimul
indic
sex
differ
seen
ifni
product
pdc
mediat
signal
event
upstream
first
loop
ifni
mrna
transcript
furthermor
surfac
express
level
common
ifnar
subunit
significantli
higher
pdc
femal
comparison
male
conclus
data
indic
higher
ifna
product
alreadi
establish
mrna
level
propos
contribut
higher
express
pdc
immunolog
differ
seen
femal
male
introduct
highli
pathogen
avian
influenza
hpai
virus
continu
caus
human
infect
report
mortal
rate
greater
howev
mechan
enhanc
diseas
sever
follow
viru
infect
fulli
understood
macrophag
import
protect
influenza
viru
infect
implic
exacerb
diseas
follow
infect
hpai
virus
via
dysregul
macrophag
antivir
respons
previous
demonstr
influenza
virus
uniqu
abil
replic
macrophag
featur
map
viral
hemagglutinin
ha
gene
diseas
sever
mous
model
influenza
viru
infect
correl
replic
capac
viru
macrophag
hypothes
influenza
virus
alter
critic
macrophag
function
replicationdepend
manner
method
macrophag
infect
follow
influenza
virus
liveuvinactiv
influenza
viru
replic
macrophag
liveuvinactiv
express
ha
gene
ha
product
replic
macrophag
begin
h
postinfect
macrophag
treat
ifnk
phagocyt
capac
nitric
oxid
product
measur
ifnk
signal
respons
macrophag
infect
describ
measur
western
blot
phosphoryl
rtpcr
express
ifnkregul
gene
result
macrophag
infect
ha
viru
less
effici
phagocytosi
compar
cell
infect
ca
viru
ha
viru
inhibit
ifnkdepend
upregul
phagocytosi
nitric
oxid
product
importantli
respons
inhibit
replicationdepend
manner
macrophag
respons
could
rescu
uvinactiv
ha
viru
moreov
haexpress
viru
block
ifnk
signal
express
inhibit
ha
viru
replicationdepend
manner
phosphoryl
inhibit
viru
infect
conclus
data
demonstr
influenza
virus
decreas
phagocyt
capac
ifnk
respons
macrophag
chang
depend
influenza
viru
replic
suggest
macrophag
dysfunct
sever
diseas
effect
uniqu
abil
virus
product
replic
macrophag
introduct
innat
immun
respons
mani
microbi
infect
initi
intracellular
pattern
recognit
receptor
prr
induct
type
interferon
ifn
major
mediat
respons
often
initi
recognit
microbi
nucleic
acid
prr
cgasst
trif
sole
adaptor
signal
investig
whether
also
requir
sting
signal
method
test
requir
trif
gene
induct
sting
gene
express
measur
rtqpcr
western
blot
elisa
microarray
assay
trif
cell
line
primari
cell
analyz
trifst
interact
identifi
interact
region
coimmunoprecipit
pulldown
assay
vitro
bind
assay
use
sting
activ
monitor
measur
dimer
use
biochem
assay
intracellular
membran
mobil
use
fluoresc
microscopi
need
trif
stingmedi
regul
replic
studi
measur
viral
cellular
gene
express
viral
dna
synthesi
result
mous
human
cell
ifn
cytokin
gene
induc
trif
cell
treatment
variou
sting
ligand
cgamp
cdigmp
transcript
profil
analysi
show
sting
requir
trif
induc
gene
effect
trif
mediat
direct
interact
sting
via
carboxyl
termin
domain
two
protein
trif
enhanc
sting
dimer
membran
mobil
dimer
sting
undetect
trif
cell
ligand
treatment
distinct
cluster
sting
observ
upon
ligand
stimul
wt
cell
trif
cell
infect
trigger
sting
signal
induc
ifnstimul
gene
isg
inhibit
viru
replic
howev
could
induc
isg
express
trif
cell
viru
replic
effici
absenc
trif
other
observ
associ
specif
trif
mutat
herp
simplex
enceph
patient
could
attribut
associ
defect
sting
signal
caus
enhanc
viru
replic
exampl
mutant
trif
associ
herp
simplex
enceph
although
mediat
signal
show
defect
sting
signal
inabl
bind
sting
consequ
replic
effici
trif
cell
wt
cell
uncov
unexpect
obligatori
need
trif
sting
signal
thu
reveal
new
connect
two
intracellular
nucleic
acid
recogn
prr
sting
trif
mediat
sting
signal
promot
sting
dimer
membran
mobil
result
also
indic
defect
sting
signal
could
respons
observ
genet
associ
trif
mutat
herp
simplex
enceph
patient
introduct
innat
immun
system
repres
major
barrier
viral
infect
innat
immun
first
line
host
defens
myocard
clinic
defin
inflamm
injuri
heart
muscl
brought
assort
virus
autoimmun
process
caus
diseas
target
tissu
coxsacki
viru
usual
associ
viru
infect
mediat
myocard
method
calcul
lethal
dose
week
old
interferon
receptor
knockout
mice
wildtyp
mice
infect
differ
dose
infect
intraperiton
inject
ip
elisa
qrtpcr
use
measur
cytokin
chemokin
express
level
tissu
blood
collect
infect
wildtyp
mice
plaqu
assay
use
titer
viru
differ
tissu
infect
mice
result
shown
interferon
pathway
determin
outcom
infect
type
interferon
receptor
knockout
ifnar
mice
highli
suscept
infect
anim
infect
plaqueform
unit
pfu
die
within
day
immunocompet
mice
surviv
infect
pfu
next
examin
viru
tissu
distribut
demonstr
ifn
determin
abil
establish
infect
replic
specif
tissu
studi
induct
interferon
beta
interleukin
beta
serum
tissu
follow
infect
found
induc
tissu
specif
innat
respons
type
interferon
ifn
respons
inflamm
respons
interleukin
beta
acut
phase
viru
infect
viru
clearanc
late
stage
infect
wildtyp
mice
develop
robust
neutral
antibodi
respons
found
type
interferon
regul
inflamm
respons
adapt
immun
viru
infect
conclus
induc
tissu
specif
innat
respons
type
interferon
ifn
respons
inflamm
respons
type
interferon
critic
control
viru
infect
regul
inflamm
respons
adapt
immun
viru
infect
mice
disclosur
interest
none
declar
introduct
transcript
factor
compris
tyrosinephosphoryl
stat
transmit
signal
type
interferon
receptor
genom
provid
potent
transcript
activ
domain
recruit
addit
cofactor
requir
initi
gene
express
compar
stat
rel
posttransl
modif
describ
find
major
fraction
constitut
phosphoryl
threonin
untreat
cell
type
phosphoryl
inhibit
signal
respons
type
ifn
use
mass
spectrometri
analyz
immunoprecipit
cell
express
flagtag
wildtyp
protein
discov
phosphoryl
mutat
alanin
prevent
phosphoryl
express
either
flagtag
wildtyp
cell
immort
human
mammari
epitheli
hme
cell
follow
analysi
ifnbinduc
express
typic
isg
quantit
realtim
pcr
qpcr
illumina
gene
express
array
besid
isg
induct
also
test
abil
ifnb
inhibit
viru
replic
cell
growth
cell
investig
mechan
phosphoryl
rais
antibodi
phosphoryl
perform
electrophoret
mobil
shift
assay
emsa
test
dna
bind
abil
immunoprecipit
integr
discov
novel
phosphoryl
neg
regul
respons
type
ifn
untreat
cell
type
major
cell
phosphoryl
constitut
respons
interferonb
mutant
much
effect
wildtyp
mediat
express
mani
interferonstimul
gene
protect
cell
viru
infect
inhibit
cell
growth
level
phosphoryl
vari
differ
cell
decreas
longterm
treatment
ifnb
phosphoryl
increas
level
heterodim
lack
tyrosin
phosphoryl
decreas
amount
form
respons
ifnb
interferonbtr
cell
express
wildtyp
contain
much
less
capabl
bind
interferonstimul
respons
element
cell
express
lie
cyclindepend
kinas
cdk
consensu
sequenc
cdk
inhibitor
decreas
phosphoryl
find
describ
studi
indic
cdk
inhibitor
may
acceler
augment
respons
type
ifn
decreas
phosphoryl
coadministr
cdk
inhibitor
type
ifn
might
novel
strategi
treat
cancer
melanoma
respond
significantli
therapi
treat
multipl
sclerosi
viru
infect
much
work
remain
done
includ
understand
phosphoryl
modul
interact
determin
cdk
catalyz
phosphoryl
determin
phosphatas
lead
dephosphoryl
respons
ifnb
disclosur
interest
none
declar
method
analyz
fli
mutat
endoplasm
reticulum
er
stress
machineri
found
er
stress
involv
express
immun
respons
gene
gene
express
profil
identifi
molecular
mechan
antivir
er
stress
result
report
er
stress
facilit
express
humor
protein
activ
jakstat
pathway
addit
show
er
stress
regul
antivir
rnai
immun
cleav
viral
rna
suppress
viral
replic
insect
collect
studi
indic
drosophila
antivir
immun
requir
er
stress
activ
immun
signal
pathway
lead
express
antivir
protein
conclus
er
stress
highli
conserv
mechan
among
eukaryot
mammalian
studi
indic
er
stress
play
import
role
inflamm
antimicrobi
immun
research
suggest
immunolog
er
stress
evolutionarili
conserv
mechan
would
provid
new
insight
evolut
adapt
mechan
arthropodborn
virus
dengu
viru
zika
viru
introduct
play
critic
role
host
defens
extracellular
bacteri
fungal
pathogen
heterodimer
receptor
complex
form
signal
shown
regul
granulopoiesi
well
chemokin
product
lead
optim
recruit
neutrophil
effici
erad
variou
pathogen
wherea
predominantli
produc
lymphocyt
chemokin
thought
made
target
cell
method
play
critic
role
host
defens
extracellular
bacteri
fungal
pathogen
heterodimer
receptor
complex
form
signal
shown
regul
granulopoiesi
well
chemokin
product
lead
optim
recruit
neutrophil
effici
erad
variou
pathogen
wherea
predominantli
produc
lymphocyt
chemokin
thought
made
target
cell
result
condit
ko
mice
display
impair
abil
recruit
neutrophil
airway
lumen
well
defect
control
bacteri
burden
upon
infect
k
pneumonia
includ
drug
resist
isol
express
new
delhi
impair
associ
reduc
epitheli
express
defect
could
restor
recombin
lix
gene
product
murin
conclus
data
confirm
requir
epitheli
express
host
defens
k
pneumonia
suggest
agon
epitheli
may
serv
novel
therapeut
target
combat
k
penumonia
includ
antibiot
resist
strain
disclosur
interest
none
declar
introduct
btk
tec
kinas
play
critic
role
b
cell
develop
mutat
btk
gene
result
bcell
immunodefici
human
howev
patient
also
known
suscept
recurr
bacteri
viral
infect
suggest
btk
role
also
innat
immun
show
absenc
btk
impair
host
interferon
respons
result
btkdefici
mice
resist
p
c
induc
sepsi
suggest
inhibit
btk
could
use
dampen
cytokin
storm
result
exagger
host
immun
respons
observ
sar
coronaviru
ebola
viru
crisi
method
comput
model
indic
strengthen
interact
sting
result
innat
immun
system
also
sens
foreign
dna
bacteria
initi
signal
via
adaptor
sting
induc
ifn
respons
via
dna
sensor
like
helicas
btkdefici
cell
also
impair
ifnb
product
stimul
stingsign
agonist
infect
infecti
pathogen
malaria
parasit
listeria
monocytogen
btk
phosphoryl
critic
stingmedi
ifnb
product
propos
biolog
applic
gener
novel
antibodi
antibodybas
diagnost
biomark
human
viral
diseas
well
screen
identifi
novel
btk
inhibit
activ
disclosur
interest
none
declar
introduct
interferon
regulatori
factor
irf
key
transcript
factor
innat
immun
wellestablish
factor
orchestr
antivir
immun
program
littl
known
specif
role
respons
viru
infect
studi
indic
play
critic
role
effect
immun
respons
west
nile
viru
wnv
upon
infect
bone
marrowderiv
dendrit
cell
bmdc
lack
defect
produc
type
interferon
ifni
result
uncontrol
viral
replic
express
inflammatori
cytokin
chemokin
respons
wnv
infect
also
depend
observ
suggest
effector
function
target
gene
essenti
compon
antiwnv
immun
howev
transcript
target
identifi
distinct
overlap
role
irf
defin
overal
action
program
dc
effector
function
known
method
studi
address
question
comprehens
genomewid
interrog
bmdc
upon
wnv
infect
undertook
largescal
transcript
profil
highresolut
chromatin
occup
map
identifi
bona
fide
primari
target
gene
first
use
rnaseq
approach
compar
gene
express
profil
wnv
mock
infect
wildtyp
bmdc
identifi
wnvrespons
gene
whose
express
requir
presenc
perform
chromatinimmunoprecipit
follow
sequenc
chipseq
wnvand
mockinfect
bmdc
hone
direct
gene
target
bind
induc
upon
wnv
infect
result
intersect
two
approach
allow
us
interrog
global
function
orchestr
antivir
immun
gene
ontolog
network
analys
reveal
cellular
pathway
constitut
immun
program
like
play
distinct
complementari
role
irf
coordin
effect
antivir
respons
conclus
present
data
character
transcript
antivir
program
orchestr
bmdc
effect
control
wnv
infect
introduct
human
sting
encod
gene
innat
immun
sensor
cyclic
dinucleotid
cdn
critic
infect
inflamm
cancer
previous
identifi
haq
second
common
human
allel
carri
billion
peopl
worldwid
vivo
signific
haq
allel
remain
unknown
method
studi
use
bacin
transgen
report
mice
identifi
cellular
sourc
infect
hypervirul
wbeij
tuberculosi
strain
result
observ
first
tuberculosi
infect
predomin
cell
express
innat
monocyt
howev
day
tuberculosi
infect
express
also
strongli
detect
cell
mice
defici
cell
deriv
floxflox
mice
mice
defici
monocyt
deriv
floxflox
lysmcr
mice
show
signific
reduct
lung
bacteri
load
chronic
tuberculosi
infect
compar
fulli
compet
control
mice
cell
tuberculosi
infect
lung
detect
among
cell
express
high
level
tbet
abl
coproduc
ifnk
upon
ex
vivo
stimul
addit
express
cell
partial
regul
type
ifn
signal
conclus
summari
data
reveal
despit
multipl
cellular
sourc
mainli
cellderiv
suppress
protect
immun
respons
tuberculosi
infect
disclosur
interest
none
declar
introduct
rigi
signal
pathway
essenti
recognit
virus
initi
host
ifnmedi
antivir
respons
activ
rigi
interact
polyubiquitin
chain
gener
bind
mav
lead
product
type
ifn
show
specif
interact
subcellular
local
key
protein
pathway
interact
key
partner
rlr
pathway
examin
bimolecular
fluoresc
complement
bifc
stimul
emiss
deplet
sted
microscopi
techniqu
allow
us
isol
visual
analyz
proteinprotein
interact
live
cell
result
dimer
rigi
mav
local
differ
compart
cytoplasm
cell
complex
accumul
specif
cytoplasm
dot
wherea
rigimav
complex
locat
similar
mav
mitochondria
addit
mav
compet
rigi
bind
suggest
upon
mediat
activ
rigi
rigi
move
away
interact
mav
mitochondria
first
time
distribut
protein
also
analyz
viru
infect
cell
show
differ
viral
protein
modifi
specif
complex
pathway
bifc
techniqu
provid
us
tool
allow
us
defin
spatial
event
differ
interact
among
rigi
mav
rlr
pathway
also
abl
show
distribut
certain
time
point
context
viral
infect
show
strike
format
complex
display
differ
locat
within
cell
introduct
human
myxoviru
resist
protein
mxa
mxb
express
upon
stimul
type
type
iii
interferon
ifn
induc
viral
infect
mxa
wellknown
elicit
potent
antivir
effect
multitud
rna
dna
virus
mxb
long
unrecogn
serv
antivir
function
three
independ
research
group
provid
first
clear
evid
potent
antivir
effect
mxb
human
immunodefici
viru
type
primat
lentivirus
subsequ
evolutionari
analys
howev
conclud
amino
acid
motif
associ
lentivir
restrict
subject
posit
select
primat
addit
residu
associ
mxb
gtpase
function
highli
conserv
among
mammal
capac
bind
hydrolyz
gtp
requir
inhibit
replic
altogeth
indic
mxb
addit
antivir
nonlentivir
function
yet
uncov
argu
potenti
viral
target
mxb
would
nuclear
target
process
similar
thu
select
larg
dna
viru
herp
simplex
viru
type
promis
candid
subject
mxb
suscept
test
first
select
cell
cell
cultur
model
due
high
endogen
mxb
express
permiss
infect
test
mxb
absenc
interferoninduc
gene
gener
cell
stabli
overexpress
mxb
order
studi
replic
function
mxb
level
cell
employ
sirna
target
endogen
andor
exogen
mxb
result
observ
inhibit
replic
cell
ifn
treatment
reduc
presenc
sirna
target
mxb
underlin
import
mxb
ifnmedi
suppress
furthermor
result
indic
replic
strongli
inhibit
cell
compar
control
cell
line
replic
cell
recov
larg
extent
sirnamedi
knockdown
mxb
transgen
express
hand
vesicular
stomat
viru
vsv
rna
viru
depend
nuclear
entri
accomplish
replic
unaffect
presenc
mxb
mxbdirect
sirna
conclus
summari
establish
mxb
specif
effect
restrict
factor
futur
experi
help
elucid
mechan
respons
antiherpesvir
function
mxb
disclosur
interest
none
declar
introduct
tolllik
receptor
tlr
predominantli
express
host
immunocompet
cell
play
critic
role
earli
innat
immun
respons
invad
pathogen
sens
microorgan
although
essenti
recognit
gramposit
bacteria
function
infecti
diseas
still
debat
rhodococcu
aurantiacu
intracellular
gramposit
bacterium
induc
granulomat
inflamm
resembl
sarcoidosi
wildtyp
wt
mice
present
studi
investig
extent
contribut
host
innat
respons
bacterium
infect
late
granuloma
format
use
mice
method
intraven
inocul
cfu
viabl
r
aurantiacu
pb
surviv
wt
mice
week
old
femal
monitor
bacteria
organ
enumer
pb
alon
inject
control
local
system
cytokin
product
morpholog
chang
liver
assess
elisa
h
e
stain
respect
follow
stimul
heatkil
r
aurantiacu
moi
protein
concentr
gene
express
level
cytokin
mous
periton
macrophag
measur
elisa
realtim
pcr
respect
result
mice
hypersuscept
r
aurantiacu
infect
display
high
mortal
rate
compar
wt
counterpart
mice
also
show
decreas
product
proand
antiinflammatori
cytokin
includ
tnfa
ifnk
liver
earli
phase
infect
high
bacteri
load
organ
moreov
histolog
studi
reveal
reduct
number
size
hepat
granuloma
day
postinfect
mice
upon
stimul
heatkil
bacteria
macrophag
mice
show
lower
express
tnfa
gene
protein
level
compar
wt
mous
macrophag
conclus
defici
attenu
inflammatori
cytokin
respons
also
antiinflammatori
cytokin
respons
r
aurantiacu
infect
decreas
product
proinflammatori
cytokin
contribut
reduct
bacteri
elimin
organ
earli
phase
infect
inhibit
hepat
granuloma
format
late
phase
howev
decreas
level
antiinflammatori
cytokin
exacerb
mous
surviv
previous
show
key
element
protect
mice
mortal
find
thu
indic
essenti
role
regul
activ
function
immunocompet
cell
especi
macrophag
initi
phase
system
r
aurantiacu
infect
disclosur
interest
none
declar
introduct
tyrosin
kinas
janu
kinas
pivot
role
immun
infect
tumour
surveil
cytokin
signal
promin
type
interferon
ifn
interleukin
previous
shown
mice
highli
suscept
listeria
monocytogen
infect
due
impair
ifnk
product
cell
role
cell
type
molecular
mechan
respons
decreas
surviv
absenc
howev
illdefin
method
investig
kinaseindepend
cell
typespecif
function
challeng
kinaseinact
mutant
condit
knockout
mice
flfl
intraperiton
l
monocytogen
surviv
rate
bacteri
burden
spleen
liver
determin
furthermor
ifnk
serum
level
evalu
use
enzymelink
immunosorb
assay
elisa
addit
splenocyt
mice
lack
nk
cell
compart
flfl
test
intracellular
express
ifnk
flow
cytometri
result
contrast
mice
infect
mice
produc
ifnk
although
significantli
delay
compar
wildtyp
wt
mice
nevertheless
upon
high
dose
infect
mice
exhibit
similar
surviv
mice
surprisingli
upon
challeng
low
dose
l
monocytogen
mice
display
higher
bacteri
burden
wt
mice
succumb
infect
thu
data
reveal
despit
late
ifnk
product
express
kinaseinact
suffici
protect
mice
lowdos
system
l
monocytogen
infect
worsen
diseas
compar
complet
loss
regard
cell
typespecif
function
data
unveil
critic
role
nk
cell
antilisteria
immun
contrast
mice
macrophageneutrophilspecif
delet
resist
infect
delet
dendrit
cell
grossli
impact
surviv
conclus
thu
hypothes
due
employ
differ
cytokin
pathway
cell
type
exhibit
protect
detriment
function
immun
respons
bacteri
infect
introduct
interferon
stimul
gene
isg
divers
set
gene
upregul
respons
interferon
major
compon
cellular
immun
intracellular
pathogen
virus
despit
import
isg
cellular
immun
function
isg
unknown
recent
screen
effort
found
multipl
isg
inhibitori
infect
panel
virus
interestingli
small
number
isg
found
enhanc
infect
multipl
virus
one
robustli
enhanc
isg
promot
infect
divers
set
virus
aim
studi
determin
mechan
action
viral
infect
turn
better
understand
purpos
seemingli
enhanc
viral
infect
host
standpoint
method
lentivir
ectop
express
gene
edit
use
modul
express
viral
infect
quantit
use
flow
cytometri
base
system
viral
replic
quantifi
plaqu
assay
use
subgenom
replicon
experi
analyz
viral
entri
use
rtqpcr
base
cell
fraction
base
confoc
microscopi
base
approach
result
found
ectop
express
enhanc
infect
multipl
unrel
envelop
virus
includ
influenza
viru
yellow
fever
viru
equin
arteriviru
role
viral
infect
confirm
mediat
knockout
experi
mechanist
studi
show
specif
enhanc
viral
entri
receptor
mediat
endocytosi
viru
prior
viral
replic
shown
import
optim
infect
multipl
clinic
signific
unrel
virus
vitro
mechanist
studi
found
affect
specif
stage
viral
life
cycl
prior
replic
yet
endocytosi
viru
studi
help
clarifi
role
enhanc
isg
cellular
immun
introduct
host
genet
background
play
key
role
determin
outcom
pathogen
process
infect
extent
remain
establish
individu
genet
profil
influenc
cytokin
network
earli
phase
respiratori
infect
orchestr
innat
immun
aim
defin
host
genet
profil
associ
cytokin
network
relev
diseas
sever
p
aeruginosa
respiratori
infect
method
achiev
aim
exploit
system
biolog
approach
vivo
model
acut
respiratori
infect
use
highli
geneticallydivers
mous
resourc
popul
name
collabor
cross
cc
mice
model
acut
pneumonia
cc
inbr
line
challeng
p
aeruginosa
monitor
diseas
sever
includ
mortal
morbid
seven
day
next
quantifi
specif
marker
diseas
phenotyp
mice
inbr
line
includ
bacteri
load
panel
cytokin
chemokin
luminex
technolog
murin
lung
earli
stage
h
infect
result
cc
murin
popul
exhibit
broad
rang
patholog
phenotyp
rang
lethal
diseas
complet
recoveri
infect
defin
two
distinct
group
cc
inbr
line
resist
cc
inbr
line
suscept
cc
inbr
line
perform
cluster
analysi
base
mean
surviv
time
bacteri
burden
level
kc
tnfa
next
resist
suscept
cc
inbr
line
directli
compar
found
cytokin
differ
secret
particular
observ
diseas
sever
associ
reduc
bioavail
increas
level
level
ifnk
similar
two
group
note
diseas
dynam
associ
cytokin
network
gener
conserv
among
cc
inbr
line
although
singl
cytokin
profil
may
specif
regul
probabl
due
individu
genet
background
conclus
divers
host
genet
profil
determin
outcom
respiratori
infect
regul
highli
conserv
immunolog
mechan
particular
suggest
balanc
mediat
respons
may
critic
determin
diseas
sever
p
aeruginosa
respiratori
infect
geneticallydivers
murin
popul
disclosur
interest
none
declar
introduct
certain
bat
speci
asymptomat
carrier
highli
pathogen
virus
mechan
underli
viral
resist
remain
unclear
character
antivir
mechan
bat
may
provid
insight
could
use
develop
target
antivir
therapi
key
defens
mechan
viral
diseas
rapid
activ
interferon
ifn
respons
result
express
pool
antivir
effector
known
ifnstimul
gene
isg
studi
ifnisg
system
pteropu
alecto
bat
cell
determin
whether
ifn
signal
isg
effector
function
uniqu
featur
speci
method
use
rnaseq
defin
tempor
regul
isg
type
ifn
bat
cell
ncounter
nanostr
technolog
use
valid
rnaseq
data
well
compar
isg
induct
bat
human
cell
line
studi
function
differ
bat
human
isg
use
highthroughput
flow
cytometrybas
screen
assay
compar
antivir
activ
bat
isg
rel
human
ortholog
result
observ
treat
bat
cell
ifn
induc
express
gene
identifi
isg
human
earli
h
treatment
bat
cell
seem
faster
potent
respons
ifn
human
cell
measur
isg
induct
use
function
screen
identifi
bat
potent
antivir
effector
across
multipl
viru
famili
bat
unlik
human
capabl
induc
ifnlik
antivir
state
cell
absenc
viral
challeng
even
cell
lack
intact
ifn
pathway
result
assess
rel
vivo
contribut
differ
dc
subset
involv
prime
hsvspecif
cell
assess
endogen
polyclon
hsvspecif
cell
respons
found
effect
vivo
cell
prime
depend
presenc
dc
subset
special
crosspresent
langerhan
cell
plasmacytoid
dc
dispens
crucial
demonstr
vivo
requir
crosspres
dc
relat
infect
instead
reflect
true
capac
crosspres
hsvderiv
antigen
vivo
conclus
find
consist
view
skinresid
dc
either
directli
infect
contain
viral
infect
materi
migrat
skin
drain
lymph
node
hand
cargo
lnresid
dc
prime
cell
work
demonstr
divis
labor
distinct
dc
subset
highlight
vivo
hsvspecif
cell
prime
depend
heavili
entir
crossprim
dc
disclosur
interest
none
declar
demonstr
initi
lack
proinflammatori
cytokin
respons
follow
exponenti
increas
term
cytokin
storm
day
prior
death
aspect
contribut
pathogenesi
diseas
therefor
repres
potenti
target
gener
postexposur
therapeut
develop
suboptim
antibiot
mous
model
infect
determin
full
impact
cytokin
storm
infect
result
last
year
laboratori
focus
use
antiinflammatori
compound
either
alon
combin
antimicrobi
potenti
increas
surviv
andor
extend
time
death
demonstr
proof
principl
use
hosttarget
therapi
ie
antibodi
combin
levofloxacin
f
tularensi
schu
infect
increas
surviv
widen
window
opportun
tradit
antibiot
treatment
use
immunohistochemistri
potenti
role
macrophag
regulatori
cell
pathogenesi
diseas
also
identifi
recent
explor
role
regulatori
cell
appear
absent
earli
stage
infect
f
tularensi
consequ
context
immun
dysregul
use
dereg
mice
specif
deplet
regulatori
cell
administr
diphtheria
toxin
shown
bacteri
burden
liver
spleen
significantli
reduc
compar
wild
type
control
infect
f
tularensi
live
vaccin
strain
conclus
ongo
research
host
immun
respons
look
establish
key
immun
cellsmolecul
infect
order
improv
likelihood
identifi
novel
hosttarget
postexposur
therapeut
treat
tularemia
andor
increas
efficaci
exist
antimicrobi
introduct
cytosol
sens
nucleic
acid
alert
cell
invad
pathogen
lead
initi
program
aim
limit
infect
program
mediat
cytosol
receptor
cofactor
dna
cgasst
rna
rigi
sens
includ
initi
proinflammatori
respons
tight
regul
paramount
limit
collater
damag
cell
cycl
fertil
repres
two
scenario
inappropri
respons
nonpathogenderiv
nucleic
acid
would
dramat
consequ
report
unbias
approach
identifi
neg
regul
nucleic
acid
sens
discoveri
put
rheostat
fertil
result
demonstr
regul
interact
physic
compon
nucleic
acid
sens
pathway
target
kinas
critic
signal
downstream
dna
rna
sens
ubiquitin
degrad
delin
domain
mediat
inhibitori
function
furthermor
identifi
natur
occur
human
nonsens
mutat
associ
male
steril
result
loss
protein
function
hyper
respons
nucleic
acid
conclus
discoveri
point
fundament
requir
control
nucleic
acid
sens
machineri
suggest
regul
may
critic
germlin
disclosur
interest
none
declar
result
human
pdc
pick
flare
signal
dosedepend
manner
inhibit
cold
condit
low
percentag
cell
contain
signal
also
contain
dsred
signal
indic
decreas
spore
viabil
uptak
pdc
express
surfac
human
pdc
compar
human
monocyt
known
express
upregul
stimul
viral
stimuli
curdlan
induc
upregul
costimulatori
marker
well
product
ifna
upregul
final
pdc
hiv
patient
express
modestli
higher
baselin
level
cell
surfac
remain
consist
curdlan
viral
stimul
shown
human
pdc
phagocytos
kill
aspergillu
spore
directli
express
regul
respons
pdc
curdlan
stimul
indic
present
function
human
pdc
suggest
may
use
human
pdc
recogn
bglucan
compon
fungal
spore
final
higher
baselin
level
hiv
patient
pdc
may
explain
lowlevel
chronic
immun
activ
experienc
hiv
patient
describ
neg
affect
pdc
function
disclosur
interest
none
declar
method
cytokin
detect
perform
elisa
method
supernat
splenic
cell
cultur
plamodium
berghei
infect
rat
product
cytokin
correl
either
age
anaim
surviv
result
young
rat
succumb
infect
adult
surviv
clear
blood
parasit
phenotyp
analysi
spleen
dendrit
cell
reveal
agerel
distribut
two
subset
cell
cell
associ
suscept
induc
cytokin
profil
high
amount
young
rat
dendrit
cell
exhibit
cytotox
profil
high
amount
increas
lymphocyt
nk
cell
resist
adult
rat
conclus
investig
focus
malaria
protect
mechan
may
link
parasit
cytotox
induc
dendrit
cell
matur
might
relat
express
phenotyp
non
suscept
adult
disclosur
interest
none
declar
introduct
toll
like
receptor
signal
tlr
known
initi
multipl
cell
type
exposur
varieti
damp
follow
tissu
injuri
studi
role
tlr
signal
pathway
particularli
regul
acut
respons
injuri
use
acetaminophen
apap
induc
acut
liver
injuri
model
mice
method
age
match
gene
knock
male
mice
fast
overnight
h
prior
intraperiton
inject
mg
apapkg
bodi
weightserum
altast
measur
whole
blood
hepat
damag
assess
formalin
fix
paraffin
section
stain
h
esect
stain
fluorescentley
label
detect
cell
prolifer
cyclin
measur
whole
liver
total
protein
extract
western
blot
result
mice
defici
trif
one
adaptor
protein
determin
signal
event
downstream
exhibit
exacerb
respons
intraperiton
inject
apap
reflect
elev
serum
astalt
level
increas
area
necrosi
visual
h
e
stain
liver
section
comparison
age
match
wild
type
trifdefici
mice
show
markedli
enhanc
hepatocyt
prolifer
evidenc
increas
stain
cyclin
express
h
apap
challeng
compar
outcom
observ
mice
defici
transcript
factor
interferon
induc
gene
implic
signific
role
interferon
signal
reduc
injuri
conclus
apap
overdos
result
rapid
hepatocyt
cell
death
due
gener
toxic
metabolit
recoveri
injuri
depend
upon
infiltr
inflammatori
monocyt
experi
underway
evalu
role
ifn
signal
distinct
popul
test
hypothesi
respons
injuri
involv
interplay
multipl
cell
type
disclosur
interest
none
declar
introduct
ra
gtpaseactiv
proteinbind
protein
ubiquit
express
mammalian
cell
play
divers
biolog
role
notabl
key
compon
stress
granul
form
within
cell
cytoplasm
upon
variou
stress
signal
recent
studi
shown
stress
granul
format
impair
viral
replic
virus
express
protein
cleav
inhibit
stress
granul
format
suggest
potenti
role
stress
granul
antivir
respons
method
sirnaknockdown
result
impair
poli
ic
mediat
ifn
product
result
show
play
critic
role
drive
ifnb
product
follow
poli
ic
stimul
macrophag
mechanist
bind
requir
poli
ic
induc
ifn
product
also
interact
act
synergist
downstream
kinas
dok
found
earlier
act
critic
mediat
depend
trif
signal
also
show
addit
convent
stress
signal
heat
shock
arsenit
treatment
stress
granul
format
induc
poli
ic
stimul
cell
indic
link
stress
granul
format
ifn
signal
conclus
particip
host
innat
stressgranul
format
ifn
product
upon
viru
infect
method
method
propag
mous
noroviru
infect
mice
analysi
viral
growth
immun
respons
previous
describ
result
previous
found
ifnk
critic
control
clearanc
intestin
function
independ
b
cell
howev
ifnk
receptor
defici
allow
intestin
replic
emphas
import
viral
gene
determin
tropism
present
studi
find
select
ifnab
receptor
defici
suffici
system
persist
spite
function
b
cell
respons
cellular
tropism
macrophag
dendrit
cell
find
delet
ifnab
receptor
lysmexpress
myeloid
cell
villinexpress
intestin
epitheli
cell
result
increas
earli
viral
titer
system
persist
without
persist
fecal
shed
persist
set
correl
increas
cellular
humor
adapt
immun
respons
control
clear
infect
furthermor
increas
earli
replic
persist
also
observ
mix
bone
marrow
chimera
dc
unabl
respond
ifnab
demonstr
cellintrins
ifnab
respons
requir
control
clearanc
system
noroviru
infect
conclus
taken
togeth
prior
studi
find
indic
noroviru
tropism
determin
rel
import
ifnab
compar
ifnk
ifn
respons
regul
noroviru
persist
independ
adapt
immun
function
disclosur
interest
none
declar
introduct
converg
evolut
dictat
divers
group
virus
target
host
factor
order
manipul
immun
respons
improv
infect
yet
immun
infect
linear
respons
complex
interact
govern
diseas
outcom
success
virus
must
employ
combin
approach
combat
host
immun
even
among
close
relat
virus
divers
strategi
may
produc
similar
infect
result
achiev
distinct
mechan
therefor
suscept
particular
host
factor
may
uniform
across
viral
famili
appli
virus
infect
tissu
project
sought
leverag
uneven
viral
antagon
identifi
critic
host
factor
govern
diseas
outcom
method
build
upon
establish
system
biolog
platform
compar
host
immun
respons
across
varieti
phenotyp
output
follow
infect
highli
pathogen
coronavirus
sar
merscov
well
pathogen
influenza
virus
result
identifi
differenti
regul
subset
interferon
stimul
gene
isg
follow
infect
compar
across
rna
express
proteom
epigenet
data
develop
consensu
list
host
isg
differenti
regul
within
viral
famili
predict
modul
isg
one
virus
indic
possibl
role
host
immun
viru
infect
list
util
vitro
sirna
knockdown
well
crisper
gener
knockout
mice
identifi
isg
efficaci
virus
manipul
target
result
initi
screen
identifi
sever
isg
target
differenti
activ
follow
infect
includ
other
absenc
regul
merscov
vitro
produc
increas
pathogenesi
rel
control
mice
follow
sarscov
challeng
importantli
increas
suscept
govern
increas
viral
replic
rather
alter
aspect
pathogenesi
includ
cytokin
stimul
immun
infiltr
overal
immun
activ
studi
seek
identifi
mechan
action
multipl
target
isg
data
highlight
util
leverag
viral
cross
comparison
mean
identifi
novel
host
factor
impact
diseas
outcom
result
identifi
multipl
target
impact
pathogenesi
unlik
explor
use
tradit
vitro
screen
base
viral
replic
togeth
studi
defin
new
approach
defin
critic
host
factor
impact
viral
infect
pathogenesi
introduct
obes
character
public
health
concern
worldwid
mainli
childhood
adolesc
period
origin
obesityrel
complic
result
chronic
adipos
tissu
system
inflamm
studi
shown
releas
inflammatori
cytokin
relat
increas
product
inflammatori
cytokin
object
identifi
quantifi
serum
level
tnfalpha
adolesc
three
level
weight
excess
method
cross
section
studi
includ
adolesc
gender
weight
excess
care
adolesc
outpati
clinic
adolesc
alloc
three
group
overweight
ow
obes
ob
extrem
obes
eo
studi
includ
anthropometr
evalu
dosag
biochem
test
character
metabol
syndrom
ow
ob
eo
definit
accord
american
academi
pediatr
aap
metabol
syndrom
character
accord
idf
central
obes
identifi
three
paramet
alter
quantif
carri
use
cytometr
bead
array
cba
bd
tm
kit
monoclon
antibodi
mark
pe
fluoresc
measur
bdfacscanto
ii
flow
cytomet
number
count
event
particlesev
valu
express
pgml
result
level
higher
eo
adolesc
group
median
pgml
follow
ob
ow
group
median
pgml
median
pgml
level
also
higher
metabol
syndrom
individu
adolesc
without
syndrom
vs
pgml
p
similar
data
observ
beta
level
extrem
obes
individu
higher
level
paramet
ob
ow
individu
conclus
level
beta
associ
excess
bodi
weight
adolesc
paramet
potenti
diagnost
marker
metabol
syndrom
age
group
introduct
obes
metabol
syndrom
manifest
latent
adipos
tissu
inflamm
consequ
system
inflamm
close
relat
disturb
insulin
signal
result
develop
insulin
resist
type
diabet
insulindepend
glucos
uptak
via
activ
mediat
pathway
phosphoryl
akt
kinas
govern
insulin
directli
phosphoryl
mostli
depend
activ
also
insulin
action
distort
signal
inflammatori
condit
could
reduc
abolish
agent
skew
inflammatori
macrophag
mph
acquir
altern
antiinflammatori
phenotyp
work
studi
influenc
activ
mph
insulindepend
akt
phosphoryl
adipocyt
use
vitro
model
chemokin
cocultur
polar
raw
mph
differenti
adipocyt
activ
use
novel
smallmolecul
compound
dchc
mph
polar
character
real
time
pcr
also
model
paracrin
effect
mph
differenti
adipocyt
use
macrophag
condit
media
cm
shortterm
load
insulin
cell
analyz
akt
phosphoryl
westernblot
result
found
express
predominantli
inflammatori
marker
tnfa
cell
produc
mostli
antiinflammatori
factor
mph
treat
dchc
mph
characteris
intermedi
express
inflammatori
marker
antiinflammatori
marker
closer
phenotyp
found
cm
exert
decreas
increas
adipocyt
effect
observ
cell
media
use
adipocyt
treatment
contrari
mph
mph
cm
induc
increas
decreas
declin
phosphoryl
inflammatori
condit
may
due
regulatori
inhibitori
serthr
phosphoryl
regulatori
mechan
oper
via
varieti
protein
kinas
includ
proinflammatori
kinas
ikk
propos
mechan
increas
inflammatori
condit
may
associ
ikkdepend
activ
possibl
shown
studi
thu
possibl
mechan
mediat
influenc
polar
mph
insulindepend
aktphosphoryl
may
associ
diverg
regul
ikkkinas
target
cell
introduct
inflamm
biolog
respons
protect
organ
harm
stimuli
occurr
inflamm
activ
immun
cell
secret
mani
inflammatori
mediat
includ
cytokin
chemokin
promot
inflammatori
respons
lung
gut
share
mani
similar
physiolog
inflammatori
patholog
cigarett
smoke
cs
harm
mixtur
caus
acut
chronic
inflamm
thu
investig
cs
exposureinduc
lung
gut
crosstalk
inflammatori
respons
method
mice
expos
cs
h
per
day
week
mice
place
smoke
chamber
fill
smoke
kentucki
refer
cigarett
mice
expos
cs
min
rest
fresh
air
environ
min
total
durat
exposur
cs
h
per
day
individu
bodi
weight
measur
twice
week
mice
sacrif
day
hematoxylin
eosin
h
e
stain
perform
lung
colon
tissu
determin
histolog
chang
tumor
necrosi
factor
tnf
interleukin
il
monocyt
chemoattract
protein
mcp
synthesi
bronchoalveolar
lavag
fluid
balf
colon
tissu
analyz
use
enzymelink
immunosorb
assay
elisa
result
cs
group
mice
bodi
weight
decreas
con
group
mice
bodi
weight
increas
cs
group
show
histolog
chang
infiltr
immun
cell
surround
perivascular
peribronchi
region
lung
similarli
cs
exposur
induc
cell
infiltr
intestin
mucosa
addit
data
show
increas
proinflammatori
cytokin
tnfa
decreas
antiinflammatori
cytokin
balf
colon
tissu
conclus
studi
confirm
accumul
immun
cell
lung
colon
tissu
excess
secret
inflammatori
cytokin
inflam
tissu
result
indic
cs
exposur
induc
inflamm
lung
well
bowel
disclosur
interest
none
declar
introduct
protein
arginin
methyl
novel
posttransl
modif
mediat
protein
arginin
methyltransferas
prmt
major
isoform
prmt
famili
respons
divers
biolog
function
includ
cellular
differenti
although
import
function
variou
tissu
increasingli
recogn
role
ranklinduc
osteoclastogenesi
osteoporosi
yet
describ
show
key
molecul
involv
osteoclast
differenti
method
osteoclastogenesi
determin
trap
stain
f
actin
ring
format
bone
resorpt
assay
sirna
scrambl
sirna
use
silenc
endogen
express
nfkb
mapk
activ
analyz
transfect
assay
western
blot
respect
realtim
pcr
perform
examin
express
osteoclastogenesisrel
gene
histolog
chang
increas
trapposit
cell
cathepsin
k
express
examin
metaphysi
ovx
mice
densiti
bone
marrow
evalu
microct
result
rankl
treatment
increas
adma
express
bmdm
jnk
depend
manner
silenc
sirna
attenu
ranklinduc
osteoclastogenesi
result
also
reveal
regul
nfjb
transcript
activ
interact
nfjb
rankltreat
bmdm
vivo
studi
show
defici
protect
effect
bone
loss
ovx
mice
conclus
taken
togeth
result
suggest
play
import
role
progress
osteoporosi
signal
cascad
may
also
good
therapeut
target
postmenopaus
osteoporosi
method
studi
subject
subject
atherosclerosi
subject
atherosclerosi
healthi
control
snp
allel
serum
level
analyz
result
confirm
abl
neutral
vitro
show
capac
buffer
control
snp
within
compar
patient
healthi
control
found
level
significantli
lower
p
level
invers
correl
level
r
p
interestingli
differ
level
genotyp
lost
diabet
patient
conclus
buffer
abl
neutral
data
suggest
protect
buffer
system
disturb
patient
due
chronic
overload
buffer
increas
level
loss
serum
might
close
associ
pathophysiolog
introduct
posttraumat
stress
disord
ptsd
psychiatr
condit
defin
array
affect
attent
disturb
result
experi
wit
traumat
lifethreaten
event
combat
exposur
emerg
evid
suggest
ptsd
psychobiolog
manifest
link
system
lowgrad
inflammatori
state
character
increas
circul
proinflammatori
mediat
well
decreas
antiinflammatori
mediat
studi
howev
investig
potenti
alter
inflammatori
biomark
indic
militari
ptsd
yield
mix
result
aim
studi
compar
level
key
proand
antiinflammatori
marker
combat
veteran
ptsd
vs
healthi
traumaexpos
nondeploy
soldier
method
elig
particip
year
male
treatmentseek
veteran
era
diagnosi
current
ptsd
relat
combat
experi
fulfil
dsmiv
criteria
ptsd
clinician
administ
ptsd
scale
cap
score
traumaexpos
te
soldier
experienc
least
one
traumat
event
cap
te
nondeploy
nd
control
histori
ptsd
dsmiv
axisi
psychopatholog
studi
approv
human
research
ethic
board
western
univers
camh
drdc
inform
consent
obtain
particip
circul
level
select
proantiinflammatori
mediat
includ
interleukin
il
tumor
necrosi
factor
tnf
interferon
ifn
c
serum
amyloid
protein
saa
creactiv
protein
crp
intercellular
adhes
molecul
icam
vascular
cell
adhes
molecul
vcam
matrix
metalloproteinas
mmp
myeloperoxidas
mpo
analyz
mesoscal
discoveri
msd
multiarray
tm
platform
use
multispot
vplex
human
biomark
immunoassay
kit
sector
tm
instrument
statist
signific
p
evalu
unpair
student
ttest
kruskalw
oneway
anova
result
rel
te
nd
control
combat
veteran
ptsd
exhibit
signific
alter
basal
level
multipl
inflammatori
marker
particular
markedli
higher
circul
concentr
tnfa
crp
mpo
detect
ptsd
group
rel
nd
te
group
contrast
undetect
sampl
signific
differ
observ
ptsd
control
saa
importantli
level
found
significantli
higher
te
control
rel
ptsd
nd
conclus
find
show
elev
proinflammatori
cytokin
vascular
adhes
injuri
molecul
lower
antiinflammatori
combat
veteran
diagnos
ptsd
compar
healthi
control
support
hypothesi
ptsd
associ
chronic
lowgrad
system
inflamm
among
symptomat
individu
dysregul
may
central
link
ptsd
poor
physic
health
foremost
increas
risk
atherothrombot
diseas
disclosur
interest
none
declar
introduct
zincfing
transcript
factor
import
function
cell
maintain
hematopoiet
stem
cell
renew
bone
marrow
lead
cell
matur
thymu
regul
cell
differenti
class
ii
immun
organ
transcript
express
euchromatichistonelysin
nmethyltransferas
enzymat
activ
zinc
finger
domain
gene
directli
gata
respons
vegfa
express
level
previous
found
vegfa
repress
induc
brown
adipocyt
differenti
white
adipos
tissu
overexpress
brown
adipocyt
specif
factor
method
tetracyclineregul
revers
vegfa
repress
transgen
mous
model
vegftetoteto
baktgtg
develop
studi
h
e
stain
blood
smear
follow
wright
stain
carri
hematolog
analysi
quantit
rtpcr
western
blot
immunofluoresc
use
measur
gene
protein
express
level
experi
result
first
found
circul
red
blood
cell
number
reduc
p
hemoglobin
reduc
p
lymphocyt
number
increas
p
megakaryocyt
number
increas
bone
marrow
spleen
gene
express
increas
bone
marrow
circul
vegfa
repress
induc
gene
express
increas
decreas
subgroup
hematopoiet
stem
cell
increas
bone
marrow
regul
vegfa
result
may
directli
regul
express
methyl
activ
introduct
mediat
hyperact
fibroblast
breast
cancer
stroma
associ
malign
develop
breast
cancer
factor
unclear
order
explor
mechan
effect
breast
cancer
studi
effect
epiderm
growth
factor
egf
express
fibroblast
cocultur
breast
cancer
cell
breast
cancer
growth
method
human
breast
cancer
cell
line
human
fibroblast
line
esf
cocultur
transwel
insert
method
effect
egf
express
fibroblast
cocultur
breast
cancer
cell
detect
revers
transcript
quantit
polymeras
chain
reaction
rtqpcr
westernblot
vitro
effect
egf
express
fibroblast
breast
cancer
tissu
tumorburden
nude
mice
vivo
analyz
use
immunofluoresc
laser
confoc
microscop
breast
cancer
volum
tumorburden
nude
mice
examin
data
present
mean
sd
analyz
use
spss
statist
differ
analysi
two
group
perform
student
ttest
p
valu
consid
statist
signific
differ
result
egf
express
esf
cell
group
higher
group
p
indic
could
promot
egf
express
fibroblast
condit
breast
cancer
cell
fibroblast
cocultur
vitro
also
show
tumor
microenviron
play
synergist
role
function
egf
express
breast
cancer
tissu
tumorburden
nude
mice
mark
fluoresc
antibodi
observ
use
laser
confoc
microscopi
fluoresc
intens
group
breast
tumorburden
nude
mice
much
stronger
group
p
fluoresc
intens
significantli
differ
group
breast
tumorburden
nude
mice
indic
target
egf
fibroblast
breast
cancer
cell
breast
cancer
tissu
tumorburden
nude
mice
egf
express
group
tumorburden
nude
mice
suggest
basal
express
egf
breast
cancer
cell
signific
effect
egf
express
breast
cancer
cell
day
inject
tumor
volum
group
tumorburden
nude
mice
significantli
larger
group
p
promot
growth
transplant
tumor
nude
mice
result
egf
immunohistochemistri
show
densiti
valu
egf
human
breast
cancer
tissu
higher
breast
hyperplasia
p
method
colostrumdepriv
germfre
piglet
gf
colon
ecn
la
h
hysterectomi
bred
gf
piglet
one
week
later
infect
st
h
bacteri
colon
intesin
cfu
count
secret
tnf
alpha
xmap
technolog
transcript
occludin
rtqpcr
protein
express
monitor
result
infect
st
caus
bacteremia
somnol
anorexia
diarrhea
piglet
high
level
tnf
alpha
level
piglet
preliminari
associ
ecn
almost
complet
suppress
case
preliminari
associ
la
transcript
gf
ecn
la
piglet
group
colon
compar
st
group
highli
increas
contrast
transcript
occludin
depress
st
group
introduct
type
type
iii
interferon
ifn
well
recogn
nonredund
import
limit
viral
infect
howev
role
inflammatori
mediat
less
well
character
ifn
type
signal
common
jak
stat
pathway
type
distinct
receptor
complex
function
redund
type
type
iii
ifn
restrict
type
iii
ifn
receptor
express
primarili
epitheli
cell
suggest
import
role
type
iii
ifn
mucos
surfac
inflammatori
bowel
diseas
ibd
ulcer
coliti
uc
crohn
diseas
involv
perturb
complex
interact
mucos
immun
system
commens
bacteria
gut
cytokin
act
import
crossregul
multilay
interact
method
character
contribut
type
type
iii
ifn
format
progress
resolut
uc
use
mice
defici
type
ifn
type
iii
ifn
type
iiii
ifn
signal
murin
model
acut
uc
follow
exposur
mice
dextran
sodium
sulfat
dss
contain
water
result
import
ifn
signal
acut
phase
inflamm
demonstr
onset
enhanc
patholog
weight
loss
concurr
peak
ifninduc
promoterdriven
luciferas
express
dsstreat
transgen
report
mice
accordingli
experi
reveal
enhanc
sensit
doubl
type
type
iii
ifn
receptordefici
mice
dssinduc
diseas
measur
decreas
bodi
weight
colon
length
diffus
destruct
colon
epithelium
increas
mortal
furthermor
distinct
express
profil
sever
proinflammatori
antiinflammatori
cytokin
colon
homogen
serum
well
differ
innat
immun
cell
infiltr
observ
ifn
receptordefici
mice
comparison
wild
type
mice
conclus
data
suggest
type
type
iii
ifn
play
import
role
modul
inflammatori
respons
tissu
homeostasi
repair
dssinduc
coliti
loss
ifn
signal
may
exacerb
inflammatori
respons
retard
mucos
wound
heal
disclosur
interest
none
declar
introduct
psoriasi
chronic
inflammatori
skin
diseas
character
hyperprolifer
impair
differenti
keratinocyt
coupl
influx
inflammatori
cell
epidermi
especi
dermi
mechan
underli
psoriasi
human
mous
model
still
incomplet
understood
although
cytokin
clearli
shown
make
crucial
contribut
antibodi
proven
highli
efficaci
treat
diseas
cytokin
signal
via
obligatori
adaptor
identifi
critic
role
signal
imiquimodinduc
psoriat
inflamm
mous
model
share
featur
human
diseas
result
cytokineciksmedi
signal
keratinocyt
essenti
neutrophil
microabscess
format
contribut
hyperprolifer
markedli
attenu
differenti
keratinocyt
part
via
direct
effect
cytokin
keratinocyt
interestingli
signal
keratinocyt
also
exert
neg
feedback
delimit
accumul
cdt
cell
skin
led
reduc
product
time
dermal
cdt
primari
sourc
cytokin
model
demonstr
neg
feedback
mediat
part
via
member
famili
cytokin
strongli
induc
keratinocyt
appear
function
least
part
via
autocrineparacrin
mechan
suppress
recruit
cdt
cell
therebi
dampen
product
stand
contrast
cytokinesciksmedi
signal
nonkeratinocyt
particularli
dermal
fibroblast
earli
phase
inflamm
promot
cellular
infiltr
enhanc
accumul
cdt
cell
skin
compris
initi
posit
feedforward
mechan
conclus
data
show
ciksmedi
signal
dynam
central
develop
dermal
epiderm
hallmark
psoriasi
induc
distinct
patholog
via
target
cellspecif
effect
also
initi
mechan
ultim
mitig
damag
latter
mechan
may
offer
addit
avenu
therapeut
intervent
genter
pathogen
caus
selflimit
gastroenter
human
pig
aim
work
modifi
lp
salmonella
typhimurium
modifi
signal
local
product
inflammatori
cytokin
method
oneweekold
hysterectomyderiv
germfre
piglet
gf
infect
typhimurium
st
isogen
rfag
mutant
h
salmonella
cfu
count
trif
transcript
ileum
evalu
rtqpcr
tnfalpha
protein
elisa
result
st
rfag
mutant
compar
colon
ileum
gnotobiot
piglet
transcript
increas
st
group
transcript
rfag
group
similar
gf
piglet
decreas
trif
increas
st
group
rfag
group
compar
gf
piglet
tnfalpha
induc
st
piglet
conclus
receptor
lp
st
induc
high
level
tnfalfa
ileum
may
harm
rough
lp
mutant
induc
futur
incorpor
molecul
relat
lp
lbp
would
contribut
clarifi
relat
lp
type
introduct
human
inflammatori
bowel
diseas
ibd
complex
heterogen
interact
variou
genet
environment
factor
lead
loss
immunolog
toler
gut
resid
microbi
flora
subsequ
chronic
inflamm
gastrointestin
tract
singl
ibd
anim
model
accur
mimic
complex
heterogen
human
diseas
howev
mechanist
anim
model
use
hypothesi
test
interrog
biolog
pathway
drug
discoveri
method
aim
character
greater
tempor
biolog
resolut
model
innat
acut
coliti
induc
stimul
proinflammatori
receptor
agonist
antibodi
lymphopen
order
gain
better
insight
pathobiolog
result
comprehens
analys
time
cours
inflamm
show
dynam
natur
colon
versu
system
immun
respons
chang
cytokin
network
histopatholog
chang
gut
spleen
liver
unexpectedli
found
inflammatori
respons
caus
timerel
dysbiosi
gut
flora
coliti
induct
model
depend
upon
presenc
innat
lymphocyt
treatment
antibodi
proinflammatori
cytokin
tnfalpha
attenu
inflammatori
cascad
differ
indic
uniqu
function
role
pathway
activ
cytokin
conclus
data
reveal
novel
diseas
mechan
model
lead
better
understand
pathobiolog
coliti
model
introduct
intestin
epitheli
cell
iec
constitut
primari
barrier
separ
us
outsid
environ
apic
side
face
lumen
gut
basolater
side
face
lamina
propia
fulli
function
combat
pathogen
intrud
iec
develop
specif
mechan
regul
intrins
immun
respons
toler
presenc
commens
flora
lumen
gut
tailor
respons
key
maintain
gut
homeostasi
littl
known
molecular
mechan
lead
perfectli
balanc
immun
toler
method
use
human
iec
grown
transwel
recapitul
epithelium
architectur
order
address
immun
homeostasi
achiev
gut
result
address
whether
polar
natur
iec
influenc
innat
immun
respons
upon
viral
infect
found
infect
iec
initi
basolater
side
stronger
innat
immun
respons
trigger
respons
character
prolong
product
type
iii
interferon
ifn
compar
infect
eman
apic
side
use
crispr
gene
edit
molecular
transcomplement
approach
demonstr
asymmetr
respons
mediat
rigi
like
receptor
pathway
fulli
depend
polar
natur
iec
addit
found
unlik
mous
human
iec
fulli
respons
type
iii
ifn
importantli
defin
first
time
function
differ
two
ifn
epitheli
cell
conclus
result
demonstr
human
iec
develop
uniqu
mechan
regul
immun
respons
function
infect
side
specif
function
type
iii
ifn
polar
respons
would
repres
strategi
maintain
gut
immun
homeostasi
avoid
excess
respons
virus
locat
lumin
side
maintain
full
respons
virus
pass
epithelium
barrier
disclosur
interest
none
declar
introduct
recent
discov
typeiii
interferon
ifn
genet
regul
clinic
signific
associ
impair
clearanc
hepat
c
viru
hcv
infect
typeiii
ifn
play
critic
role
innat
immun
respons
viral
infect
although
induc
similar
antivir
profil
typeiii
ifn
specif
contribut
innat
immun
respons
unclear
delin
function
properti
distinguish
typeiii
ifn
may
give
insight
uniqu
role
hcv
viral
infect
method
compar
antivir
respons
induc
recombin
versu
protein
express
stabl
induc
cell
line
use
exogen
human
hepatoma
cell
line
measur
sever
ifninduc
respons
includ
activ
luciferas
report
control
ifnstimul
respons
element
isr
phosphoryl
induct
ifnstimul
gene
isg
abil
induc
antivir
activ
infecti
challeng
sendai
viru
sev
result
show
significantli
higher
antivir
activ
within
first
h
treatment
antivir
activ
ifn
compar
h
antivir
activ
declin
sharpli
h
unlik
maintain
activ
data
support
stronger
transient
induct
stat
phosphoryl
compar
also
show
despit
poor
secret
significantli
potent
cell
engin
express
gfptag
effect
inhibit
sendai
viru
infect
earli
time
point
compar
introduct
necrot
enterocol
nec
lead
caus
death
gastrointestin
diseas
prematur
infant
although
specif
molecular
mechan
respons
nec
develop
remain
unclear
nec
character
intestin
epitheli
barrier
disrupt
enterocyt
apoptosi
impair
mucos
heal
recent
evid
suggest
critic
role
regul
intestin
epitheli
barrier
integr
promot
epitheli
heal
hypothes
signal
import
protect
nec
subsequ
defici
mice
would
suscept
nec
method
experiment
nec
induc
neonat
postnat
day
wildtyp
wt
knockout
intestin
defici
villincr
x
flfl
mice
use
gavag
formula
feed
time
day
intermitt
hypoxia
n
min
twice
daili
recombin
administ
intraperiton
mg
gram
bodi
weight
daili
wt
mice
nec
sever
assess
use
histolog
small
intestin
mrna
express
proinflammatori
marker
ino
immunohistochemistri
perform
enterocyt
prolifer
apoptosi
result
wt
mice
experiment
nec
result
disrupt
intestin
mucos
architectur
decreas
enterocyt
prolifer
increas
express
proinflammatori
cytokin
ino
within
intestin
importantli
knockout
intestin
defici
mice
suscept
experiment
nec
develop
demonstr
acceler
necrel
mortal
derang
villi
architectur
histolog
upregul
proinflammatori
marker
ino
immunohistochemistri
reveal
decreas
enterocyt
prolifer
increas
enterocyt
apoptosi
knockout
intestin
defici
compar
control
strikingli
demonstr
recombin
attenu
experiment
nec
sever
wt
mice
introduct
propoli
resin
product
made
honeybe
variou
plant
part
attract
attent
research
biolog
properti
highlight
immunomodulatori
effect
monocyt
circul
mononuclear
phagocyt
adopt
differ
role
depend
activ
stimuli
microenviron
lp
one
potent
activ
monocyt
drive
cell
polar
work
aim
investig
propoli
immunomodulatori
action
cytokin
product
lpsactiv
human
monocyt
assess
cell
viabil
tnfa
product
method
human
monocyt
obtain
healthi
donor
stimul
lp
propoli
p
combin
lp
p
h
possibl
cytotox
effect
assess
mtt
assay
lpsinduc
cytokin
product
determin
elisa
signific
differ
determin
analysi
varianc
anova
follow
dunnett
test
p
result
data
show
cell
viabil
affect
monocyt
incub
propoli
alon
combin
lp
propoli
inhibit
tnfa
product
lpsactiv
human
monocyt
wherea
combin
lp
p
increas
releas
conclus
propoli
display
antiinflammatori
activ
decreas
lp
action
tnfa
product
human
monocyt
moreov
propoli
induc
product
even
presenc
lp
find
may
provid
novel
therapeut
approach
modul
monocyt
activ
propoli
disclosur
interest
none
declar
introduct
even
highli
biocompat
materi
titaniumbas
devic
caus
degre
host
respons
thought
play
signific
role
subsequ
regen
respons
howev
mechan
involv
trigger
host
respons
well
role
host
respons
ensu
regener
remain
unknown
aim
studi
evalu
role
signal
molecul
part
signal
complex
genesi
modul
inflammatori
immun
respons
titanium
ti
implant
impact
follow
heal
regener
experiment
group
compris
eightweekold
male
wildtyp
wt
mice
mice
target
disrupt
ceepafobusp
process
tidisc
implant
subcutan
tissu
wt
mice
compar
evalu
use
microscop
molecular
realtimepcrarrayelisal
assay
paramet
assess
day
time
point
valu
p
consid
statist
signific
result
tidisc
implant
wt
mice
result
local
releas
measur
elisa
major
endogen
ligand
better
character
damp
complex
exogen
ligand
lp
measur
lal
assay
lta
measur
elisa
detect
implant
site
releas
follow
moder
transitori
leukocyt
influx
inflammatori
process
resolut
parallel
fibrou
connect
tissu
format
disc
encapsul
mice
present
signific
decreas
inflammatori
respons
delay
connect
tissu
capsul
format
matur
evidenc
histomorphometr
birefring
analysi
realtimepcrarray
show
impair
heal
respons
absenc
associ
decreas
level
growth
factor
cytokin
heal
marker
vegfa
tnfalpha
data
confirm
elisa
note
sever
msc
marker
nanog
ne
reduc
ko
mice
suggest
host
respons
also
contribut
msc
migrat
andor
activ
tidisc
implant
conclus
summari
possibl
activ
critic
mediat
host
inflammatori
heal
respons
classic
titaniumbas
biomateri
subcutan
tissu
compart
evidenc
signific
decreas
inflammatori
respons
delay
connect
tissu
format
well
decreas
level
molecular
marker
mice
compar
wt
mice
evid
contribut
overal
understand
role
host
immun
respons
heal
process
biomateri
graft
disclosur
interest
none
declar
introduct
shown
critic
transcript
factor
develop
distinct
subset
dendrit
cell
dc
character
express
peripheri
lymphoid
tissu
use
mice
defici
dc
shown
multipl
model
requir
antigen
present
cell
apc
prime
cell
critic
sourc
need
gener
protect
cell
respons
infect
protozoan
parasit
toxoplasma
gondii
protect
infect
gondii
depend
cell
respons
gener
immun
nonrepl
cp
strain
gondii
despit
low
dose
parasit
antigen
cp
immun
result
cell
respons
magnitud
activ
infect
well
understood
cell
cytokin
signal
requir
cp
gener
cell
respons
surprisingli
shown
gener
neither
cell
respons
cp
immun
despit
previous
undescrib
role
depend
dc
dc
prime
cell
aim
studi
determin
role
dc
play
prime
cell
cp
immun
method
mice
immun
cp
cpsova
cpscremcherri
parasit
intraperiton
inject
parasit
periton
exud
cell
pec
obtain
periton
lavag
use
ml
ice
cold
pb
omentum
ln
spleen
process
mm
filter
gener
singl
cell
suspens
singl
cell
suspens
stain
flow
cytometri
analysi
lsr
fortessa
bd
bioscienc
statist
analysi
perform
use
prism
softwar
graphpad
softwar
result
intraperiton
immun
low
dose
cp
capabl
gener
cell
respons
prime
within
two
day
omentum
shown
express
cell
peritoneum
omentum
drain
lymph
node
spleen
day
postimmun
dpi
track
interact
cp
host
immun
cell
tissu
report
mice
immun
cpscremcherri
parasit
analyz
dpi
shown
resid
periton
macrophag
cell
primarili
interact
parasit
dc
directli
interact
cp
role
ifng
depend
migrat
infect
inject
cell
peritoneum
omentum
cell
prime
analyz
block
ifng
dpi
mice
cpscremcherri
inde
ifng
requir
parasit
antigen
transport
omentum
cell
interact
parasit
observ
omentum
cell
increas
express
dpi
compar
mice
inject
control
igg
antibodi
conclus
hypothes
cp
immun
induc
promot
nk
cell
produc
earli
ifng
peritoneum
futur
work
aim
determin
whether
dc
subset
requir
process
present
parasit
antigen
cell
cp
immun
dc
serv
requir
sourc
induc
nk
cell
ifng
product
subsequ
deliveri
cp
antigen
apc
omentum
introduct
immun
system
gener
innat
adapt
respons
ensur
clearanc
pathogen
essenti
host
protect
develop
sustain
immun
antigenspecif
memori
respons
need
dendrit
cell
dc
key
player
bridg
innat
adapt
immun
respons
activ
polaris
cell
effector
cell
crucial
adapt
immun
induct
immun
respons
crucial
fight
infect
also
detriment
host
tight
regul
need
ubiquitin
import
mechan
regul
immun
respons
multipl
ubiquitin
ligas
studi
context
immun
role
pellino
protein
emerg
signific
progress
made
delin
role
physiolog
role
poorli
understood
current
studi
aim
use
mice
explor
function
immun
respons
method
spleen
lymph
node
mice
match
wildtyp
litterm
analys
flow
cytometri
assess
normal
develop
immun
system
studi
cellular
respons
immun
cell
purifi
cytokin
product
prolifer
examin
follow
agonist
antibodi
mitogen
activ
studi
dendrit
cell
biolog
bone
marrowderiv
dc
bmdc
gener
activ
assess
follow
stimul
variou
pathogen
associ
molecular
pattern
result
immun
system
young
adult
mice
develop
normal
signific
differ
variou
cell
type
includ
b
cell
frequenc
number
spleen
lymph
node
wildtyp
mice
purifi
cell
prolifer
produc
similar
level
proinflammatori
cytokin
stimul
vitro
furthermor
bmdc
stimul
variou
tlr
ligand
express
similar
level
secret
compar
level
proinflammatori
cytokin
compar
wildtyp
cell
indic
dispens
dc
activ
howev
delet
inhibit
product
dendrit
cell
key
cytokin
drive
cellular
respons
cell
conclus
find
highlight
novel
mechan
regul
immun
respons
increas
understand
pellino
protein
function
describ
regul
variou
immun
signal
pathway
never
implic
regul
dendrit
cell
function
overal
studi
show
specif
regul
secret
dc
implic
import
role
cellular
respons
introduct
propoli
produc
honeybe
sever
part
plant
product
use
sinc
ancient
time
due
mani
biolog
pharmacolog
properti
retino
acid
ra
metabolit
vitamin
potent
regul
immun
cell
play
import
role
cell
differenti
goal
studi
verifi
propoli
influenc
rastimul
human
monocyt
regard
cytokin
product
tnfa
method
human
monocyt
obtain
healthi
donor
n
incub
propoli
retino
acid
combin
propoli
ra
concentr
h
cell
viabil
assess
mtt
assay
cytokin
product
determin
elisa
signific
differ
determin
analysi
varianc
anova
follow
dunnett
test
p
result
propoli
ra
combin
affect
cell
viabil
alter
seen
tnfa
level
incub
propoli
ra
combin
propoli
ra
product
similar
control
hand
ra
increas
product
wherea
propoli
counteract
ra
action
led
level
similar
control
conclus
propoli
exert
modulatori
action
prevent
rainduc
product
sinc
cytokin
involv
plenti
biolog
activ
differenti
cell
well
result
may
provid
new
approach
develop
immunomodulatori
drug
contain
propoli
treat
inflammatoryautoimmun
diseas
disclosur
interest
none
declar
introduct
herpesvirus
includ
human
pathogen
human
cytomegaloviru
hcmv
replic
within
dissemin
mucos
organ
experi
use
murin
cytomegaloviru
mcmv
model
betaherpesviru
infect
reveal
import
cell
control
persist
import
site
viru
replic
salivari
gland
demonstr
virusspecif
cell
within
mcmvinfect
salivari
gland
reactiv
multipl
viral
epitop
express
immun
regulatori
cytokin
util
cre
flox
mice
examin
impact
product
cell
mcmv
persist
studi
report
mice
protein
phenotyp
rna
sequenc
character
mucos
cell
result
mice
lack
cell
exhibit
heighten
virusspecif
cell
respons
improv
control
viru
replic
data
suggest
target
mechan
regul
gener
mucos
cell
improv
antivir
control
develop
salivari
gland
cell
independ
previous
identifi
cytokin
tgfbeta
transcriptom
analys
protein
phenotyp
cell
reveal
cell
exhibit
distinct
transcript
factor
surfac
receptor
express
profil
compar
cell
implic
multipl
pathway
current
examin
laboratori
develop
import
regulatori
cell
popul
develop
cell
critic
determin
herpesviru
persist
mucos
tissu
cell
exhibit
distinct
transcript
signatur
may
inform
strategi
aim
enhanc
protect
antivir
immun
mucos
surfac
result
produc
macrophag
respons
variou
stimul
agent
includ
tnfa
wherea
tgfb
ifn
inhibit
product
moreov
level
circul
rise
respons
inflamm
induc
thioglycol
inject
periton
caviti
order
elucid
function
produc
mous
although
defici
mice
compar
number
major
immun
cell
popul
immun
organ
effector
function
cell
alter
exampl
activ
splenocyt
mice
produc
abnorm
level
cytokin
compar
splenocyt
isol
wt
littermatesto
elucid
role
innat
andor
adapt
immun
respons
test
mice
model
acut
gondii
infect
found
level
serum
periton
caviti
significantli
increas
respons
infect
surprisingli
defici
mice
resist
gondii
infect
indic
reduc
pathogen
load
increas
surviv
analysi
variou
cytokin
chemokin
serum
infect
wt
defici
mice
reveal
mice
lower
level
sever
proinflammatori
mediat
includ
high
level
chemokin
strong
correl
increas
mortal
suggest
subleth
dose
gondii
infect
mice
die
sepsi
rather
infect
conclus
therefor
result
indic
reduc
inflamm
level
mice
protect
immunemedi
tissu
damag
gondii
infect
togeth
studi
indic
proinflammatori
cytokin
play
import
role
innat
andor
adapt
immun
respons
roth
rb
hevezi
p
lee
method
cell
line
lack
inflammasom
machineri
infect
induc
dimeriz
contruct
cell
death
activ
secret
measur
western
blot
elisa
assay
flow
cytometri
fluorsec
microscopi
mtt
viabil
assay
elispot
assay
follow
induct
dimer
studi
mlklinduc
inflammasom
activ
bone
marrow
deriv
macrophag
deriv
varieti
necroptot
gene
defici
mice
stimul
either
inflammasom
necroptot
stimuli
inflammasom
activ
cell
death
damp
releas
measur
elisa
western
blot
flow
cytometri
monocyt
cell
harbour
induc
wildtyp
mutant
mlkl
construct
creat
directli
assay
domain
role
mlkl
induc
inflammasom
activ
result
cleav
activ
proinflammatori
cytokin
beta
yet
mechan
releas
depend
cell
death
remain
controversi
address
issu
gener
novel
inflammasom
independ
system
directli
activ
dimer
system
dimer
induc
cleavag
secret
requir
process
subunit
moreov
direct
dimer
allow
activ
separ
cell
death
introduct
shown
recurr
activ
acut
periton
inflamm
drive
tissu
damag
fibrosi
transit
chronic
diseas
set
control
promot
expans
profibrot
interferon
ifn
c
secret
cell
respons
repeat
inflammatori
activ
investig
potenti
chang
provis
compet
host
defenc
versu
inflammationinduc
tissu
injuri
use
rnaseq
profil
gene
signatur
resolv
profibrot
periton
line
tissu
method
acut
periton
inflamm
establish
wild
type
wt
mice
stimul
use
cellfre
supernat
staphylococcu
epidermidi
se
fluoresc
label
staphylococcu
epidermidi
isol
optim
time
point
periton
line
tissu
rna
extract
western
blot
determin
inflammatori
leukocyt
resid
infiltr
cell
periton
lavag
sampl
collect
analysi
use
rnaseq
multiparamet
flow
cytometri
immunodetect
assay
result
profil
occur
via
transsignal
signal
periton
line
tissu
follow
se
challeng
identifi
h
optim
time
point
rnaseq
analysi
bioinformat
analysi
rnaseq
data
wt
mice
identifi
gene
signatur
relev
control
antimicrobi
immun
leukocyt
recruit
adhes
leukocyt
effector
function
vascular
permeabl
homeostat
turnov
extracellular
matrix
consist
chang
mice
show
alter
neutrophil
recruit
impair
antimicrobi
innat
respons
phagocytosi
respiratori
burst
follow
infect
staphylococcu
epidermidi
mimic
tissu
microenviron
associ
onset
periton
fibrosi
mice
adopt
transfer
ip
either
tcell
profibrot
cell
expand
ex
vivo
condit
media
se
challeng
resid
periton
monocyt
cell
adopt
transfer
cell
togeth
se
trigger
substant
alter
capac
stromal
periton
tissu
respond
acut
inflamm
defin
use
rnaseq
context
signal
presenc
cell
led
increas
periton
levelswith
rnaseq
analysi
identifi
chang
splice
conclus
data
provid
insight
dynam
relationship
ifnk
determin
balanc
compet
host
defenc
inflammationinduc
tissu
damag
propos
initi
expans
cell
lead
retrograd
amplif
bioactiv
acut
inflammatori
respons
control
via
stromal
tissu
follow
recurr
infect
disclosur
interest
none
declar
research
propoli
immun
perform
use
anim
studi
regard
propoli
immunomodulatori
action
human
cell
monocyt
incub
simultan
propoli
human
tumor
antigen
known
induc
product
proinflammatori
cytokin
profil
work
aim
investig
modulatori
action
propoli
cytokin
product
tnfa
human
monocyt
method
human
monocyt
obtain
healthi
donor
n
incub
propoli
combin
p
h
cell
viabil
assess
mtt
assay
cytokin
product
determin
elisa
signific
differ
determin
analysi
varianc
anova
follow
dunnett
test
p
result
propoli
combin
p
affect
monocyt
viabil
stimul
tnfa
product
effect
product
hand
combin
decreas
tnfa
product
increas
product
result
previou
studi
lab
other
reveal
hcv
act
regul
innat
immun
respons
infect
cell
viru
replic
hepatocyt
acut
activ
rigilik
receptor
signal
viral
detect
rigi
respons
quickli
block
hcvdirect
process
prevent
activ
downstream
interferon
regulatori
factor
transcript
factor
support
viral
persist
hepatocyt
howev
despit
regul
innat
immun
defens
hepatocyt
hcvinfect
liver
typic
state
persist
innat
immun
activ
outcom
suggest
role
immun
crosstalk
signalingcompet
liver
cell
direct
hepat
respons
infect
importantli
found
hcv
produc
chronic
infect
phagocytos
liver
macrophag
call
kupffer
cell
wherein
intern
virion
trigger
inflammasom
hcv
product
infect
kupffer
cell
induc
potent
product
releas
drive
hepat
inflamm
underli
liver
diseas
investig
macrophag
hub
inflammatori
signal
reveal
hereto
unappreci
role
signal
regul
inflammatori
well
interferonantivir
respons
gene
therefor
hypothes
proinflammatori
signal
molecul
act
drive
innat
immun
activ
kupffer
cell
hepat
compart
respons
viral
insult
liver
result
maladapt
nonresolv
respons
chronic
infect
underli
last
hepat
injuri
conclus
investig
cellular
respons
hcv
hepatocytemacrophag
cocultur
set
identifi
crosstalk
signal
network
cytokin
mediat
underscor
liver
diseas
outcom
furthermor
abl
link
profil
degre
liver
injuri
predict
pathway
immunoprotect
versu
immunopathogen
chronic
hcv
infect
disclosur
interest
none
declar
introduct
accur
precis
measur
cytokin
express
essenti
meaning
assess
innat
adapt
immun
process
mice
ubiquit
model
mani
infecti
diseas
question
relev
translat
result
studi
led
increas
usag
nonhuman
primat
nhp
model
infect
diseas
part
develop
work
rhesu
macaqu
periodont
diseas
model
differ
cytokin
measur
methodolog
assess
spike
recoveri
assay
method
kit
assess
luminex
technolog
kit
milliplex
map
nonhuman
primat
cytokin
magnet
bead
panel
electrochemiluminesc
kit
meso
scale
diagnost
vplex
proinflammatori
panel
nhp
kit
kit
consist
human
specif
antibodi
control
reagent
report
crossreact
cytokin
produc
rhesu
macaqu
nhp
speci
recombin
macaqu
cytokin
assess
acquir
two
separ
vender
mybiosci
r
system
result
experi
reveal
great
variabl
assess
cytokin
concentr
accur
detect
cytokin
eg
detect
eg
detect
eg
ifng
detect
eg
cytokin
furthermor
detect
cytokin
across
rang
concentr
alway
linear
final
variabl
observ
differ
kit
suggest
differ
sensit
degre
crossreact
kit
reagent
limit
human
reagent
crossreact
nhp
cytokin
illustr
experiment
anoth
luminex
technolog
kit
bioplex
pro
tm
human
cytokin
assay
recombin
macaqu
cytokin
assess
detect
kit
conclus
taken
togeth
data
suggest
caution
use
draw
conclus
immun
polar
base
nhp
cytokin
data
corrobor
altern
method
reli
detect
human
specif
antibodi
eg
qpcr
data
also
highlight
need
move
beyond
use
crossreact
human
reagent
develop
nhpspecif
reagent
anim
model
continu
increas
usag
import
introduct
cytokin
known
causal
factor
neuroinflammatori
diseas
human
howev
understand
mechan
via
mediat
central
nervou
system
cn
inflamm
injuri
unclear
transgen
mous
term
mice
model
cnsrestrict
product
replic
mani
key
neuropatholog
behaviour
chang
found
human
neuroinflammatori
diseas
microglia
tissueresid
macrophag
cn
may
major
target
effector
cell
neuroinflamm
therefor
object
studi
gain
understand
natur
microgli
respons
cn
method
wt
mice
egfplabel
macrophag
macgreen
mg
gener
combin
situ
immunohistochemistri
confoc
microscopi
ex
vivo
flow
cytometri
approach
employ
determin
morpholog
distribut
number
molecular
signatur
microglia
brain
agematch
mgwt
compar
mice
result
compar
mgwt
mice
display
significantli
increas
number
egfp
cell
throughout
brain
neg
peripher
monocytespecif
marker
increas
microglia
number
due
significantli
increas
prolifer
particularli
younger
mice
shown
brdu
incorpor
threedimension
reconstruct
morphometr
analysi
reveal
mgwt
microglia
exhibit
typic
highli
ramifi
morpholog
long
fine
primari
secondari
process
contrast
microglia
exhibit
dramat
alter
morpholog
stunt
thicken
primari
process
reduc
secondari
branch
final
compar
mgwt
microglia
mice
alter
molecular
signatur
significantli
decreas
level
fcrl
level
increas
level
unchang
studi
indic
microglia
major
respond
cell
cn
undergo
dramat
morpholog
transform
increas
prolifer
addit
exposur
cn
mediat
mark
alter
uniqu
molecular
signatur
defin
tissueresid
myeloid
cell
introduct
respons
associ
host
defens
well
autoimmun
diseas
patient
experiment
anim
model
cell
caus
tissu
damag
produc
stereotyp
profil
proinflammatori
cytokin
includ
interleukin
il
granulocyt
macrophag
colonystimul
factor
gmcsf
recogn
signatur
cytokin
cell
pathogen
effector
model
autoimmun
method
use
recent
develop
model
spontan
uveiti
mice
express
transgen
cell
receptor
specif
retin
autoantigen
irbp
investig
suscept
diseas
mice
defici
background
addit
irbpspecif
cell
suffici
defici
mice
polar
condit
adopt
transfer
wt
host
investig
cytokin
profil
abil
induc
uveiti
result
found
defici
reduc
sever
uveiti
mice
howev
dozen
mucos
vaccin
approv
human
use
digmp
cdg
attract
mucos
vaccin
adjuv
candid
activ
sting
stimul
interferon
gene
pulmonari
dendrit
cell
administ
intranas
pulmonari
dendrit
cell
consist
two
function
distinct
subset
dc
dc
cdg
target
pulmonari
dc
subset
promot
mucos
adjuv
activ
known
method
intranas
vaccin
flfl
cre
tnfr
mice
pneumococc
protein
antigen
pspa
mucos
adjuv
cdg
two
week
last
immun
pspaspecif
antibodi
respons
determin
bronchoalveolar
lavag
bal
blood
pspaspecif
cellular
respons
determin
lung
spleen
cell
elisa
matur
pulmonari
dc
subset
determin
flow
cytometri
analysi
result
investig
role
differ
pulmonari
dc
subset
mediat
mucos
adjuv
activ
cdg
use
mice
found
dc
mediat
cdginduc
antibodi
product
popul
pulmonari
dc
still
intact
mice
suggest
dc
suffici
cdginduc
humor
immun
furthermor
delet
dc
flfl
cre
mice
demonstr
dc
need
cdginduc
antibodi
product
respons
lung
addit
cdg
adjuv
activ
complet
depend
tnfa
signal
type
interferon
found
cdginduc
tnfa
signal
requir
activ
pulmonari
dc
conclus
result
demonstr
cdg
target
activ
pulmonari
dc
promot
mucos
adjuv
activ
introduct
macrophag
migrat
inhibitori
factor
mif
pluripot
proinflammatori
factor
act
mediat
innat
immun
implic
pathogenesi
numer
autoinflammatori
disord
includ
gout
level
serum
mif
correl
diseas
outcom
clinic
studi
shown
correl
elev
level
mif
serum
patient
autoimmun
disord
date
unclear
whether
mif
specif
regul
express
secret
famili
cytokin
biolog
activ
mif
murin
bone
marrow
deriv
macrophag
bmdm
inhibit
use
small
molecul
inhibitor
concurr
bmdm
deriv
mif
mice
employ
evalu
effect
mif
deplet
regul
famili
cytokin
mrna
express
analyz
qrt
pcr
protein
express
secret
secret
assess
western
blot
level
secret
determin
elisa
result
show
deplet
mif
macrophag
significantli
reduc
cytokin
famili
releas
respons
stimuli
effect
secret
tnfa
moreov
diminish
respons
independ
nfkb
function
product
instead
mif
deplet
specif
inhibit
respons
cytokin
secret
unaffect
follow
activ
inflammasom
conclus
find
reveal
novel
role
mif
modul
inflammatori
respons
link
mif
directli
inflammasom
activ
studi
first
time
implic
specif
role
mif
releas
famili
cytokin
highlight
potenti
target
mif
patholog
introduct
pathogenesi
allerg
diseas
includ
asthma
strongli
associ
robust
respons
cell
produc
thymic
stromal
lymphopoietin
tslp
cytokin
express
upon
epitheli
infect
dysfunct
implic
pathogenesi
allerg
disord
although
function
tslp
stimul
dendrit
cell
promot
differenti
well
appreci
direct
mechan
action
tslp
effector
state
remain
elucid
previous
tslp
shown
increas
respons
human
cell
enhanc
surviv
murin
cell
induc
signal
pathway
sought
determin
role
tslp
cell
differenti
gain
insight
molecular
mechan
action
tcr
activ
method
adopt
transfer
wildtyp
wt
tslp
receptordefici
cell
tcra
ko
mice
follow
hous
dust
mite
hdm
administr
use
defin
cell
specif
effect
tslp
asthma
model
cell
activ
tcr
presenc
absenc
tslp
assess
cytokin
product
differenti
cell
primari
secondari
respons
adopt
transfer
wt
mice
flow
cytometri
rnaseq
chipseq
analys
perform
explor
cellular
molecular
profil
tslpand
cell
result
found
tslp
signal
cell
allergen
exposur
lung
enhanc
allerg
airway
inflamm
vitro
analysi
reveal
tslpprime
cell
produc
increas
amount
proallerg
cytokin
notabl
primari
well
secondari
respons
accompani
distinct
epigenet
chang
cytokin
locu
importantli
tslp
induc
cytokin
express
independ
tcr
activ
cytokin
requir
sustain
differenti
enhanc
product
proallerg
cytokin
introduct
signal
essenti
develop
mainten
natur
killer
nk
cell
protein
key
transcript
factor
mediat
action
cytokin
previous
report
splenic
nk
cell
decreas
doubl
knockin
dki
tetramerdefici
mice
tetram
act
maintain
normal
number
nk
cell
remain
unknown
method
use
flow
cytometr
analysi
analyz
nk
cell
bone
marrow
thymu
liver
spleen
wild
type
wt
dki
mice
also
compar
prolif
respons
cfse
label
determin
nk
cell
viabil
use
annexin
v
stain
measur
activ
caspas
use
flica
stain
moreov
use
rnaseq
chipseq
analys
identifi
tetram
regul
mrna
tetram
target
gene
mous
nk
cell
result
found
markedli
decreas
low
matur
nk
cell
especi
bone
marrow
dki
mice
indic
essenti
role
tetram
nk
matur
despit
development
defect
dki
nk
cell
bone
marrow
spleen
exhibit
similar
prolifer
observ
wt
nk
cell
interestingli
tissu
resid
nk
cell
dki
liver
develop
normal
also
found
decreas
express
bone
marrow
nk
cell
splenic
nk
cell
dki
mice
potenti
explain
partial
block
latestag
matur
nk
cell
moreov
dki
nk
cell
suscept
wt
nk
cell
cytokin
withdrawalinduc
cell
death
direct
regul
express
tetram
respons
stimul
increas
activ
caspas
dki
nk
cell
conclus
find
reveal
critic
role
dimer
earli
develop
nk
cell
indispens
role
tetram
latestag
matur
surviv
convent
nk
cell
vivo
disclosur
interest
none
declar
method
dissect
role
mirna
cell
homeostasi
use
mice
condit
delet
look
specif
mirna
role
cell
regul
use
mice
condit
delet
mir
cluster
isol
lung
cultur
examin
cytokin
product
growth
cell
vivo
studi
function
mice
challeng
natur
allergen
papain
result
cell
sever
reduc
knockout
mice
mir
cluster
knockout
cell
prolifer
express
significantli
reduc
compar
wild
type
cell
respons
vitro
knockout
cell
transfect
matur
mir
mimic
show
increas
product
compar
control
mimic
transfect
cell
knockout
cell
exhibit
increas
express
mir
cluster
direct
target
rora
knockout
cell
show
increas
express
inhibit
via
sirna
approach
cell
expans
function
impair
knockout
mice
papain
allerg
model
conclus
mirna
regul
divers
aspect
cell
biolog
includ
homeostasi
function
mir
cluster
requir
support
cytokin
product
cell
repress
express
direct
target
signal
inhibitor
mir
amplifi
similar
signal
support
product
cytokin
cell
suggest
mir
might
use
drug
target
allerg
airway
inflamm
disclosur
interest
none
declar
intracellular
neg
regul
often
induc
limit
cytokin
signal
classic
neg
feedback
loop
character
central
domain
ctermin
soc
box
sequenc
motif
recruit
ubiquitin
ligas
complex
use
multidisciplinari
approach
show
ci
encod
cish
critic
neg
regul
signal
nk
cell
result
cish
rapidli
induc
respons
delet
cish
render
nk
cell
hypersensit
evidenc
enhanc
prolifer
surviv
ifnk
product
cytotox
toward
tumor
associ
increas
jakstat
signal
nk
cell
cish
delet
correspondingli
ci
interact
tyrosin
kinas
specif
inhibit
enzymat
activ
target
proteasom
degrad
cish
mice
resist
experiment
melanoma
prostat
breast
cancer
metastasi
vivo
intrins
nk
cell
activ
remark
cish
mice
treat
antibodi
current
one
effect
treatment
advanc
melanoma
develop
even
fewer
metastas
control
cish
mice
highlight
potenti
therapeut
benefit
could
achiev
therapi
combin
loss
ci
function
conclus
studi
uncov
potent
intracellular
checkpoint
nk
cellmedi
tumor
immun
hold
promis
novel
cancer
immunotherapi
direct
block
ci
function
crp
supar
predictor
mortal
hr
ci
crp
supar
adjust
age
sex
model
adjust
crp
supar
hr
crp
supar
interact
supar
crp
p
auc
roc
curv
analysi
predict
mortal
ci
sex
age
ad
crp
improv
auc
ci
p
ad
supar
better
ad
crp
auc
ci
p
combin
sex
age
crp
supar
improv
auc
ci
p
conclus
like
crp
supar
posit
correl
compon
innat
immun
includ
crp
total
leukocyt
count
monocyt
neutrophil
crp
supar
strong
predictor
mortal
acut
medic
patient
adjust
risk
factor
supar
add
signific
prognost
inform
establish
inflamm
marker
crp
biomark
may
therefor
aid
risk
stratif
acut
care
set
patient
increas
crp
supar
higher
risk
die
introduct
cell
drive
autoimmun
inflamm
product
proinflammatori
cytokin
includ
gmcsf
ifnk
betasit
amyloid
precursor
proteincleav
enzym
physiolog
role
central
nervou
system
cn
develop
includ
myelin
best
known
role
promot
amyloid
plaqu
format
alzheim
diseas
also
thought
contribut
neurodegen
process
trigger
cn
injuri
upregul
respons
inflammatori
stimuli
hand
defici
caus
impair
myelin
cn
report
reduc
repair
follow
peripher
nerv
injuri
therefor
sought
investig
role
neuroinflamm
mous
model
multipl
sclerosi
experiment
autoimmun
encephalomyel
eae
method
activ
eae
induc
immun
mog
cfa
passiv
transfer
eae
achiev
cultur
cell
immun
donor
mog
activ
cell
polar
condit
follow
transfer
naiv
recipi
clinic
score
monitor
cell
analyz
flow
cytometri
elisa
naiv
cell
also
differenti
condit
analyz
flow
cytometri
elisa
qpcr
rnaseq
result
mice
suscept
eae
expect
myelin
defect
sever
eae
increas
unexpectedli
defici
result
defect
ifnk
product
mogreact
cell
defici
restrict
cell
result
protect
diseas
activ
eae
passiv
transfer
myelinreact
cell
promot
cell
intrins
demonstr
vitro
vivo
cocultur
act
downstream
rorct
express
factor
gmcsf
rorct
affect
confirm
rnaseq
wt
cell
uncov
novel
regul
cell
function
autoimmun
inflamm
cellintrins
promot
product
investig
mechan
finetun
function
achiev
disclosur
interest
none
declar
introduct
system
lupu
erythematosu
sle
complex
autoimmun
diseas
affect
multipl
organ
includ
kidney
skin
nervou
system
heart
vascular
system
character
abnorm
adapt
innat
immun
cell
inflammatori
cytokin
synthes
cell
play
pivot
role
pathogenesi
diseas
sever
studi
shown
blockad
inflammatori
cytokin
cytokin
receptor
feasibl
approach
treatment
sle
tofacitinib
inhibitor
janu
kinas
jak
block
signal
downstream
multipl
cytokin
sever
ongo
complet
clinic
trial
shown
tofacitinib
exhibit
signific
clinic
efficaci
diseas
rang
rheumatoid
arthriti
psoriasi
inflammatori
bowel
diseas
method
evalu
impact
tofacitinib
patholog
sle
util
mrllpr
lupuspron
mice
model
tofacitinibtr
mice
display
decreas
serum
cytokin
level
includ
ifnk
tnfa
splenocyt
show
reduc
express
type
iii
ifn
signatur
gene
reduc
renal
skin
inflamm
lower
level
ana
diminish
deposit
immunoglobulin
complex
decreas
albumincreatinin
ratio
urin
also
observ
furthermor
neutrophil
deriv
form
treat
mice
show
reduc
product
neutrophil
extracellular
trap
drug
induc
signific
improv
endotheliumdepend
vasorelax
endotheli
differenti
conclus
taken
togeth
data
suggest
modul
adapt
innat
arm
immun
system
interf
cytokin
signal
interferondriven
genet
program
tofacitinib
amelior
sle
phenotyp
vascular
dysfunct
lupuspron
mice
support
concept
tofacitinib
jak
inhibitor
may
benefici
sle
despit
high
metabol
bat
long
lifespan
time
compar
size
nonfli
mammal
howev
molecular
mechan
observ
total
unknown
aberr
excess
inflammasom
activ
recent
link
viral
pathogenesi
agerel
diseas
one
hypothes
differenti
regul
inflammasom
signal
may
play
role
biolog
featur
bat
method
investig
inflammasom
activ
bat
primari
immun
cell
cell
line
result
data
show
activ
significantli
reduc
bat
cell
compar
human
mous
counterpart
low
induct
asc
speck
format
activ
respons
variou
natur
synthet
stimuli
conclus
result
far
suggest
involv
multipl
molecular
mechan
differ
step
signal
pathway
includ
uniqu
loss
sensor
gene
famili
genom
level
alter
express
function
key
inflammasom
protein
inflamm
nonchemotact
function
cell
inflamm
autoimmun
known
gpcr
abil
activ
batteri
downstream
signal
pathway
cell
thu
hypothes
intrins
signal
along
costimulatori
signal
influenc
differenti
plastic
function
regulatori
cell
treg
autoimmun
method
acut
coliti
induc
mice
give
dextran
sodium
sulphat
dss
wv
drink
water
develop
progress
coliti
monitor
daili
weight
loss
loos
stool
bloodi
diarrhea
spleen
mesenter
lymph
node
payer
patch
lamina
propria
effector
cell
cell
treg
analyz
flow
cytometri
immunohistolog
stain
splenic
cell
mice
cultur
presenc
antimous
mab
irradi
cell
deplet
spleenocyt
togeth
cell
polar
reagent
tgfb
treg
tgfb
signal
studi
cell
primari
cell
sort
mice
stimul
recombin
result
inhibit
induc
treg
differenti
direct
toward
pathogen
lineag
increas
express
associ
molecul
aryl
hydrocarbon
receptor
ahr
cultur
treg
inhibit
surfac
express
suppressor
molecul
fasl
cultur
treg
differenti
condit
signal
increas
rorct
express
associ
molecul
furthermor
induc
phosphoryl
akt
mtor
activ
promot
bind
rorct
conserv
noncod
region
promot
cell
show
reduc
phosphoryl
differenti
cell
prevent
develop
autoimmun
coliti
analysi
pbmc
human
inflammatori
bowel
diseas
ibd
patient
show
increas
rorct
express
cell
compar
healthi
volunt
conclus
activ
modul
critic
balanc
treg
cell
requir
mainten
gut
toler
target
inhibit
migrat
pathogen
cell
inflam
tissu
also
help
maintain
increas
ratio
turn
may
help
control
inflamm
autoimmun
disclosur
interest
none
declar
introduct
parasit
worm
helminth
success
pathogen
infect
approxim
world
popul
caus
chronic
infect
associ
regulatori
immun
respons
helminth
suppress
antiparasit
immun
respons
also
combat
patholog
inflamm
includ
autoimmun
inde
region
high
preval
helminth
infect
low
incid
autoimmun
diseas
consequ
helminth
triall
potenti
therapi
autoimmun
diseas
howev
use
live
helminth
treatment
rais
mani
regulatori
practic
concern
led
search
identifi
specif
helminth
immunoregulatori
molecul
lab
demonstr
fasciola
hepatica
excretorysecretori
product
fhe
attenu
develop
experiment
autoimmun
encephalomyel
eae
mous
model
multipl
sclerosi
suppress
infiltr
diseasemedi
cell
cn
protect
mediat
cytokin
method
fhe
mixtur
mani
protein
small
molecul
provid
basi
identifi
characteris
individu
immunomodulatori
compon
address
fraction
fhe
sizeexclus
chromatographi
fraction
assay
vivo
abil
promot
respons
posit
fraction
screen
mass
spectrometri
sever
candid
protein
identifi
clone
transform
yeast
express
purifi
macrophag
treat
vitro
protein
assay
abil
promot
altern
activ
assay
effect
candid
protein
autoimmun
inject
mice
eae
candid
protein
begin
day
continu
throughout
diseas
cours
parallel
isol
small
extracellular
vesicl
exosom
fhe
variou
centrifug
step
test
efficaci
promot
respons
vivo
result
demonstr
fhe
protein
exosom
antiinflammatori
properti
candid
protein
promot
product
antiinflammatori
cytokin
altern
activ
bone
marrowderiv
periton
macrophag
function
studi
demonstr
protein
regulatori
activ
vivo
attenu
clinic
sever
eae
vivo
exosom
increas
eosinophil
recruit
reduc
neutrophil
number
peritoneum
effect
correl
increas
altern
activ
marker
macrophag
product
antiinflammatori
cytokin
conclus
find
demonstr
exosom
specif
protein
helminth
f
hepatica
promot
regulatori
immun
respons
could
exploit
treatment
human
inflammatori
autoimmun
diseas
disclosur
interest
none
declar
introduct
epidemiolog
studi
shown
lower
incid
allergi
autoimmun
diseas
develop
countri
high
preval
parasit
infect
attribut
induct
regulatori
treg
cell
previous
demonstr
infect
mice
helminth
parasit
fasciola
hepatica
treatment
excretorysecretori
product
f
hepatica
attenu
experiment
autoimmun
encephalomyel
eae
mous
model
multipl
sclerosi
ms
suppress
pathogen
myelin
antigen
mog
specif
cell
aim
studi
examin
whether
could
exploit
immunomodulatori
properti
helminth
parasit
prevent
develop
autoimmun
either
induc
autoantigenspecif
treg
cell
train
innat
immun
system
regulatori
method
mice
subcutan
inject
total
extract
te
f
hepatica
te
myelin
peptid
mog
mog
pb
day
induct
eae
mice
monitor
daili
clinic
sign
diseas
day
eae
induct
mice
sacrif
mononuclear
cell
isol
brain
analys
flow
cytometri
result
prophylact
treatment
mice
mog
presenc
f
hepatica
te
suppress
mogspecif
effector
cell
respons
prevent
onset
eae
interestingli
prophylact
administr
f
hepatica
te
alon
without
antigen
also
protect
develop
eae
associ
reduct
cn
infiltr
pathogen
ifnkproduc
cell
furthermor
found
te
suppress
lpsinduc
product
bone
marrow
deriv
macrophag
dendrit
cell
manner
independ
moreov
te
found
suppress
ifni
product
gene
express
cd
cell
stimul
interestingli
te
also
suppress
induc
express
cd
cell
final
pretreat
te
prime
macrophag
antiinflammatori
lead
increas
decreas
tnfa
product
upon
restimul
lp
period
rest
conclus
result
demonstr
pretreat
mice
parasit
product
prevent
develop
cell
mediat
autoimmun
diseas
antigenindepend
innat
immun
regul
find
suggest
addit
innat
immun
train
memori
lead
heighten
inflammatori
respons
innat
immun
system
also
train
becom
antiinflammatori
disclosur
interest
none
declar
introduct
ncx
nitric
oxid
releas
deriv
indomethacin
report
possess
potenti
benefici
properti
includ
chemoprevent
antiinflammatori
effect
howev
effect
ncx
inflammatori
periodont
diseas
yet
report
present
studi
influenc
possibl
mechan
ncx
product
proinflammatori
mediat
examin
use
murin
macrophag
activ
lp
isol
prevotella
intermedia
pathogen
implic
periodont
diseas
method
lp
p
intermedia
atcc
isol
employ
standard
hot
phenolwat
protocol
condit
cultur
media
assay
realtim
pcr
carri
measur
murin
ino
mrna
level
ino
protein
express
level
signal
protein
assess
immunoblot
analysi
nfjbdepend
seap
report
assay
perform
use
report
cell
line
dnabind
activ
nfjb
subunit
analys
use
elisabas
nfjb
transcript
factor
assay
kit
result
ncx
significantli
downregul
p
intermedia
lpsinduc
product
inosderiv
well
mrna
express
cell
note
ncx
much
effect
parent
compound
indomethacin
reduc
lpsinduc
product
ncx
exert
suppress
effect
product
p
intermedia
lpsactiv
murin
macrophag
inhibit
nfjb
activ
induct
conclus
ncx
could
potenti
use
host
modul
inflammatori
periodont
diseas
although
studi
requir
verifi
disclosur
interest
none
declar
introduct
strawberri
notch
homolog
put
transcript
factor
express
identifi
previous
constitut
strongli
upregul
variou
cytokin
includ
lipopolysaccharid
lp
astrocyt
central
nervou
system
cn
although
observ
suggest
may
role
astrocyt
homeostasi
regul
inflammatori
respons
littl
known
concern
function
healthi
inflam
cn
therefor
aim
studi
delin
function
gener
mous
model
cellspecif
delet
astrocyt
method
mice
flfl
gener
intron
flank
exon
murin
gene
flox
flfl
mice
cross
gfapcr
mice
condit
disrupt
gene
astrocyt
mice
histolog
examin
perform
brain
control
mice
differ
age
primari
cultur
astrocyt
obtain
control
mice
physic
molecular
phenotyp
cell
compar
mice
given
dual
stagger
intraperiton
inject
purifi
e
coli
lp
variou
marker
neuroinflamm
analys
result
offspr
develop
normal
display
outward
phenotyp
least
month
age
cultur
astrocyt
mice
neither
unrecombin
mrna
protein
detect
confirm
cremedi
disrupt
gene
morpholog
astrocyt
mice
indistinguish
control
mice
despit
increas
level
protein
astrocyt
marker
glial
fibrillari
acid
protein
gfap
aldehyd
dehydrogenas
famili
member
level
gfap
mrna
higher
cerebrum
adult
mice
compar
agematch
control
litterm
follow
lp
inject
express
variou
inflammatori
glial
marker
found
similarli
affect
control
mice
conclus
new
model
allow
condit
delet
gene
specif
cell
type
success
gener
initi
find
reveal
loss
astrocyt
compromis
develop
viabil
cell
associ
subtl
phenotyp
chang
overtli
alter
neuroinflammatori
respons
follow
system
lp
challeng
expect
insight
function
astrocyt
gain
ongo
studi
profil
transcriptom
cell
greater
interferon
signatur
medic
use
indic
factor
exert
differ
impact
monocyt
gene
express
could
separ
identifi
subset
antiinflammatori
gene
set
express
ncl
invers
correl
antidsdna
titer
rho
p
posit
correl
complement
rho
p
sle
patient
group
conclus
use
singl
cell
gene
express
identifi
uniqu
gene
express
pattern
reflect
major
clinic
immunolog
characterist
sle
patient
evid
bulk
cell
data
support
critic
import
singl
cell
techniqu
disclosur
interest
none
declar
